Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection (Bundle) - XML Representation

Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions
: Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection (Bundle) - XML Representation

Raw xml | Download


<Bundle xmlns="http://hl7.org/fhir">
  <id value="bundlepackageleaflet-enbrelsolution"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2023-08-16T00:00:00Z"/>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
  </meta>
  <language value="en"/>
  <identifier>
    <system value="https://www.minzdrav.gov.ru/"/>
    <value value="enbrel"/>
  </identifier>
  <type value="document"/>
  <timestamp value="2023-08-16T00:00:00Z"/>
  <entry>
    <fullUrl value="Composition/compositionruen"/>
    <resource>
      <Composition>
        <id value="compositionruen"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
        </meta>
        <language value="en"/>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><a name="Composition_compositionruen"> </a><p><b>Generated Narrative: Composition</b><a name="compositionruen"> </a><a name="hccompositionruen"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition &quot;compositionruen&quot;  (Language &quot;en&quot;) </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><p><b style="color: maroon">Exception generating Narrative: unknown extension http://hl7.org/fhir</b></p></div>
        </text>
        <contained>
          <Binary>
            <id value="image1"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image2"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image3"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image4"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image5"/>
            <contentType value="image/png"/>
            <data
                  value="iVBORw0KGgoAAAANSUhEUgAAAbAAAACHCAYAAAB3RgyLAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAAFiUAABYlAUlSJPAAADDASURBVHhe7Z2HWxRZvv539h+49ze7996Z3bszu8/esOlumJ2d4Mw4ecfJzjg6ZsesKAYUVDCL5JwREAURc0DMShDMgiioBFFJZsWc9f2d7+kqpyirq7tJSvf3w/M+XSdWF1V93nMqnPoJGOYp8ROGYZiWoLQlDNPuKIcgwzBM81DaksdQlFZqnLPRFtvU3v8nZ9wvDNPGPCd+N4yzoOxUiS4ooTijeObpwvuFYZoFG5gzoexU08bQLK2j0Bbb8LT/Ly1Zv76sM+xjhrEDNjBngvao8uHUtMU2Pu3/W0vWry/rCscAwwjYwJwJ2qPKh12oeelTW04Na+NUrKWpYaM0M9T8RmWM0rRxarz2Ux+vDRO24tR4bbqKNl2Ptpy1PGaYldfHacPqsjVpMYoj1Dhr6QzzjMIG5kzQHlU+noDirUmLWdhaGn2qUtHnNUKfx6y8tTRabk45wloaLdubl1Dzm+Wxha3yZmFbeQlr+WlZlYp2mWGeYdjAnAnao8qHVbTpRnkpTi8VW2la9GFb2KpPi9m6zNK0ULy95YzqMMtPGJUxw9Y6zOo3SyP0YcKR8gzzjMIG5kzQHlU+rKJNN8prVt6RNLO8Wiifmldbxqy8Ps1a2KgOijNK1+c1SyPM8hNGZcywtQ6z+s3SCH2YcKQ8wzyjsIE5E8pONW2AtGlG+ewtq0efZpZXxaxMS9alhu3NRziSRpjlJ4zKmGFrHWb1m6UR+jDhSHmGeUZhA3MmlJ0q0QUfo403yqOPM8tvb5o19OXtrU9d1n+q2IonaFkfNvpUMcqrxSy/Pdgqrw3Tsio1bPZJWFsmbIUZ5hmFDcyZUHbqYyhKLxWjOBVH0/Rx+rA19Pn0ZfTpKto4szx69HltLathFaM4Qp9fH7YXW+W0ado8+jL6sIpRvBqnxuvDDPMMwwbmTCg7lWEYxhVgA3MmlJ3KMAzjCrCBORPKTmUYhnEF2MCcCWWnMgzDuAJsYM6EslMZhmFcATYwZ0LZqQzDMK4AG5gzoexUhmEYV4ANzJlQdirDMIwrwAbmTCg7lWEYxhVgA3MmlJ3KMAzjCrCBORPKTmUYhnEF2MCcCWWnMgzDuAJsYM6EslMZhmFcATYwZ0LZqQzDMK4AG5gzoexUhmEYV4ANzJlQdirDMIwrwAbmTCg7lWEYxhVgA3MmlJ3KMAzjCrCBORPKTmUYhnEF2MCcCWWnMgzDuAJsYM6EslMZhmFcATYwZ0LZqQzDMK4AG5gzoexUhmEYV4ANzJlQdirDMIwrwAbmjNw9tkPZv8bU1Z2F1/hQlBw8psQwDOP83EPFuuUYP2g2evf1Q79+fujbaxb6TF2P0gu3lTyty+XS3VifU4SrYvlcVTFiNp7AfTyyJLYcNjBnxJaBEXnioPIYH4bLl68rMQzDMIyT81PFJp5d7DGwhw8fIilpldBKClkiW5Hjx2vECK8Cx6tqUX7kJCrLT+HM2Yu4cKER5y9cbr7OX8alS424ceM6bt++idu3buKWDVG+W7du4MqVK6IslW+BLjfirNiO2tozaKT6Ll/G9Rs38OjRI6fSQ5ZyJD897t69h+rqetTUnBb7pPV/o4xL4hwGRly6dA0TJkRibZZ9+e3h1u1bSE9fj6ne0RjQaxq6d/NBiH86/OemICoiA4mxy5EQs6xZShSKF+WpHs9xIXAbGYCxY0Nsyt09GBMnhiM2LhMLU1chJWEpUhKXNUupSSsQFpaOnt9PgZdHONJTV2JenEhLXov589cJZXVopQgtEEpjIT5uLSIjV0pFRVkUEbECcXFrkCV+M7nb9qLoQDkqj9eKTs150Um6o/wKWsapUw1IS9uAWbNSMHdugviMwbRpicjPL1FyMEyzcR4DI3buPAy34YEoP1qrxDSP48frsWZtLubOTsKs6YnYu68MO/KKMWpUKIJDlqKkpBI5W/di++Y9zVYOfYo6Nq7fifDgZfjjH37Av/zrl/j5z7ua6mc/+1p+fvGpF5Yv3oyC3CJs27QH20R9jmr75r3YsmWPaOyz0ef7WZg9PRnZa3dgUfoG2eiki8+OrDQh2pZMocUuKtr2zPSNCAtdIowjWShFo2TMmJGCgIB00ZHKRERQBqLDMhAeno4Av1R4ekRjzNgYpKZmY/v23Th69ASuXr2p/Epsk5GxBSNG+CM4eCHWrSvEyZO1KCurQFLSOowaGYjU5GyI8aGS2z6ee+45iGbhsWiEbRRnlldN12OW9qyj/e4deTscxLkMjMhcvAGBAam4fdvxHuRx0fscNSoSX3wyCW+8Mgz//Zs+6PKhByZ5RokfYB7WbygUo6Aw5OUVob7+PKpP1LdM1fWih3oa9Q3nRU94JX7zm1741a964Ne/7mkqyvPCf3wL3zkLUFd/TjQMp43rtyWx/pMnG0SP+xI2btqFwUPmip5xsTytWFNzxil0iiVVL46T06cvNNGZMxfQ0HAOFRW1OHrsFIoPHMXunYeQk3MA2esKhPlvQnT0GmE4axEbmymMKA3jxkVhwoQYLFqUhf37y9DY+KSh0Qhuuvc8jHcLE53KMhm3S3QuqeOncqK6Fm5Dg5C+cJMS4xhGjbStOFoWTYrTNe7a7XLWbbSC8xnY3bv3MX16ApYs2aLE2AeZQK9es9H5HXf0/W4mBvScI5bH4rVXhuCLjyeg8+ujMEOMUDzEj9fXN1VeNyovP9Uqqq6uw+HDlfjqK0/88pfdDU1Lrxde6Ia33nYTPeMD0gSN6rVXFRWn5N2c06YmIDIyE5WVtSKuxjAvy/lUWVkjVVVVJzpxdY87NjXiGKdOAKWVlh7HgQPHUFhYgvXrd4tR2Rq4uYUKM4vCmjU7xDF4Rv6OqoUx9ew5DdOnzcOtm7dkXGXlKTG6T8SxsmoZVjl6pBr9es/EwYMVSoz92DIrFX2cUR4j7M33rKD9vh3tu7cA5zMwokGMaNxG+YsfXZUSY86t27fhNSEa73YajRGDAjGKNDgIQ/v5ofObo9Cjqw/6dpuDzz/yxNChAQjwW4DiomOoEj92owbBUZFZUKMRFbUML77YDS+//L2haen1b//WVfSQV8rGpqWGQyOyTdk7MXFCpGiojsqGzCgfy/VExxZ1aqqqauVxQaLwkSMnsHHjLriPCcOEcRFISliBIYN8ZQfvzp07uNzYiO1b9mDy5Ah5OtGI2MjlmO4Ti0cPHW9w7TEne/IY0dFMQPt9O9p3bwHOaWDE5k074TMlEo2NV5QY62zZvAvvvzUKw/r5w21gIEb8ECA1ekgQvvl0Crq8NxZuwtS6dpmC3t2nyvP3G9bvwkll5HPs2MkWi0ZRWVk78d//3RsvvWT7NCKJRmFubkHSqKlBMarXXlEjVVp2Av37+2Lz5n2ykWqah7az5duqNoqWsKVxLC+vkcv6vKx2VrlF6j4yE43aaWRG14tP1ZzGzh3FmDY5Hv/480A5Otskfn+xkRkInJuKvLxi5Zf2JNeuXcOgAXOQn7tfibEfo4baVkOuxtGnaF6apOvTVGnr08fZwmx9hFmdttanrVNdjxqvzW+rHiPMylhLU9erptu7rhbgvAZ2/94jRIZnIiJisRJjzPXrNzBimD++6TJZGpZqXqSRwswG9Z6Df/xtKPp2n4PBYrl398l49z03ZGbmyNOOdP2A7rSqq2uZzp07j7KycnTr5i1HYUaGpdd//md3/PWvg1FUdATnz19AbS3VdVqRZbm+3iJaVtO1cVqdOXMOoaEZWL58mxjFnpH6Me2sTKdlSz3NEzV6ZFpUz2lRZ0XFSdEIUtg4P6vtRPuxulqjCqFjDYaGpZqcURqJzgLU1p7FnBkp+Ov/9cWChVmoEPnv3buv/NKss2z5FvhMjVZC9qM2mCr6hlOfTljLY6usrbARap3W6jWr0yyN0OdtzjqsYVbGWhp9mm1rG+G8BkacO3cRXl5RyMmx3rsrKqrAe++4YVh//ybmpTWx9zq747svhcENDsQHnUfjw4/GYunSrfK035kz9CxVo1jX5Rbp4sWr8qK6p2cM/v3fvzE0LL3oZo6XXvpeXnS/cuW6MLFG+ThBY+MNZfmqDFPdjY3XceHCFTSKfBSmh77pjrKLFy3p585Z8mdn5yEpabWs49Kl68Lgb8nn3fLz96OgoEhsKz2/1rztpfXTyC47ewdqRGO3b1cJ5s9bKToDG8Uoslw+F9fculmOifbjmTOXcfq0qkacbrCooYHC1CE6I4zJIhrhN7k2qoyYtSZGN0HRmYRxo2PFqGoubt2yXAOzxenTlzBo4FxRX9NrZPagbUC1n9o0Lfo4a/mN8onmqIn0dRtha33W6rSVpl+3vl576rGGUf1GqHUbrVfF3rqaiXMbGLFv31FhYhGorbNcZNYTF7sEn30wVhqVNQP75lMvfPr+OIwZGoJ33xqNnt9Px4KkVXLkdeHCNWEGV3Hjxg05mmuubt6kB5TvIDx8JX72s68MDUsv9Y7FtWsLcPv2bfmgc07OQWzbdgB3794RDUKNSNuJlSvzUFJcLkald7Ejbz9SUrKQnLwBW7bsw86dxaLxOSHXf/HiJcyfvwZTpsRi06ZdSEvbLMrmyJ766NEh+Oij0aIROy6vbxhtgy3duHFTGO1VsY5V2Fl4AFFBaYiLXiLv7iwtrTAsw2p90bF65Qp1UG6IY9ci6qxcoI7M+WvC4EjCzISpUQdN1dmzV4S5XURtzXnUHD8nb/og49Ia2QkxEispKUfXL6YgPna1XY3Xw4ePEBW2CNHR5mdLjFAbSG1DaRSnoo8zKqdfJozqsgd716fH0TRr9ZrVYw1bZShdNM0yj611NWf9DuD8BkakpKyRN15cv9b01vqbt+6iRw8f9P7Wx9TAen03FR90GgP3IcHo3Gk03EeGIjpyCSqrGmRD8OCB7dMk9rJ0aR7+5V8+f8KsjESjL7rhIzMzWykNBARk4PU3hooRTgMSE9fggw/cERq6EBPGhsnrDB+/Pxbjx4cjOCQDnhMj4TsrDsuWrpdlb9y4hU8+8cTvftdHGFagMLlVcHMLxJ49pcJgqkV9q8So7ZrM2xIOHTomT5ceKa1CVQXdGHAS+/eXtuWBztiAZrO5f/++6AjdFx2he/JYuHr1lhyJ02idOmo/mtoVaWYkGp2p5qWK7mhdsGC96PCMkXcx2kNu7gFxzIXK7+EIagNp1JDa06AaldMvE0Z12YO969PjaJq1es3qsYYj67a1ruas3wFcw8BodDJjWhyy1uYrMRbox/dFl0kY2GuOMKonzUs1sAG95+D1V0dIA3vnDTdM8U5CUPAi0fOsFT/wW2L0cles44H88bdEtJvXri7Ei//RFS+9bGxaWpF50Q0fEREZlvKigpXLc/DFPz0Q7J8K37lJ6PW9N4rEKHT5iu348EN3fPzPMThwoFxu/6mTdYgMSxcj1HgZJj7/3BvP/78vkDbfYop0Kqm8/KQYdT0URk2PKTx84ns7KmqjqC71k/yfllvjf8iyrVu37strU9TxItMyn9rpkTSVe/ceiGPgrjzWr127JUbrV4ShXZUmduLE6SajMLrBg+5Y7NlzFiIilyr1mENG5+4eJMqdUmLsx5GGUx+vDRst6z9V9GFrmJVrbhqhzyuaSrtGRfqwEWZl9MvqOq2FtfW0Aa5hYES1+JGNGRsifmgnlBhg164ifN/VG4P7zDU1sKF956LTq8PxQ8/Z+OcH4+XMBYGBaThcXC16ptfFj/gqzj8+9dJ83bx5D3miJ/rG64Pxi1/Yfh6MDOxXv+qOiRPDxPqviobpATIWbUSgMK4vPh6PPr1nIjYmA5s27JI96A8+HI9xY8IRGpSBwsKD4v8RCQ+PSHz11RQxIqoSI6NKfPqpJ/78+74Y0M8Xu3cehNeEWAQHZ8iG6tKlm4bf21HR/+zixRvy0yid1fai48Fy/fOaPH2onkq8fv2m0D1pVA+od2GFe/fuiXosJkYdQf31sBMnGrBw4QZ89910u27koNPLYWHzkZ3dtJNpD0YNpbU40aQ0aejVsFbaNG0d+vK2MFufWt6sTlvrU9PVupuzDmtYK6OPV8Pqsj6ujXEdAyM2brQ853T9huVU4vz5q/HNZ15Wb+AgkYEN6++HLu+Owbef+aD7195YsWIbPEQ9BfklOF17SYxSLqOh4VKLdfnyTezYUYTOnUfgxRe/MzQtrVQDGz8+RJS/KMtv2bILSzOykZG+HqtX52J7zh7s3lMqv2Nw4AJkrclFgP98jBgRAH8xStuyZTdmz04UppyMqKhMTPKMwFi3YISLUZ2/3zzMmZOMgoJDwsDo4r7x93ZUdfUXUVleJ3rd5yyNoDBfqt9yU4FxGVZbSfzP6+nmDcvNHHSty2JMFpMjXblCoht67kjjevDgoRiF3ZGdGmsGRiMwukHqqy7eOFhs36uO6FQ/TVvFdExUA2tHXMvA7t97gKjQxUiMXy7DAX7pwsC8DY1LlWpgn33ogc8+8MTwgX7Yv7cMPXrMwrZt+0VPs77JD7clotkM1q8vRKdOI8QIzF4D64FRo4JF+ZPyNMzq1XmIjFwsrynsyC+W0wOdFN+RTuskxS1HavJapCStxryEVXIURs/97NhRgpUrC7Br9zEkxCzHgL4zsWnTbmF8h5Cbs180QBU/3n3WClqxbDsWpmRh+/Z9cgaSPbsOo/RwFQ4erMSRI00bQlbbqqK8BieOncaJKqETFtXV0eMTF1Bfd1GYm8XY6PoXmZUqy1mHq8IAL8i7E40MrPTwcQzoMxOLF1s3JTp1vGdPGS5euiyO3XwkJKxWUpiOBhuYAa1pYER97QVMHB8uGufDcHeLQtdPp8BtUNPnv7SiU4s0Qvv808l4543RcHePEEZxGt9+O/2ZMjAyKHouzdd3ISZ6RiIkZBFCAtPgMS4cI4YGizzhiIxYLMxjK7wmRsB7Ck2JlYwgORoLxMyZKcjPKcKcWcn44tNJGDIkAO6jAhA4NwWrVuaKBspybcPoe9srMkGaENZvZjKWL9kme9th4RmIFt/Vf24acnJLcOjQ8VY1y7YSfcdnVUbf10zqA8xkQqqOHjuBimM1OF5ZD/mw8qkGobOoPXUeDXWW0Vt9/QV567zevEiW+RVPwFMciwF+C5Vf35Pcv/8ICfErERWWji+/9MH06alKCtORUE8bktrRxFzPwIg9YmQxc2YiOr87Bj2/mYZRtgxsgD+6/NMTb/59GKbPSBY/3LP4+mvvZ8rAqMdLc9XRlD10CzzNQr52bb4wsyj4+y/C8GFB2Czis0VcUPB8pKWtx1zf+QgXI1L3UYHCULZiU9YOLMvcjLHC9MaNC8OMaQmIF6O2goJiaWBG39kRUeNKjV3ArBTEhC0W32sBpot1DOg3G1Mmx2GbGJG11CTbUnLmiWrLVEotEe0r9bkqvSjNqExzZLQNjkprbGRI9PxXVUUdKsX3tOxP43KURtsTGLhAdKIilF+edQ6L0fewYWHi2B+JuLhloqPj+DNhjMvhmgZGZGZuwu9+1xd9vptpw8ACMVwYWOc3RuLDd9zlrAF0qmvixCjs3l3aag0FiQyMrtO9/fZIhwyMppOihp/mpiPRdzpcUomysuM4WFIhDPecaGhEj1o0KjQpK83cUVZWLSdRLSs7gQP7j8iJVemUD72409tbmMm2vaKuajkvolEPuyXat6cMe4WKD5Zj1bJtWJq5BSWHKuVNJNZGEE/b2GgUQt8hP68EwWLESBPWfvaZFz7/fJL4nIRu3XzQT8T17TEVA/vMxJD+sx9//tB7hkzrr2hw35kY9sNs0THS6Yc5Mq1Pdx/0/s5biD4dUDdv9Os7HZGRy7B/35FW7VxppZqaUZoq2o8kX98U8VuJVH515mRn78ZA8XujB+ZniGNwzrREuXzxAr3En2GewHUN7ObNO/jmm6l4v9MYuA00NzAagf3p9/3xVRcv7N1bKnQE0+k9YXvLWtXAamrOYtWqXLzyymC7ZqVXDcx9TKgof1L03mmSVYsBWHr0lhnGKUw9e0uv2BJn6e1bPmkbKkQ83Tm2TzR8NLosEcZHDSDlsWYqzRWtT1W5aAjVZfW76yVHPsJAaM5Eo/S2Fs24cuhQFWZPTUaXj8bhzU5ucqTw1lujHuvtt0fhnXdG4733xuD3v++Hl1/qjj/+oQ9+JToib77uhs5vj8E7ndzR+S139Pp2OtyHBsupy7QaI+KG9fPD119MwaefCnMUxuioPvpwPP7yh/74+N3xYsS9DzTFk9E2tbXouKIOkMe4YDk9mT3Qg/MREZbb7q9euYGdhQcxe848+HjFYEnGVnmMMIwG1zUwol+/ufgvYQB9vp1h9TqYamAvCUPp+qWPnDOuoOAgZs6aJxt72Qgb/ICbo9OnzyM2dhWef/5LQ8PSiwyMngPznZ2MSsWcjOq1V7QthYWl6Np1qhyhUSNklK81pfbUjdJI9J2Kio7J1+Ps3XtUGrFRvrYSrb+4uAIjRgTD2zMeWzfvFqPSI/I66Jkz5+U+U0VvQbh0qREL5q/HgD4zsGL5RtBbDiLClmJXzlEUbC01Ve6GEpSXOv4clBa6DT4+fhX+/eddhRFOxuHDFbITYrRtbSk6dg4frsIPfWdh6ZLNyrezziPxtyA1C+kLNygxP1IlOi7Tp6bAxydKiWEYiYsbWH8/vPaXYXjnVZoL0Vde79IbGM1CP+D7Ofi1MIthwwNEo3VBXkeKDEmXp9tas5GnlwtGR6+weyopdSaO8IBFqBLfo6UjJTKHLVv3Y+y4CHkqsrVHXo6KTtnR3Hrh4UvkaShqENvTwGj7q6pq4OUVhxkzkuQDvfZw8cJlcXykoa72LI4eq8aUybEo2HIY+ZsPmWp7djGOlNBzivatxxr0DNcrrwwRx0h3JCVlyZkxjLavLUU3d1CHg06vHj1q25TpBbQRYelYtSJHiXmSE9Ute9M643S4toENHxSMLz+ajA87jcHHnScIAwt+wsTIwLp/6Y0//qE/oiIXy152etp6xEVnoqy09UYp1FiePFkv7yL8ueg9GxmWXuprV1JFj59GCi29TkTmsGTRRkSEZ4iw5RUrRvnaS3TnG72wc/jwQGzYUCgfEzDK1xqymJXYl5r/Id3VmZGxEePHh8nXftjLCbEvQoMXokGMyvbuPYRpPvOwQxhY3qYSU21bV4Sy4mo8fGT9AWI9ZWWV0iy0nDnbiB49pmP06Ah4eMSKY5Zm/W/ffUmno2Njl6F7dx/5kllbnDt7CTOmxqPIzmfGGEbg2gY21TMWXT+ZhEF9fNHru5nydKHWvFQDo2fA/vbnQViWuUWeKgoJzUBScpZsFFqrYaDGs0KYhpf4TvbORk8G9vLLPbF8RZ58IWVLDMzSgNch0DcVi0WjTacjn+aNE/T/oBtPZsych+CgDNTWtuyt02aS+1F80o0s6v6k9dNdnWPGhIvRqP2n9egW4qDADERFrcC9e3cRKkZiqfOzcaCwErtzj2JXzpEntHN7GQq3lspRWE21fXMHqtDraKZOjRMjmHsyfOvmbSxYkA1//4XymcDZs1PkowvtcTpYFf0P6S3j3/eYJu8otIei4goMGOCHu3bM2sEwCq5tYLOmJeLLjz2lcRmZF4nuUHz3zZF49dXhyMs7KAzsgnymav78DfKuwdZq5GkEdehgOQYP8MULL3xraFh60Q0c//u7fvKFgS29WC8b8YpaDBzo9/iFlkb52kt0A8nKldsxeOBceQ1Kjo4M8rWGToiRVlrqeowbGYL83CK57XV15xAWtkTebbh8eR6ysnbZJR8x2nrllf6YNDkKHuPD8fe/DIH3lGQEzspEXOhqpMSsQ3J01mMlRWUhLXkDlqRvReq8DcLsNsk3CBjVbST6bt27T0Fg4CJs3VqEiJBFGDk8GPv2HRPpO8SIPhWHDx9vNwOj2+rprtdlyzajy0fjcerEOeXXZs6qFdvh5ztfCTGMXbi2gUVFL8HnH3nIB5WtzYXoJuL/9pdBePW1ESgpqRI/0hqMHRcpZw2g6zNGP+LmiE5X0fNW77/vjl/+0vYt9CS6U/GrzybK2+DpTjmjeu0VNdr0XNuECRHy5pSnceFfFZlVcXE5RowIwuL0TfJ0lFG+1pBlpHcK4z1i8Pvf9kVE8OLH5j1xQgy6d5smOiwRGD48xC65uYVh7NhoefrOzS1cLruJDs+Y0VEImLMQ0cIUI0MyH4vWl5y0CplLNmJe4mqMFfmGDTOu20i0jpEjwvDWGyPQr58vFi3aIB/zoFPddD118uQEeWyoI8u2Fq2rtOw4vvpqEoJD0vHgwSNYXjd0U/zijB9wvXH9Dry94rBrh/U3NzOMAa5tYFlZ+fjiYw8M6UuT+RqfPhzQYxb+9sfBwljGydN09HJMvznJ2FlQ0mLT0IrMcPXqAvz2t70eX9uypRde6IaJ4yNx7Gh1i0co9DZderA4JmaFMhpr32smWtH/Ii5uBbw8okFTS7X07kozWW7Rr8X0mUn48/8OEKOgbHmtrUA0psFzUrB/TykuXboiR972iG7yMRKdeqabKWpqz8j/tVY0kqcR9CmxXssdjU/Wa01nz17E+XOXkJy4CtNnJMjrqDQCys8vwtChfmIktL1Nrx1qRaO8UzUNmO6Tgh7fTRP/N3q56i3RIarAgQOV4v9wCUaTNBw8SJ2VAPk+PIZxANc2sNLSSnz+8UQMkq9TedLARg0OQtcuXnjjr4PRv+9s1IoGKDFxLebMmo+jR1rvugKZBfX6Q0Mz8bOffY0Xf9FNPshspheFnn/+a1nGcv2r+Y08jbboIeKRIwOxalVeq44sHRU9pkATGg8ZMhfbtuyRpxKN8rWmyMB27jyENat34PDhajkazss5gMiAhdhV2LodlbYQfb+SQ1VwGxmM5OS1Yv81YKYwZF/f+S0+tWyv6LdAxpkhRsyd/jEcUyZHYeXSzXKey+KDVdi7twK7d1veuq1n1qwkJCTY99oVhtHg2gZ2+/ZdfPLRRPT65skbOCynFIPwzptj0PmNUZg4NlL2lCd7JcJvblqr3ppMoye60D5lcgz+748D8Le/DMYrwjTN9Nc/D8Trrw3H2qyCFvewaRSQOG8NfHziRANeKQ3NKF9bixpBGkFMnBiNoKAMacxtOfpSRacQyQRodETro+2n07Le3rFYu3aHbJjpuz0t0fFxXHw/+o7WdO7cZfnaHI8xYZg9KwXuoyPkbPBtvS8t1wvPiu9Qh9WrcvH+26MRE7saZ8WocOuWQkybEovoyMWig1QtDYxmf6EZ7VXqas5i+LC58n/MMA7i2gZGrzIfOcQf33ShW+ibGhiNvvp0m4nOr43GJ++OR4B/GvbuK4XfnBTRUOyUr043+kE3RzR6Onr0pJyrcM2y7Vi7wrYo3/p1NGKoko2cUb32iBqgI8I8J3vFITlprTCz9jndZCQyUnqHFE0kTDOUt+W1LzPR/qCJa2fNSMWQQfRG6iNy/9Bbqdtb9EA5TbNVWHAQ+WJUmJ/bVDtyi+Tn+g2FiIxagQ/fHYP33holzIKmkmqb/x8ZKnWaaH/R27rp7cs0MfQnn4xG374Byq/LQuPlG4gJX4KoiMU4eqxGfK9jmlHYQwT5L8D8lNV48ND+RwcYRsG1DYzIzNwsRlhu8nqXdvQ1alAwunwwQWi8MDgvxMWuQGrqBowaFYrKKstowejH3RxRg0m9aGoQ6kRP1B7R6UxqoFpy6pBEp8tSU9djkmc0jorGsqXX0por2v5i0TsfNSIYifFr5V2ARvnaSzRZbakwDpps2FP8b/z8FmDu3NSnI9FpCvFNRYT/QkOFiTxzZszDlCnzhIktFcdoIDZmF8j/qdG22SM6rlQ9HgWKzg6dXqYbbBYt2ggvr1hMmkT/m4VYvHgLli7bgmGiQ3ha7DstVZX1CAtJxfbt++WpRHp/GLF+/U4MHDhDXsdjmGbABlZbew4fdR6H3prppEYNDsb3Xaej0xsj0L/HLGFgnvJVJD4+8YiKWiaNxuhH3xxRA0HPO2WtzMWS9I1YnrHJpjLT1mP1ilx5V2RLTrFRA0cPjo4bE4a01GzUtOJ2OSL6H9B3iYtbCc+JkTgutqk1OwjNFc2/eOTIcfmGAJqjcs2aPKF8Ocu/o6Jb2h3VunUFUhuyd6Iw/yD27i7F3l2Hpeja0mPtPIziA8fknYeNjdeQsWiz6AiEiNHbSXnamzo6epEZ0f/YmizH5Ul5rZfmgSwsPIwlGRsx2TMWw4YHIihoIZYs2SYfcbh//8fRU1JCFiZPiMG169eVGAurVm/H8uVbRJ11uHjxKnJyiuUEyDk5+5QcDOMwbGD04GlC3Cq89spIDOnrLydVHdzLFx++MxZffzEJg3r5ocv7HvCdkYT+/X1R1oo3b5BO1ZzFiiVb8eZrI/C7/+2H//vTD6b60x8H4Dcv98DoURGiV9z8mzcsplEne+z0lurKCkucUV5HRIbqqOhGgx35B+RNJDm5B+TokhpYe0TGR+WtiU71GolGnnLEK9ZlJrorkE55XbhgEY0WyOjJGOxSDX2ellN9HTt6EuUGongjHSqplPNAkvbtPyofb1BFs81rRdfs8vOKsWnTXmF+BejXdyaC5qYjf0cJNm7c00SbNu0ReQqxcmWO1IoVFq0UnaJVQhS3aOF6LEhYhUD/BWKU5C/2TQhSkldg+7Z9Yp/VyzkXjbhz5z4C/DPg4x2D6uO1Tabfolvpjx9vQNK8VXKGDnpjOMO0ADYwgp5TmTo1AR+/OwZvvToU//VyL/zjLyPk25o//dBDmEUQhg8PwOLFjj2TRA85k9nR6Re9KJ6uI9BDpp9/PgXPP/+VfP6Lnu2ypl+I9J///Gt06uSGjZt2yVOJdKPDk7Lckk31WxPdgr112x6xXUHYKxrABhFWy1Ca0a3gtkTvSaMbIujWd7pmpBdda9PrqMhP8wVO907AVJ8EFInvsnvnIewubKpdpIKmovj8/GJkZxc+Hq3olS20wUDrxAgnJSUb8fFrkJCw1i7RHagx0SvlCxiTk1cbKAvzdUpNXofkpNWIi1mC+EhjJUYvwTyR/lixQiIu0He+vJNQL3rgN0in8ICF8BgbiZ4952DAAH/06TMHb7w+HJ918RLhANH58nusPn184eOTKEa8mYiN/VGJscuRFCu2L2oZFqdtwNate+TExbW154Vh3Woy0jLjzt17SBbmN3Swr/j/LhOj1kJs2LAH6WnrMHyYH8a4hWL//sNKboZpNmxgKnfu3pa3AE+elIShw4LkHX6v/X0E3IR50Xn++PjVsjdOjTudqrElyku9fHrDMD1Y2lRVoHd10buOhg4NxC9+0Q0vvtjtCcOiuBc0oimm/ud/+mHa1ETkbd+LbZt2Y+tGnUTclg27sCh9I1IXZMtphfRKS8tGyrx16PHtNIwfFy7nP8wQPW5SWuo6TJuWLK+neHvbL8o/eXI8goPTEBaWjtBQrdKEFiE8NBNRQpEaxYnGcvb0BLzb2Q3BQWmi8VyK2AjRoOqUEJ0pGnbRyMY0VUz0YoSHGytMKFIoRqfY8EyEhaSL75yICRPi4elJ17lsa8LEeEz3ScaC+WuxbPkmLFmyoYmWipH0Sr0yt2LF0q3YLvZXcfExaQh6lZQcEcfJk6qurhGjvka7dE6MEq9du60czRYyMzZgnjCQpwVNhJyUtEYcF4niGElETOQybNm8E3fv8Q0bTKvABmbEw4cPkJt3ADNmJOPbbyfjT3/6Ab17+2LIkCAMHBhgl34QGjk0BLNmJsLPLxlz5yZplIyZU+ehX78ZePXVIfj734fgtdeGPaHPP5mAbz73wtefeQpNxLddJwszjRGNwirMixO95YRlSE1ahvnznhSNCBYsNDawdGFYgf504T9FGh31theJ+AyRnz7j49eKHvka0UNfa7co/zxhitu37xGjon3IzdVqr9B+5OcWo1CoQFFhXjFyt+1Ht68nIW3hRpw4qY4g65qI3oJ88lQdamqFan7UKaGGhjPyAdg7d+4J3X1Ct03k7Fy5el3OrEKnDRnGCWEDM4N6tgUFh5GXV4KcnIPYtq3IbtG8dAX5JfImgPKKkygvP9FEpYeqRc9bpJXTdaAnL6KT6mvP4ky9GM3Vn5N3dp09cwGNjVflzBAXLzbi0uUrInwFl5uoUX7ev28+KeqdO3dEHksjTpMjSBlNk9DG0CMJoSEL7T49xTjG1q37RKcnyvABYobp4LCBMU8Puolk6tQolB+jd2AxbUVEyGIsXbzZcBonhunAsIExTwcaIdL71RLjVyoxTFtx7twleI4PFx2Flr3tmWGeMdjAmKfD7t2H4DkhHJfONyoxTFtCz695eETjHr9vi3Ee2MCY9ufmzduYMycZ69cXKDFMW3Pz5h354svNm3cqMQzT4WEDY9qfrKxcBAYuxKNHPz7kyrQ9x45Uw8sjHHX1Z5UYhunQsIEx7cu5M41wHx0oH/Jm2h+aBSMsZBEePuDOA9PhYQNj2peIkAwsSF2LR1bezsu0LWfPnscUr0gU7ihRYhimw8IGxrQfNBPF5CkRaGi4oMQwT4ONm3Zi2rR4XLp0VYlhmA4JGxjTPly/cQOzRKOZs5VnhXjaPHr0QM4Mf/z4aSWGYTokbGBM+7Bk6VbMnpXEM248Izx48ID3BdPRYQNj2h56hYa7ewgOHapQYhiG0fGc0uQxzgQbWMeGevoxMcsQGpqpxDAMYwAbmDPCBtaxOVJ6HFM8I3H1atM39DIMwzgrin2xgXVkrjTexKypCcjdvl+JYRiGcX4U+2IDay53r15E2aHjKCqi19JbdKC4GpWnrqK9ZsMrKTmG+LhluHv3nhLDMAzj/Cj2xQbGOAfiULYpxpznnnvuqbyzzlGe5e/Zku/WUf7/zwLi92yBDYxxBsShrCxZsBVmmGcJMi86RtnA7EP8ryywgTHOgDiUlSULtsLOjjP15l1lZMIjMPsh75KwgTHOiDi0lSXXhA2s48EGZj8W9xKwgTHOiDi0laUfUePoU5uuhrVxhBo2SiPUeG2auqyP16Km6dPVMDVktKw2ZmpYG0eoDZ5Zfn0ZM9T6tMv6ulW067C3DGFUTsVanWqcGq+uR4utdarlrOWxhnb92jrMwmr96rKaR43Xok3TllUxKqvGacup4YcPH+KnP/1pk7AzIrbNAhsY44yIQ1tZskBhVVqshY3y21pW81vLR1gLq+VI+sbKKKxvxLRp+mV7UOtztG512VYZwixsbxota9dB2KrH1veyhVGdRmF1Xdpls/Vqw9qyKvp0a2kEmZbWrPRhZ0P8ryywgTHOiDi0laUfMYrTQunaPPr8ZmkqRvFmeW3VqTZsWtnTqOnT7MGsvD11G8Xry9m7LVr0afo69eXM8hNGZcxwpD5ry4RZGtGSdDYwF0Bsrqlag9aqx17ae30dBaP/i7X/FcWrado8+vxGYVt5CLNy2jSjskYNmYo+zayBswez8kZh+r5meQizOrU4kmarTrP8hFEZW6hlrH2qaMOOpBGOpBNqmD7JrFTTcnbzIsSxZ8EVR2Bis5WlHzGKe9ah79wRv3d7YO8+1sdpw2ZpWszKEPbWaVTWqCFTsdag6Zftxay8tfpsrdNWuoojabbqNMtPGJWxhVrG2qeKNuxIGuFIOqGG6ZMNzIUQm60sdXzs3RZn2mZ7MNpeW3G0rA9rsZamX7aWRjiSl7DWaOmXCaM0fR4zHK3baJm2wZ46CGv1EEZp+k8Vo7xazPLbC5XRb5s2rKKt29Z69XmpPmv/P31ZQi2jxpNxUdjZzYsQ22mBDaxjY++2ONM2m0HbqZc+Xos+Xhu2Fm8UVtGn61Hj9fm0stZQadP0cdbC+rqsoS2vlVndaliF4m2t21pZwqxeNc6ePFr0+a2Vtwcqq1+n0XfQy2y9aryaR5tGaNON0JdxhdEXIf4nFtjAmoZpWZW1sPqpLmvRxunzaqWPdwR9HVrUNG28Ns5aPNM6uPL/0qgBZpi2QPzOLLiqgemlxVrYKL9+WQ2ry9p0wlbYFtr8+vrN6jZLI/Rhpnm48v+RDYxpL8TvzAKPwIwbHTXOkbyEtWUVe+qzhj31qVC8Nk2fT03XimkZrvy/VE91kdjEmLZGHGcW2MCsY5TPVpy1ZS1qvLV0axjl18dR2Kh+o3wMwzAdEdF+WWAD+xFtvLqsz2tU1qgcYZSXUOOtpVvDKL/Z+uxNYxiG6UiI9ssCG5gFbZw+XZ/mSF5r6OuxF3392nqM0lT0ebRphD7MMAzzrCLaKwuuZGBic02lz2MtrH6qyypqnF5GWIu3B2292nrUeG2a0bKKGqePZxiGeZYRbZYFVxyBtQTxL1OWWkZr1cMwDONqSPMi2MAcQ/zLlKXm0xp1MAzDuCrSvAg2MPsR/67Hag4tKcswDMNYEO2oBTYwhmEYpiOh2BcbGMMwDNOxUOyLDYxhGIbpWCj2xQbGMAzDdCwU+2IDYxiGYToWin2xgTEMwzAdC8W+2MAYhmGYjoViX2xgDMMwTMdCsS82MIZhGKZjodgXGxjDMAzTsVDsyzlQtolhGIZxAZSm3zlQtolhGIZxAZSm3zlQtolhGIZxAZSm3zlQtolxcZTDgWEYpuOgtF+Mi6McDgzDMB0Hpf1iXBzlcGAYhuk4KO0X4+IohwPDMEzHQWm/GBdHORwYhmE6Dkr7xbg4yuHAMAzTcVDaL8bFUQ4HhmGYjoPSfjEujnI4MAzDdByU9otxcZTDgWEYpuOgtF+Mi6McDgzDMAzDMAzzrPGTn/x/dPq9fQhL3nMAAAAASUVORK5CYII="/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image7"/>
            <contentType value="image/png"/>
            <data
                  value="iVBORw0KGgoAAAANSUhEUgAAAXYAAAEHCAMAAACN/p0zAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAL9UExURQAAAP///wAAAAEBAQICAgMDAwUFBQYGBggICAkJCQsLCwwMDA0NDQ4ODg8PDxAQEBERERISEhMTExQUFBUVFRYWFhcXFxgYGBkZGRoaGhsbGxwcHB0dHR4eHh8fHyAgICEhISIiIiMjIyQkJCUlJSYmJicnJygoKCkpKSoqKisrKywsLC0tLS4uLi8vLzAwMDExMTIyMjMzMzQ0NDU1NTY2Njc3Nzg4ODk5OTo6Ojs7Ozw8PD09PT4+Pj8/P0BAQEFBQUJCQkNDQ0REREVFRUZGRkdHR0hISElJSUpKSktLS0xMTE1NTU5OTk9PT1BQUFFRUVJSUlNTU1RUVFVVVVZWVldXV1hYWFlZWVpaWltbW1xcXF1dXV5eXl9fX2BgYGFhYWJiYmNjY2RkZGVlZWZmZmdnZ2hoaGlpaWpqamtra2xsbG1tbW5ubm9vb3BwcHFxcXJycnNzc3R0dHV1dXZ2dnd3d3h4eHl5eXp6ent7e3x8fH19fX5+fn9/f4CAgIGBgYKCgoODg4SEhIWFhYaGhoeHh4iIiImJiYqKiouLi4yMjI2NjY6Ojo+Pj5CQkJGRkZKSkpOTk5SUlJWVlZaWlpeXl5iYmJmZmZqampubm5ycnJ2dnZ6enp+fn6CgoKGhoaKioqOjo6SkpKWlpaampqenp6ioqKmpqaqqqqurq6ysrK2tra6urq+vr7CwsLGxsbKysrOzs7S0tLW1tba2tre3t7i4uLm5ubq6uru7u7y8vL29vb6+vr+/v8DAwMHBwcLCwsPDw8TExMXFxcbGxsfHx8jIyMnJycrKysvLy8zMzM3Nzc7Ozs/Pz9DQ0NHR0dLS0tPT09TU1NXV1dbW1tfX19jY2NnZ2dra2tvb29zc3N3d3d7e3t/f3+Dg4OHh4eLi4uPj4+Tk5OXl5ebm5ufn5+jo6Onp6erq6uvr6+zs7O3t7e7u7u/v7/Dw8PHx8fLy8vPz8/T09PX19fb29vf39/j4+Pn5+fr6+vv7+/z8/P39/f7+/v///4IkaMUAAAACdFJOUwACmJ2sFAAAAAlwSFlzAAAWJQAAFiUBSVIk8AAANO9JREFUeF7tnQd8FNXe9+/jfd7nve997/s8t3gVFaQLiFgAESzYsVwLNkRFEFEQEClKkyI1FOlIr0JCkSIthBJ6h9AJSYCE9L51+mmf939mZpPN7gayk90k5Oar7Jw5M7vZ/c05//P/nznnzB9YDRXPf9TIXhnUyF4p1MheKdTIXinUyF4p1MheKdTIXinUyF4p1MheKdTIXinUyF4p1MheKdTIXinUyF4p1MheKdTIXinUyF4pVAnZyV0A01+MV9hyzE1Z4e82k1WdqlLadb08L1z+4NGvnJmu6lRJ2Y2ETjA6wrnBnF6ZVBnbXqR2UUInGB3h3GBOr0yqlOxFwpnmwsve81wDjykxMz3HYMPP9MrRKT6LMvZH+ke+qQJUrdJuCmcmPLuefzq6jsUHzI2eNHY9OTrmDt9wzUH0P1YJ3auM7CBNUXnVX4y0nuLwbB3PMSPTszGPFOcYFCUYL+e65FVC96olu/FiqKXveVJeFB/z7Hk2Rq6ZY+DZgXIOctfI7k84ZeebGtkDo0tk6MRf4Z/+v3EljHxO8TGvjZ4E2+KVo+M5ZBqZGtvuj66V8cIF1IGNue/ByIR9M9NzjGeXOGBg7MArd2JqPJlKoWqUdE6N7JVClZC9gtTQ/faqQZWQHZvbfx+qhOzE3P77UFVsO9IoJWGDIahQqqqoCjL/XiVTRWSH8h5OsytKRCIq1hCqIhWrqpT28EKrjAtj8u8he5WjRvZKoUb2SqFG9kqhRvZKoUb2SqFG9kqhRvZKoUb2SqHqyo5EJlfbPrKqKzsp1Kpvz2TVlR1jSlUzXe2ourLLWh62melqRxVuUs/PUwUzWe2ourLTfdPcVa2/NmRUXdnFBbuoZKarHVVX9oKuF1iema52VF3Zs99KYDWlvcJJ+ixd1qqrca+SsiMC/18c7Fad1TVgqqqyY7Z7MWGimVHtqKJGBjM2fDcEqtV1vFjVlJ0qTH7zJNNIjZGpQDCV2Y2OWcypmRnVjqopO1HU0/0czFZtx6RWSdkVl0aOT3eSatslUzVlRwLFszYzhHAVGSkacqpmk8qYs/NRhiiqrsa9apZ2hG2fn2OU4poo1QIUBKSaejjJ2PNoiDVMKKOlO4eSpOZ8dZWxaus/hk92JCCCnbIqHb8wbB+TFESoDE2k5HARqipyZuyKy+aZ/siicnmiy9yploRLdgqFWSFM2LE3/tKOTKbxok4JIgRTNWPvlqT8I0sTzVP9gRqyZL2Zrp6ETXbVjZGwJebiDZpxNZ9yu8I0FWH59Naz1y9dLMA0Icc81R9NZL3XmOnqSbhkVxl17tsTl61ieZ+TahoUf4Rvrt+ZlnU1n18CwZFZuldOifzxXjNdPQmx7ObcIHjN3LErsZBpCnaccyiMaM64HZezLmVLmIKhUTWSfbl02QlK+SDNTFdPQis71giSkUNDBXtiE7Iw4cH9llNO5/klR7LjLxcPv6BE3Q2eSmloJKFnoZmunoRUdioyVYC2NGv70bhUhPnkO6ztXbXubHqSE6myd+wj7kw2UwHQ6L7lVWUqY3gIrewqmBd79qHtV5waVcBnBKvjTr0c72LcnJeI9MnVAjMVAM01LLp6T80OsZFhTvvu2AuZqiphVVYRZUQSkMqvASZC8Q1pqtF0d+m6Uuf7O8xkNSV0snPPXMqLPpgMxVjWENJUvUuFyIgIGhh9VTc6BlS2HcsgEKoGnvdOpC7V25EJneyUUjnn8LabCnIzWfEK6yFsUpFMKIEIiqqSKEPoRLF45CRT4EIo5lklsQ28UFHLblQOoZKdEu1a7OHsdBEMCAPr4i2arKsLoSehGCFMCIRN1L1XN+6BxT0z2aHKZrpaEjoj49y1PtnpkrjloASsugeXIGbYkUIgl2fyUo+wQ2Rrj0FNCGhjGJs/m1XbPl+dkJV2RCU7cl7fetTFy6mX7Ee3pB5avjn2bIaoCFDMua2B8o5Z0pFc3gYHpP8qM1FdCVlpJ+AuQjG+cd0W81uGIpjFGIxN7o7ThcnXUtJzbYI7+fCGFb9Gn892ye5CV+xxFLhFZUrXvbRa+48hNDJ6HyNPOPKyzm0+7ZSwojIEvnry6SJ7oQn2vMys9NT0rOtxh37fK7HA9zGE7mdkPcKttoRO9iLAW7SlZCeu3OW0uzF2SO7L5336zjGiSCzMhjZVDVjcz46xV9uBSQZhkJ2vVERlJSM9aeOOm5LbxRz7rpmHAKJxawSFnDewOPDY0sULGKm24/B0wiA7l1ZzI7soZuYXXtxwwJZ7/EKxiNCggtTguvPmwKvl9WboYoYDO/TVhbDIjjFxqqKKVUalgrzk2A2R8SX0NTxJfgMqML2WUuUWt1qrAWGRXcfsegeRbekJWSplmsr7hRWIYEvvXKTICYan125ElMAVoZoQPtm90GRJknmPGI9QZe5omgf8oMiBcOGwq6SUXoPqQoXIDkVf44YFTDkUeFGjpUegVCRs31Q370OuzoRfdt1YCCq7vnpAx45DovPZrRdjVDU2bRa71ZWpDlREaQfbQpPHPtnqrQ8/frPRS4cxH8lRGkST2fczmPsW9r86UAGlXSMK29fhnuGHYtMZ2/pMox26214KqizjL3eBOQpriwoFAV7A7iEFvowGgQakCcYY8bCZIAJ5Yf0C4ZfdqSF24tHOeyLn9Ju1c1N6Trc6B0vpiuFIIs0deN3cCRcUqUgVdTOmMlmEFp6qAm/pVSOqgIugd3WET/nwy44Eh9LpsbULJ+Yg4fzk0Usy3m1wxTwUAFFge2aGv6udCypnnDt8cN85EBmcXXBYKS4u4YoApR+Fb35mBciO6ZhmqyL2u+0OxcauzdgQ9VSv0g23qrK588x02ACjoh6d9s3Lde6r9Zcn359wlgd4GuKdns60c6fOJEhwXTRV470cYSL8smvs+H3frL/InKJAJJVJkYsiH9pkHvMHMxQx2UyHD9vGPg0f+mTA3JgDv01+tdmTUxyM8E6g85Pfbf3gvbWbf/jdlH3hrXFhlV0FJ5xQ26udj01MJkjgkSpWXLtPvfIetF98PDXUa/NUD7KCB4ertBMIHjRNY2jVG3XeW2iM/gYSf3q8w2EwO44h9Z/tN37Bol9GDXq/6T2vD90DoQPFKiZQX+Gby9ziB+4xDZ7wyi5zXX9udti50q2ILi4xeDVb9/xSd5txgv+8AVnWfog20yGGUiI7FYVd6dTo9TUOMw+DOXHsf7fuVpb3zd9nxBuxMbWd3fB18wc/npcCTS3SJDA6qirDf9DehqZHOqyyw29CLO7+kcx2QDNvacC/TREFz3ynxE7rPybWzSQf3TG9Pj7eTIcYcEr5ENglTV9e5mCqW8/jlY4SlvBp8+Ujam3gjavskTVtcecHH57B1/hQHQUiXA/J7lRoaZ2mQRJW2Xl3ltC1QzpL3YkFUNz4xocGsImtuzR57KlmTXpf0nNKsG1SmNbVwDzyje9xf/80DQqvYS10H5FILLfvX+tOYqKkaQTO4249mHpnbL97no2O6dPx+Sc7duu/QR8YXmJEoXXCXNoxi6q3jdHrvcdMmTU338jdM4Kt+usny8/b05Y987yZVwRhs0eYyVBDmMIuPtZsp6MQyiwhpn5guTVJxoUD3zwFcvPqqCk8VkIOqJ/ofNc//+PFkZuWjOjT/u5Hvo7K1qtrCAiH7LwI6YsJgpHJe6aLCzyHdau3bY1aepoJxMX2zGNLv7fxzhe2r34PvdRhZC4+SBHp97OeCjEQf2KNpXV46ii08gpTi/qVQXamgMXRdi7LpQocNKwIxEuUuiVm29DpJ8QQkzJjJz9d95UpEGhzwMjrkRU/i49AMXLLTmhl53WXYFmBLw919PKGQV2f+/s58xgjp6ZudNjV7PUX2NzVTHbzoanz658hThnxMRyGEEjrvkU/O6RQoqmYIvzZA3GED9gxs72hwqFfkvllJ+B+eVDhbNuqfpeYyC1+/rZhjWsNuAzXUGNEFDC0A2DzqeQGFy1IQiu7LEkS/4LqzfU/vN+hTcNHanfbbTjAhDdVOdPGiCxqIcMLNjNFopLICp6ZxGSsahh77uLZR1wwEqEEgehMYoseWIBBIl7P/ECKui4imamYScWyC/CLmBz702Fo+vlQKnJq6CPNRkOQjSWZEPitsIXTZKN9DoLQys4bQ8e1lV2fqv/wI52X77r0+4hEpnecE4yRorHC6aMj598gaN0BUIJqVMVftQbrjhhRPfX0xMRbDAW2CngwELb9Xmc8dkK55l1f/mDkXD8rBcqHuc8BP59/7VNDYhRVNozJ1Z8a3T8/W79wSP/c7POFyK6fHQQhNjI5235o36J+6yEbDl6Db5S54Drirhf8JnB4VU1k0uyhV6BE7TlNsQQ1lbJ9zU6wXB5IGW0VZSuGhmfxHiJntHktH76M3tflD3w9BW9Ymk9K9ErzKT/gZF4csZ0QlQ9ehoNJw+59cU0hfFel0Hly4kdPPbcq6MIeGtnhi/ECRE73bFu71eDtV3QPUJZZ5BJNMX4lJhSsjIa4v6wi8eI1MCqIKQRfe/jD7195c/BpKGP8RMImDPKTXf8I/oONUZSwhQ1vzAKin6CfVgw0HtT5dauTYDU8n+GHIjIkLlgCcan3CVTBWCDs6tBtcDkwQvyj8elP7/soJnbiV23ub/Toi2O2ZQZ/JywUsquICCqzbfykTpORx7LMPHBZhJXHuFRGRjEuLetqIXho+gG8qXGbnr0eb9bxPNagUaVs9HTw80oCWmJNkxyC7vdxz5l3jZeG3oEFAnmhIXDNlzZcBkHpbXyO/OkbVbduxn24NPEEGBUOlQlzRLZr2PxPjeZuP3glA7KCt4qhkB3KgMI2v33vO2tTQG8jD0PBPRDFbyL4Fi6qsJNroECb4Z70VTxTcte0vW8LVAl4+6Stno/wAqkagRgGKciYhmaBYy27yNB638aAqbnjI7mr418jjk5NMuUFE09Z8r7Yad/tcCCqEivdwyExMmBCpjf+11oJ2ntkOsTYidniJdzV8gWp7NcxYOrNcidPzJXhEt3s0hI8asaujU01S1UxxqVTCvTLoRbm5SQnJMRfKo0rCcnp2Wmp3qRdy7j6ascsaFRuE9pjF8ketxW+s1+fL1jMkUZFhlpqXHox4+SIBUnQaFAIBIIkJKWdofkPTHUwVZI0UXcgwQwoVN54jEmqn51VMFu5EN5kiKs5kmyq5FJZdve3MuCTYvp6zbUx4RoQWZaurR/Vr0ent1995vGH6terWyoNH2nz7NNtPbQDnm75+GN3dboJl81XTR+opIiFEaudRYWiCKTJi37Rh3LyNlZ1K1SDZip3x8Q1cJG0SpFdZPH39+cGFxTlIxw5qsJiv09isuBrJ6mNsOMn4KsbN6kxTt1FkCqILLpFAlXZ3N4lWwNIc8Mg7h36xmMP1m/y+Ou9xy9YE/XbtuhtpfL7+siVy4tYxlk1f82Mdu328N4w/mdLLfLIgQSWMmGHZnwH7/5RhSrTdzDwPSFKIliDmBDL4CIk/bJVrBzbTmT1x4fjzB0Pmihs7xEFYQV3bUvgwMk7cpFIXIZnyc7NARcBlD3WZDf4xQPmgl+tn2egQcwou9b+q2Hrr6dt3nM6JQe8JH6nk2gAhoQfigxoZmOKEN+VoIVH0e8/3PMqk0Cs2xnjSxO28eKjO18eQGl27afTxCH61IPkTTIKfpXQEMiO6cZ/LjHTRShs38o9k3hvr89XIhpb/+IhkBLKFd9lF8a7dO8gtc5SMKEDYiCuKUaGBtg5vsVfP910AQIdkEwBGRVAFgCRp3zhqvvILmuSGzHXimb3jc4EI3cb1RmLG3MKIVwUwXFkuJ4sakKu35BYHvbJt/1EX0JhZISX2xb61jPMtkxms5Zn67PFvKEqWv3PN1eqIph9ncQfc6FQY+Z8eAJDN6cnI29ngzhFYWyt706m5QlEdKuSG0TjEQyYV0DjKV/0Im++HTB2qSZAlJA4oHmbeS6jg6V0wNQdHswXEfJ24AmmiqrNj6QQtJaEew2VIvvK2tv9zRuOj0cZU0Yc912Nh9CEzXFnug/kHqaOa7IRWpMXBjKWfrYASrO+r+OeN7p7veF50DTb3VDpIb5CZiE05AyA7wG+p4GCVIKvcqrfPc0jb7fgHlihfavAHy9xBw9cBUqT0rBXyTbujfE+g4puUsElY+63O/O5j2aOCb36C1gL18VRU6+BM+P5/rCV2I4BhckHeo5JupbOSU0cF3cjJT0tNeGpdzNSM2Wb4OlYgsYYH+7z5f0fpCNRhpZQ5JMvuUU3DpeGUeTNHXOXx1D6IkJMOdrvoXbzbnKdzNjaD37DlMT+nqvLXjSHCi66zHVWi0u73kcMF5XPNg+ScspeINvYvAd2MLloWLWHdRN0L0w+NGTFBU9h4APeMer1f+rXe6TWnx5oVp9Tty74gjzR4O5/NGr2/BSn5LnzI8ksZdDoLs33IofMS3jgwn0L9FjW501g2Q58Uvf+l4dtSZWgpS29mG5a5WIK76Mr+mHm3w9a4kCUT3aocsT5/Gcu4v9gqh3roJzwuNN25Idfz0F7yH1ffgP4wOuH9p09d+Z03NkTwMlz586f01OnYgcNjP620RgKbhmH34k42mPYK/2yJZcEzoduPIIC8bph2Poi+DcS0ta916xu633QopQ+LCN31vwbutBBX+2yUD7ZKRbYsgZ7mJP6Nub4zHXebwQ/0snyds3Q1wWD2i6x3P6TPVbdh0u9s+WsoXWPmhVHUxHZMmTwk9s0hySrSO9vCQ6VOzY+bySYj7SX5NzYl1pd9ouHvbk+7JuTISrb/pTTyGAh99k+MpWY4GMmHbtdGH4ypCTFJWSa9zpUVDjvrRSE+S08KHjeUHpmb35uxq7Hx3u6wrBbmjn+mydTiMD1456LN5r+P7wYr+aWw49wVEmURNHI8KAJdpfbISjQNh9r2e5GgO4fEyoy4eSoHdCcmBmhpXyyg++9uNZhaGYE415o8XdMmJwL7gPVJChfmmo32iEwlVF9pyMEHhxv9XS5jTIIu9LmNBmLwpCXnOYqS1jO+3DQB+3dGi+2ku6tFwMFVpUUXV5wzuGFJ/QP1HvIEeRiRbCJblFVvN8qOJwSUV2CKLMDT3UwKqH+13zR4JJcHrSB8Wn7oaecRkZU3/uAm12zrGugMYUQCZNDY/WZAXpfXlE3uZw19/PfBtmwy3B1TXNrwGxj4mUJsWXNzxhFkAosveOwj7prim4sfFBFWZFAE8HhUJAmOp12m0sszC8oKLCnZWYl52Xl5dgU1eXKdcJVRpqX8rKiypIGG7broY9zGSJSsW9SAmiN43vHIv22Xagpn+yE7fznRu96SPliJeB/0YPLoFH0OqCTMqf316cHFzJjjLMPtpFpDoiUdjcwR4xBPFjQZeTHXcBBMwXzQhWRy6X82uubLz/v0r1Hj66fdO/Rs0+ff732OvDmWx/36PRp53c6dhv7a5Jmt2lM0M2UD9gm7Hz4vSyIom7xVK2row77WM/QUD7ZsfjVB3xEjxdaqpMJiCWeJ/7F5OKk9QP3jssmAcNEYVEBKIlP1VltVnvKcj/t1+m1QhyoDwC5nXkD6nz5Va8+fXv17v1Vt649evX66vMuXbp83q1H+6faPfZxp/c6df7w/fFnJbeAna4Asks5braqwYc5pdt3bhX3TwvDrd1yN6n7ai/zMX2pM6ChwsoFu1joJ/vl4Qd7xh9J5XfJ/KH7zrgLRbKlzi6j+oC9yvph0OB3EinysescWWSL/jRFf6MH7LI7gFxbzMGoSFGSVMntjh0QI8gudyAzJbNCG1v28IfZpXcgUqfoXr/I3Akp5ZR9RIsC7DXAQVOZe8fSDMqSl+SK/uPWLkxI+M65Zz036nzXp27vn+zIQWxmk4vG56luxbFh1MT39jhxIOuObXM/3U7APdTXBdKHLNxISbl5My0h5UDuTn3NVAyt4ZEJZ5hT4I2y77UTBdXhVqKbvmXMzA9kaKg7X0zidz1CjmXZkYpFlvvw92Coi2Xnnetk8RCRnRydxwMVM9vDoVn2ZbEHZ0jMrf8U3Wvm5xgfcHlYEkNyn07M6Mahskj29x3/yaBMB7gpxEc1CSevWDZdP9GDlpubm52Za8v+ffWBeUWPhdsc5SyQZQ0LDp9rJwuq6sbSplZv8HEvpax+wL9Z8c8LHZZl5yNf2LomMX43nJn7l5mZp35y+YciOGE22vIFi46CtMegev0mevhXkWz9zzfijUxCVZb403ffPLePSgVuVLJV1ApdcZFZC5cuW7Zs6UJg0bI5M5Zu2rJ++dyZUyZ/+fagDkOWL126eNHChUvmfp7Mdi5Nguqhme/1AB/IZyjvf7rJTkIdt4qcQk85jAxmjo/eUvjAjJJoZNbPC+Yh8w6NFyRzsXrt7WMp/cf/1P+7iIkjfxw56sfhowcP/2nUMGDo6K8ffLfbw92eezpFPxuDb6dt+3Rs+945zCmjkvZZs7turD6bFrV03uJl84D5i2fOXL1rx8ZVC+YsXr14+uLZsxcsmjZ7PhxY/u5v9mEdTioygSDJD3Ak6YEPGi0RWMU+JLQcshOW+MgEcBn9ZBe16O+2MuQ/kTpzs8hWdpXPPdv2nQ/a1nr+9bc/7vL5Z5/0+LDtZ926de32eZevOn4+Rz7XrJd+MuF9OI4fu7/SZmIOv5NmClUE2vi9CiGV6aXCqx72QnRmuLBF7WR0pHP76OtIUpw+VgZQBaco4oQBj/RMNc+uICzLziOkQ82joXn0LdQC0tQtR0B2P08m/4DC0r+ewXJFokzvk8HXc+P2/8wUiMEpTi40fIrJ9Y3irmoQdyVt3TDg7llEwVQtoRrJFgsmL1FUDG0MD3PhassQEUOIiu0QPfGRNXzpGoTZvGlEyLMjWQQj4/UZkFTBuCuqTVXEKQ8+W/p0qnBgXXYis7UP5ULKS3Y+342P9j3/LZ9F4Gdksk5omFztNcmhOeZ0O6jnIagsu4fzelG4pgDeAlfxdJN9sMs7CykFC0advep2mBxHmCIjHpuCXBgL9hy3cmXRtJOCKwucRrvD6XSKilCYV+BSBbfT5hZddqfIa0LO2K0oGxGKoRlWi11Fqsr67UFCnDK0IrEf3j1Y4pM9KgjLsmOIzee14h2PXupSvnCJgl2b55gZJaDpSQTcnisje37U9acYo2hjVWVH54JRYDd7ORhcNYVtuvcEP9kwHnzsuW3x6w1adZ9+AasS73SBP8HnalOMb6w7eDjq52kzZkyfMWvmtCmTpk2NGD9ufETE5CmTJk+bNTdixMDeX07fB8UcfHoRDFLmmT3rl61YsWL5qui4VBt8jLvALWpYtjlZxvj/jmLCHSA7OIi9O/J+di/ZFX6XCbmHvqP3r/sibk/RJ6FcaV57Uw4xbZCosgt7wFtkZ77nWjInG940C6qKITvRnHuhWqjnZr5b78E2PRdujz0dfzMrNT3XZi8ssDsd+WlJV4H4xLzcrIzUhNTs9GvXr19PTLgaD/9dPBq9LeaMgNmFmSO/eOOFli0efeTRhvfUqnXvfbXrNW3R8uWBG64LDAsC1ewqU955xX270UuhoxxNKrO3HMz7xr1LO8XugqixMycFvGvjHnmUV+OEvs/8xq2L8RNFLEancpETjxM31ACJffaFPpZFP6zZWNTXlLub+Sd/7ftE7UZNHm31zMvtn+/wTse33vrg4/f/9cY7H33yySedP+3V57tBg4eNmz5r5oJlkRu37th95OyVhPirmaKgxfR97b4Gb/afMGPeig2bYk+fBA7v+m3JzC8ertXus1WZfEg795u21t5a8u5pOCmHbddSH4jiDavXV9U0IeVM7M6V6YJfcwpITzw1adfm4U+03YidyJwbCR9wZQiv2+LuXEoUkRJH6wk8FjBkV2VXxsfneGzGL6Q9/tjBXTt++3X16l/nToiImDB68JBBPTq99dZbb7/RulWr1q2aN6pXr2GTJg81aVofts0aNmzYuGnTRrWemn0+NRfe7+uapx2b8a8GLfvOiJg8Z/GKqHG1vjej5wrAuuwSiml7VXfczBxIQRum2Nj177NxoP6l/I8+eaBZg8f6G9Pz9N5g7vQdnM/Hrl750QYqwwdEP+DpCwP4iLeIUQ4asBfHQO9pVwvzc3OybyZdvnT5/JljB2MP7Nu1fcv2rTExOzY3bpXA9ebDwSCINr6s3tPMEY4Pavjn//W3evXr1Hvib+2uFeWHG+uyI/bzy+ak2iLANlImr7joXQOKyVn8w57Dx9Kg2JuH+dAuVrA6jahEOD9cH0ehscltvWZN8lE2+z9z2LRCq3Jsa7CZd2nBR6kYWmR/6xc3uvbDGxLjriSsb/ILqG7eGwgzlmVHmuOLN/zU5YUlaUyOI1BhZwkbZxc4mKTJZstF9TGl23+289vVN/frZVJVPvjWazgWBg/P/uNJgdhLL+4+6GPB9BR//A379kVNZbkZOTfBj8f6VDZveOlGMZ0bTkFYZl3e5D1qyO82QRiwLDsm19v8YKaLgbIi/RyNRB6/+HHw3Rtyvl1B5tJ4/BIR+7r5CXzQkbRVjxMp21t7hVddwQqYqx2f5Boz0coE9zH1O3sEZGeO1oOZ++rSHafWzz3MhymZJ3mgVAGnK/75u148htm2v0ZDU0OCH1oXPJZlZ+Rk3c1+XxAES45IB38mkOxX3ymkoo0KxSsqo72z1yXpZjerh/mIlKEtrns1x0SAWD+/zwW/gc+3QddeUyW2v/lSIk6H+Ctt27LIND/jxy993sKlh/d1undhvv3FLxxQ3n2H1oQD67Kj3XUv+fq5mqSq8y7wweBmRglSZkCYAxYcqyLiFoDZpizfrvFRnRq7OFzQP0t+rRvymoHFR2hRtHpQ4MbiNiDZzSIbRqN1q2Uem9389adjEFpoRpxmItHrQ5fcICx3fP0ZOLLpYaR4pmeHFeuysy2Nb/i2PyD3mfGlPmLGsc0BRl/VVBd4nwrL+3XiavPpSgQfO6OP7mCnms7Xi2AJTnTKh8sUNHyu68oHTrKhRj8EY+cmLi/UZ/ya+/CFUdbY1Xp3Gh1zz/CsDp9BWfeaDhw2yiH7uJbppj/mgWqSMPKAueNP5lJBZRkz90OrpYGfPuo3cFkMNVFqRJYh9vTm6fooGm+oY9TyW93xLBUNsVUPHnJsMhY2IEzOnvNjHlW8BtBjNS6ayuBZaVheWb/XnFcuIndFhKrWZccdO0k+sjNq2z43oH3ROT9DYY553UcUgFVJmjg2kWDRCKsoTf0pzbDeU5+DBtbvd6/qaanmy5jtrxuVdtkYkiGoElUjJ1wxIgYTZx6S+UBJPkd4RYOX2n15i/F5IcS67MoTo/ziPpo37WwJ01mCy2O0vIWbs7ZfZRmrIo7nyy7NZdMHWRPt3DFzCN6CB83xGl5QmjLwuIUiiGSi2VtNvHzR8KuoS6Vk+4SrJSwj1ZxGBz1zZWlHHvnff9lpqRkJFuuy5zRZ4XdDD0uXbnGX5tqn8uYIR8aWpCOTopIZHy3nFEfxvnWKxp7ng7sIRSvqvWnz/QRFYQtG8EDMyyiXBZX3Z3bqeCDGDdEwpi5kE7ZG3CjpRIK5U1TemoCpUVjc83e9ksOrcLiDJuuyn3nseJAGt7DH1R+S7OuiZo266ABHBkG9sC+4AL+ZXhtlUwWEXCxu8fwH1/iaLiiOB79ywjUOUnaduf+cdAyJfK6Y7EIn+56+9cSlfXXvGihQCfnduwkx1mWPeS65dHsSEEe3tTEs6oVBR+x8gjnlS/2iC9l8/uOpXXYetktsw3Lxi06+YSIRmWNSpD5qO3gK37t7GtgNcG2JLWviQaTxSTjmsQCsufu/tvBlNaz9sTJjXfZVzwX7SFP80gf23S9Oz1IVfVEC8DMwsx2HoJBsTQTbpInswpobbG0931l/2EHYim+5lbHC8fr3bMojDCludmKSZmf4FvNBKJa2/bX1Jabdbp5NebEu+4RnC4IN6Ma0HzCERyySQo3SRGjqtExoa3vncCvrZuvXEHqo4Tr95GIQOJyJ/eLAGlkogiLb2OKuJ37cn3zT7j6gr2J7K7sNZWD2nzvmEbmqlna1SwdKfde1uzXK2jd/vMJkJ5JVvlQUBEmUJM7I0cimdZCEUngj5rrKDj7xq3m+B5Wv2xIxjo8kNnOCgMoosW+bB//x33+rVbfWwFXbD8VlQ66xjAZcAI2p3r2SlLrZL/eME5hkzIkIF1Zk1wOb7PafmotklBkpIYeqKh/XhDRFFmX+fD3ZqeGs8dyvxi62bYFA2f4Gvxmnl2TvV2AfrApREDOh81svPd32seaNatV+Y9oJAWyOpD8W3XU63u+hN3Pumcp7K6uk7JntfwhWdnTzHNMKNVXhD5Hkt6L5RF1ZkRas5Z9DcWbUNQhWou4+bpxeEvfgjX5hQjDILpfbUZCXc2ZO53b12i++oIFbD9mOwRd9uiWhBgz9n6X6jwyfpbEoO2U3n17IPbtgQEmLTl1Oy8zOy3MUB+AUbxpr3vD+faoTKv24tr43Twymj7bYpgLmXBNARkzJPfD535vPSeUKs41Rud7zYDmUKD3u2wRf1/rfuy2WS/v1NrtRkLKzpPZf9Js9e/HabQcuX0m8kXDs6MHYPYci5980fl76shtMZtlvDNb3/IgfeM5MBQ+UE33VLD7RBiOw6RnDmrz2Wz5DMaMyBe+RybqPgGh254d3uMIZMlmWPenJU6rRaVhmlAvD3Koz3+5w2HIyb16/uGvb5g2/rY3NNj6Q7Znn0BS2vc66gH41YYOnmUkrwGdijc/ag78F8bHGzn9Sp0/SriFxTONTekyobjbB+lx8tf1R/5siocOK7DrxLc/ebvK+L+qNQZf1dsoYoEixXXfdoYzxNQcuTpAFrLH+TxYE7PZSSHRf37bPIqA8v85Rj/y5r5swvrp5SahIWVzr508rwTlqwWBZ9rj6KSzYFeESR+cpfFkR414RH4fHrmZAQaTMrQk/x/KlfW40HVaaC5HzbUgX5qTs1ENtzzKq+ndx8O94okEb+GpmRsixLPux+3KClZ0UfB7BBL5Ii/5z+JR9bdpFLjYiJHKOAD4bm9TkPAloZKCIzvzRTIcGmZ1t/cQe5vZTnTIVDM/JsXHhM+6WZT/RMCfYBRupO/bzmfn6+gEmitAtGZoxCFjiJyTymX2XW//EHAF/LUHs8ncBFsC2DkRGKe1bnfaLWqkElgcuvcxX3gwTlmU/1TIdBTl2jdqv/L58qjmaAtCIgL7go6s1lj3+CNGwyqbcfxGyA+uusT6L4eSQVXwkqvK1Li3ioSKVnO+D+QpnUBXDeJ/Jsuy7nkwONpqg6pmIwsgk3gemY9MEqV8iv0XlmrWM3/0WUpt+pYBpD/hrqYtF/iSJ3itJlQ/4K5hdqN3VoSDV85UMjItgpSuirFiWfU/71Fs+pC0AmOV3JDd2g+9s6GrTVLz2LH9U8OrhoigyjS6qd4r3ugaCQMuX//U65qaBj1tEOXLvOBeX+db98KHGmuzwFQ+8klbarPFSEd0zE+eeh5DEuF6CQtjVWekaWznR7nQhFyt44xso1IGfMAbNr8ym9ZPlYiMVChxs/v/so7I7fE5LQCzJzl2NA8+kBT0cXGA7Ilbya2X8Rn4H3x1tc05akQYGXVHZohZbeddfKcYLSzS1+wn/mYHlQZUE+Z1nMpgU0HsKH1Zk11fi3vdIatDWT3QfGeHknR06lEqyWoBj+q4shLARU/nqs11dcDBwBxtW+KycnquZ9+ilcgPNKr3+YH9oVO8AI8O/4am7b+rbIMCKlvRav+/6DeoXEbVq1arIdfMnT5r665oj/Jkk4LTldHvpNP/IwJ9qxFDrJ4f42ZL8obmL6xxgijnLoYKw3KSevyclWNkFlbneuYvz/P6d0dExe3bGHLmYBUaDYl7CB9fedtvuBnuX+MB+jlV4P8W1V96zVcgQvGIsy361/rVb3h4LAJ9XveYvf7rrPz/1egC/XrqxnbpmNl1S6tIuHiibNj20Tar+G440iFBC2mTcFsuyJ7c4E2x/O+/fO1fnrntn8um9HL68FBR1QhDFU//fAiYpt1ltEAm5n/LHIIQMcJp4X+/Xjfky7BWIZdkzWh8JVna+dKzrvT/PJtjFRVf1bgLuDYF9nVR/vMY0v+GPPlAifrvYTIcEjJgmYXaqzlQzo4KwLHvOSxODndgG4afKIr9FqtOMeKCZJNCWwadMvlfv5rrt50nK0U+c0A6GakodlHaKqaoNbZnCRC3YUfTWsSx7fochEHYGhR4GHVkJlcSUnWhQ4hG0pysfGu27KG1gNFb41TGmhEx2A5kdaTmZqVrxQgXhxrLseS/OBCHNnbLBixaL/dmWbQ7+gV2CRAdzDPlHRNkMNqECmj9ZbwzMnJCgamrPpvClhHCPSirCsuypLXcGGy7psu/uGzlqjrEQoN7RTdnhTx9chLUyDXVCmsjOfpfIDYOZEwr4shBbH1zP+BjXCsKy7In3J/KVR4JBl/3Ajzn5i5fyXR6PE9e1Mf98cg9fx8F35GMgkKQQ18DN0BSGUnb+5DexU0eIj6u0kQGXT2b7n0oxx0GUHS7WgQiRHVugYm6dXXF9X2vbYPgN1Y35Qt23hzubZNe3hawglOUSojUo7g2j+DoKCinllmJosSa7orH5b6QFGy7plTh6scQSN/NnBGZENPvvhuO2H1OC7N2yf3heDPkqgZrc8z4IREBzr9VPwoclI8OHr339Wk7QndRY1NiBVYxFDkjO3f1Fm0Y9dl0Hlw3rT2suO3TtIvctJsNbQyVZbz11Bdr4sKwt64e10i4x4YXuMtVjnbIDVdjBEn5PPvjxfzV+tEmbBVdkbnc0v8d33AZ09fmM20SzwcGfUIhkdq35M2A33UH+KGtYkV2TVJbfLiLoZUAwVODCCZ8tPXZpzb/uXpwK3pqKwaxiJAb1Q1H2l1tYKF09XsL5EOQD7T7idqYiuoCtyI40hd54OhKCxSAdCkljZwdc5oFRYuOl/IYGmHsLQ4Do3l72EI1U0uHuKHhZmJ1u8foNJkBpQuGW3pJtZxK78mwMH3du7pcR0OrESN7HS5wvjLc8fldiSV2vmOnQoUdgB994/HdVcmKKfdejDzGWbDuESedePgZGMGgrwy5s42teM/LmJMuya7J7zpyQBzZY5QOVrr3/fz9Og53wDbE2sCY7+IHtIVoK8gYkXK3cLcnwJnj/hxH81Rr57NiHZevCCQaKVL6S6Mr2z4y4BoXfzA0TlowMCLbw0RwoE0HXxItDbfpPIh+MNXOCB7tR3jelT7G3iiYyVQHX2N7/b23nmg94DxtWZCcaw9+2kvQRa0Ehsz2rwL5DA6Z+MC7YNxchySpe2l8DN9aqmQoI0ohLgeiZsYT+jdpFXPA02oHvqJcTK7JDYK+89pG5Ewxqxvc3jAqivjuxHOZTZXE9kykp+9I+wXKsy6ON++7JhYi4AIW0+8eDJSNDiP3tiWY6CBR2cJ75uBPncxFGwgL8AcHK6lmqhvzG6oYGCEtIwogX67067RBiAdf4KzcWbXvKyzvMdBBg1y9XzFsjqc1n61srUD7NYs+HomYLU/c4gcCEsdz13Rr/vfv+oO9clglLsjN2pYXvVOmycH5MlmnRL9RbqW8tgWTMMvvwxZvNjNBCJEo1zDvbCn5p3yI22HtoZcKK7BSxg40vmDtlhCoQCy7exeencI7W2mzZb+erYjA2Z4jedxwOsP7ITv2Lpr7fOBo2fKFCvhsyLMkusIktSwx1uS2EuAnOGHNTM0cJR9aPCzbE9SG+a7oYJtteDGH5HRsv5Y8g4vPKQhhDWTIyLvbBq4Enj5YGIVSVZu5nKjFaqAGv2ctZftSfp1qvL2UFzFhu978sI5qigdfrPQ+lnFiSXWEvDw/O4lE3wukTCl3YfGRH9y8Yf6qudTDb3akiemgd1L7oge5OfiONhvAGiCUjw1JeCnZxfwnjU2dIATFkl94Ywcp3P4Hg3EG7zHT40PgkB7Sq/r+u8M7hEF5lK7JjurbFaTNdRhBmR8dnMYrBOQO5T9ZewWzlqrLUziL78ERomzof+NP/iMLi2jfaEdp2xJKRkQe2KAzu51KEpm8wSkshRDlLWl+k5Rtjq8js4uf5cD1D3hVZAt7rB1f2QueHfkiH9oRy3zUUWJLd8fKQIEeZExazLN14C6aq3L0nMeaZWwb8/8KIBUyriGHphDJhcavW2yhT9AfdhABLsue12G2mykzq4ARTZiqz0/csYCpfTrccyASv/5LPwwn/PTg+HAjf/P6+zvHgxJXP7fVgSfaNbc4HOUoTr5zvifawyMY2vsk8D863ipvQG+MS+Jj5cMvOB05hO1GWNq87MpM3syHAiuzk8y/yyt4NRXglvRSRaw6FIBKzPdkHGqpyBh8iFZ2/z+WLe4UbTMEjIKLCUie1bjZKX24MAD8efoDVv25F9sLX5hJjcbuyIBM3yplxgnkeK53Nohvu441V+QTji3Fe/MBlr5DRRJ4vm9CvSbuJ5/k+VAGN991YLDtWZNdirvPFostKocTWLgcbbAw1VVnSs8bT28qPrftRLITXlSkBaHxjZJ06Xy7lS7W6oByBL2/NVFqRHa68u+y2neaz84tymYSMfgGF/dz0pH4gBEQNYBWzFLIJEhhLm9eh7gu9Fuqr/Ks04LNfbo8V2TGlrrIPyyIsc8x6prr5OvmcM49bWwQ/EBkfplJX+YxVMGBCeLencuDHF+6p81K3xXDFSy5WUGasyM6IEPgp4gEh6qq5fKFOc1S2q9MLN0K2YAiaPj3cQytKoMoIK3y1JcfxuePefKBfph5PWWilLMnOV0Uu+6+9tDSR9xVSipFA6LDHjoawB3VPh9CP3LgFXGOo5kZNl7c9+SR/LB3iD74IEkuyB4XqsJmutaAi95pnF4qhk50m9D4V7GjvkECxphDh9Pu1VijYKbKgI7/wyy5hRo17/KSQ/FZnlGysexkSCJk3zkxWLJQv3cpYyjd/HSpC7BD0iMzwy66bJKNa2qc2+c4OFyJkPp/GTvY0HrxRweiDbgWBFUy6v1MS/EQzu8yEX3b+RHzza/1y9xBe0Et5ynrwYNlJx/suxFwh6ANVZbfE8Lo6T1lYwawCZNd7Bzji7JmafiOunAFqEUQT2PYuMi3nLRMr6L9An2K277mnVgddfSvAyBRBC4WipxiGjGu9k5gSlrEsZYOyq+92C3rFggqVXeXdjyGFMvTzMBriNWaCgmpqXl7QoWpFyg7ilO++tT9Q1w9+4aLhW7DxtlAVmquqLTv4uha7jkoBEYbViOXM8yjQSgAjYuGOU0XKjhU+N8vcCQnQVmMW9RUr5y2TcsELUtB/viJlDxOJvU6HZZxiOKkGsqOJQ4KPVyqZaiA7O9onv8L99nJy58tOCPphmZm+Y7jzZacam9uPN653kqGpBkZGZue/09cFuoOoBrJLmvzzbB45Wb2NXwlUA9kRYrv7ZUJAEK7ZHWGgOjSpBLkGrmDhmckYJqqB7HzBjzlDnBaHTlQO1cPIaOenXOcPV75jqAay854B15WCUE+mCyvVQXZ9OcqKW0wwFFQH2e9AamSvFGpkrxTuPNn1p0zcZe74UeqB2/PHCvT778TSzqUtRd7Sr0fV4k6VvVTdze0t8S/XFVnSOTWy69TIfntM2blB0f/xV2PXOOZt+ovy6R/vAmnNl7tgA69ca32j5/wRTuGnFR/zYOyar/oHmSd4ZwXFnWzbjX+6yMaLkWdudDz5utBcIL1ce/0r3uhqlsj0YOQYmR6hvc7Ts3gyCO5I2XUxDW0NVYtf+P+e45yifC6Lro1HLn5WkVx6jkdHzzEPxjnGq7HxvNncGO8KhjvWyJhbrqgnbe7oSQ9F+bpa5ouXTl4b45/XsSIM02Rk6hvvtLExk2WlRvaijfHP65gXkGNm6hvvtLExk2XlDpcdKrmpLN8x84yNQVG+LguIY2hUJG/RxpNjZuj/TPTjnkw93ytdvAmGO092bk9NVXXNjT3TY9F3io4Dxfm6LobLYRgNI8vYQI6Z4HmeYybeZ3qnvbLM/TJzJ5b2QBQLXZLS8iuZGtkrhWoiu7dd8aa0/MqmupT2O4wa2SuFGtkrhRrZK4Ua2SuFGtkrhRrZK4Ua2SuFGtkrhRrZK4Ua2SuF//hDDRXPH/7w/wGAN4UevI+4iQAAAABJRU5ErkJggg=="/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image8"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image9"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image10"/>
            <contentType value="image/png"/>
            <data
                  value="iVBORw0KGgoAAAANSUhEUgAAANQAAACQCAYAAABwF0ViAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAADsQAAA7EAZUrDhsAADOGSURBVHhe7Z1pUJtXmu/v5/k0NTVTNVM9NXWn6t6qe+9Mp3uW6k4n3e2kEzubkziOncTpOHESx/uCWWyzY/YdzA5CQiAQi1glkMSOxCL2HYl93/fNGBs7/3vOQcTYxo5tjJDI+6s6Jd6XVxJI7/88z3OW5/kf2IP8+COgUjUgMkrKWhRP9niLkiEiIgu5uVW4d+++/pkcHNtjTwoqNCgV//qvX+Drv7rAyiwIVy4EPNaszG7i2+Nu+Jd/+Rx2tjzcv8+JimP77ElBvfOOGfa/fQV3V+/ozzyZr4654rVXz+POnbv6MxwvG9pZzc0t6I/2NntSUJLUAvzmlRP4+CNr/JVYqa++cmXtm288cOiQHQ4etGbtnXcs8Y//eAiHDzvon8mxEwwOTuDkD87o6BzQn9m77ElBUZqaOsHnk/gpKgsCgQzW1hH4m795F+fOBcDBIYY1R0chXn31HL744gaqqnQQxcrR0NCGmZlfRm/6Mrh9+zb5vOb0R1uTJsnHlcs+EMXkEGtFAtwnMDe/iKWlZf2RabJnBfUovb1j+Nu/PYjS0mZMTc3/1I6TOIpaq+npBZSqG5GvLEXYzWTc9BcjT1kBrbYX9+koB8eWtLT04sintqiu1OrPPMzExAw8XQWYmpyDu2sM+R5G9b95mMrKNpw940E6tmb9GdNkzwtqeHgSUqkKV6+G4e///mP80z99il/96gj++Z+PsvYP/3AIv/3tSQQEpCApOY98sc1MXJOTM1CpahEakoJgIrCSolosLd7SvyrHBhUVbfjhey+EBSUiKSlPf/YBCfEKpBIXnCKXlxIvIJv9vBmptAg2NpHw942HWl2nP2ua7ElB9faOMHfv+HEnfPaZE06ccIHbDT5KSurR2NiN7u5RtLcPoKNjCJ2dw6x3jIpKh7l5AL788gZxAR1hfT0calULlpdWMEJEKUnJhasrDzk5ZVhc4oS1QUlJE3x8krBCXD9vbxF8iSiWl9c/n4nxWXg6x2B4aJIdz88twd05mngGs+x4efk2+JEZCPQTs58LCytRXFzFfmeq7ClBNTZ2wcoqFG+9dQmXLwchM1OFvr4R4uMvkp60EQkJCgQFpcHHNxlOTgLcuCEkN0AyOZdKri0i8VMHxslNUFvTAkG0DJ8ftWMDG0Khgnzhq1hYWEJ8Qg58vGNRqWnRv+svG9oZubuL9EeAWJxLXLxojAxNIDdXQ+JXqf436yQn5yIttZC4gvPkcxRCFCfH/Xvrv0tLk6O5uX39wETZE4IaG5shQgrDgQNm5MuNw8jIJAYHRomrUYyTJ93xERHFoQ9tcPQjO5z81guXLwYhPDyNuSLh4RK4uAhw/rw3GxE8ctgO5pcCUFRcx8RYUdaCb792w/vvWBHRqdn7DQ+Pw4/0xMLYLCIy0w6it0tX1yDxBjIfmhxXq5pgZxMCs/NepIOa1p9dZ2Roinz+frh4wRuq4lr9WWBtbY18vkr09PTrz5gmJi+obGkZ3iFCunAhgLhyQ8yVs7PnYf+bZjj8kS0cbWIgjslDkaIe5YWtqChqQ1l+Cwb7J/Sv8IBbt1ZRX69DRIQUn3/ugE8OXUdkWAYmp+ZQUFCDDz+8ygQ5Pj7Drk9JKoCvlwhDw1PseK8ilaqRLVu39ouLD3cgA/2jiI2VPbbapKOjH+qSreMh6ia2tHTpj9ahgsrKyiWCenhofX5+Gd09w8iRlZKmJu+jN2dGiskKam3tHpwdY/DGvotQKMrZ0K2rSwxe/8NZfPVXV8Tx81FW0Iya0g4mJFVuE2mNKFE2ojCnHp3tQ/pX2pq7d+9CparD99+74Z395sQdUZEvd4nEVkSs+69AU97ErtOUNsLVmY++LQS6V4iIkODU9y4Q8qQkXopFcko2ZKQj02n70NrajZgY6bZXmty5cwcSiQw6XSf5bgagyKlAWooSXqTDCglJw/XrgcRFFOFHIx9xNUlBrd6+g7Pf++KT963R3zeGqiotucmJRTpki/iYXFSW6JglUuc1MwE92h4VFBXnBosLjw845Cmr8cH7Vjh3zov4/nPIylBj32unIU0vYb9vqNUScfOI+zPMjvcao6NT8PTkY3p6nljx2yRW1RLrnI8kcQ4cHCLh6BhNBLU9y0EtlItLJIltw9nrihNy0Virw63l25iZXoCTYxR5/6fPdxkDJieolZW7OPmNF748cgOrq3dJEFyAV37zPa5ZRTFLVFms3VJEmxsVVFfH+s1fUlSNeFE2RonbFh6WgvOnPHDDKZJYo4cnd++u3YUD+VL377eArm0QpcSdeeP108hILWK/r65ugfuNaMzNzrPjvYZSXoboyHT90To//nifub/rE+Hbtxyzs4skHp5+TJzhIemQJBbqj4wbkxOUuUUIjn3hRHq0+4iIzMJ//PYHhN/MRJW6HaVPsEiPNur+NTf2EHciHvv+dJH1vmaXAmBnG05isD6cPesJb+9Y/TsCc3PLKCqqQW2dDmEkpvo9ec/qyg4SVDfiv//7B1RUrI/4SbNU8PePfwm3lvFBXTJn+0i0ND8c++w0nZ39xHLxsGAic4AmJSg+X4a3377Mhq9Fcfl45dffIZanQA0Rk0rZtKV4tmrF8gZoW/vR1tYLH994WFn54uhn1sR/H2Tvk5+vwVdfubCfR0amcfy4M06d8sWnh+0RQK6nQ72vv36ePH8AiaTnfP21cxgeXJ9rCQwQoyDftOdSnkRTYwf5/0WkMzPMQmLqigcGxqOsrEF/xvgxGUFpSQD8h9+dQTWJlzSaFvz6375BWFAmqtW6LUXztMZiqI71GCozsxDnz7vj2rUAEh+tD/FWV+vw2Wf2WFxcINZLhEuXbrLzA/1j8PGMZa4mj5eB99+3YKNQdrYROHfGh10zNDgBJ2Lp6FKbvYifn4jN7xmCstIG+HrF6Y9MA5MQ1J079/DlX52JGybG4vwt/OWNy3Cw5hMxEctE3LetRPO0tnlQQiLJw4UL7jh92hXDw+sjdZWVrWzFxPz8PK5c8oEsfesb6MLFQCa26Zk5HHjHDBkZ64MUifFyJCUq2c+mDP3ch4fH0FCnRVJSIeJi5PDyjIaIxJyGIFWSDz/fWAiFOYiLU6K+XouBgRHSof38tpzdwiQEJZOV4y9vXiIWYwmODtH4+EMblBe1oTT/2WKmR9tmQSUlKeDoGIpPPrEmrt76RKMwVoaTJ73ZEK2tTRh5TwE7Pz09AycnPvr6xtDdNYAUcpP94Xc/oLS0EWmSYhx42wyrd+4SIS6S66KwtLjCnmdK0OHv5GQl7Owi4O4eTz4fOaTEimdnl0Nd0oARIjA6pWAI7t5dY5PopcRSpaerkZNTTISVQaxkEhxtI5GSkou7a2v6q40DoxcUHfE5fvwG+FEydHUP4dVXT0MkUELzDKN5T2qbBRUbm4WQkETy5RThyBEbuLrG43PyWFRYzX7f1NyNDz6wgr09H6e+88C7By4hNiYbElEhKopaYWsRgUMHrbG8tEzcRDuIxfnsebExUihyytnPpgTtREQiOb791hnl+rm2rbmNluIm6PpJp3F/EdWKZows3sfa7BjKlDrMv+B9PtWtRUHDIJ42CF9R0YozZ9wRE0MnlI1rotfoBVVW1oj3SM8/N7sMC4sQfP2VCypLtFBtIZRnbZsFRRdqbiyPUaub2Lq9psaHR7KGhiZhYx2Bw4euwYv02vJMDbGOLWzFRW5WNfbtuwQZ6cFTUgrw1VfObDi5tlqL8BCJ0U9EPolm0pF4egqRSFzX27dX9Wc3M4PQk4EQ5owDa31wOBwEVd9dLOvKceUIH50vOCjXmBqN4z65uLPFx0bnH1NS8uHiEo22th79WePC6AXl6CiAC3GzhobGWewkiFSwSduthPKsbbOgfg6drg9BQUmwt4lARnIJygpamZg2XouK29IiHGfO+rMRQTrB3NDQyQYu+IK0nwY6TJGVldtsWZGTU8RjS4WAWfDNIpCYP0kENQDPb6JQMXAXtzqrYPdtAgaI4Vgd7oTgZhKCRdWYoRZrbQa5/HR4esTDzV+GYu0gmgtr0Tm1hrnOFqRlt0GTJcb5kKLHBNXRMQgfr1hERWWyUV5jxagFRXdvfvihJXE9WpGZVYYD+81RJK9/4dhpoz2LoAb7x+DmIcSxLxzh7SJCkbIBFYWPC5mKOzm2CPtev4Dmlm6YmwchNDSTvYYHsWYa4p6YOlXVreRmFiCTxDHLyxtx4ZMF5XAyBT0TAwi94g0bv2Q4mvvCLbEDt+fbcP2D63AJycKVU84wE+aDZxYCWX0fhLYesBE2oi1PArPIEtzVC2plZRX5uRXw8IhBba3xr/A3akG1tPST+MWCWKdRXL0ajCuXQlFd+vzD5I+2pwmKWhQPdxHeOWCBs6d9kSUpY/Hak5YxrU8m1+Pg+9dI0FxJAvpinD7twV4rTVKIwoK9MSdVVlZPOjdzdHZufG5PFtSNs+nkc8nCl6dj0HPrLnqUGTh5XIz2YS0CL/LRdRtQpSbCOqEYiTd4CPCNwzX7ZAyQ8+O1Cvhk12FjZeDIyDi+ILGpqcztGbWgZLIyEnz6YX5uAe+/a4ZAnxRUq9ofu6mft20lqJnpeWJZJPjjn87ivf2WiAyVMXeurOCBe7dVoxPK1Sodzv3gD19fMcpKG/HJISvWszY3ayFXFOvfwTS5c2cV8SIlPN2j0dTcuWlV+bqgkgqmgHuD8PqGB83gGla6quF6IR3KNDHe+8gaZlejYHk5GK5Bxegd1ML/fBRaZteQJ06AbXIp4i3s8ev/eQYe8euWfKxeAV/FA0HRGLSpqRvuznzydyhwi3yuxoxRCyo0NBnW1jzMzCzhzb+YQRxbsKXb9byNCqqvZ4y9x9LSCokTcvDnP13AK/92Ava2fHJNA1sT+KxzXDXqDjjZCHD+tBfatT1EUFcxNj7LeleRSLbtldi7BY1b/PziSAwp2SIN2LqgJCq6+3YYPt/yUDP2I+7118LtfAbU+TJ8fTkZdGPLSr8OmZJmjI9r4XkyXC+oeFwXF0PsGAF/Lz7MzGLRPn8fqyMdULcOP7Z8i05BCKIz4eoWzZYjGStGLagbDlFwc41DT88IPvzIFgpp9TOv13tao0uPGus7kZWpxttEqL/61WF8+aULMpPVqCLW5nnfg1qyAO9kHDlih8HBYRw75ojOjmEW1IvFOfr/xnSgHUB2dincXfmormzTn32UeUSedsSho95wcvDGW789ixNXwmF33g5//LMn5PUdiLELgqUtDxe+c4OLqB41GQlEOBmYu/8jpAIBzEkMxb8SguzGfsRd84BFVB366jWIzW5+4rB5TU0bfHzikJGhYivUjQ2jFpSFeSCiwtPRTnrKjz62RW729gVFn5+fU4u/fumEv/u7D4hluoiwwAxUFLcR69e65XN+rmmK2sALk+LAu5aYmprD2bN+KC9vgVBI1/ydgVxeof+PjB86aevhIcTXX9ujqrKFWKalJwybr6GntgHiGCViRQVISilGQnweW0Xx7Q+ucM4mVmRhGLKEXEjyOkHCI4y16qAbWrd0I719aOqfQC8R3vDCPSwMdKG4qh+jgz0obxv5yeXbDP076J602tp2fH3cAa6uApbGzJgwakFdtwwGL+KBoJSy7QuKzl/RAYYbxEWzvBRCRFqDKmJh1C+whGmjUUFFhWZi/wELTEzO4tQpH5bnr7CwBn/+41k0NppOngSaN6+quoV0AiUIDkyBp2c86RjSiEXIJ49KtLR06698MvKkRAQp+/RH22NoaAo8noy9v0iUCU+3WPj7J0MuU7MMVZv3shkDRi0oV0ce3NzWXb6PiMv3MgS10ehgA13pQCdnt/r98zS6odHfOwmHP7XBQD9x+b5wgFa7vnJ9Y9+VqUIHBcbHp9DW1s1ydPj7iSHNWl+zuDX3sTQ7h7nF7a+3KyysAJ+fxd6XdkoTE1NGJ6BHMfJBiRTY2ERjepoOSlxBYlwBygu2PyhB2/qW+Be3SpsbHZSgFo8OSmhbe/DRQSuWfngv4uXGZ6vADUFdnQ4eLnz9kWlg1ILKySkn8Yg/W2x68EOLlzZs/jIbGzZX63D+lD+8vWmixgZ8/LEl5ucW9f/F3kGhKEN4qER/ZBjCgtOQSuIzU8GoBdXePohPPrnKthBYWgXB/HIYakqNS1DUBVXlNuDDD65DmVsNiUSFixf92Xq+vcQc6SBs7UJZijZDQrfEuznzMU4eTQGjFtStW7fw2WfXUVzSzJbv09ULxYrtLz16mY0tPRIV460/XYKurYdln42MlOn/g72DOEGBtNT1lfQbTE7NEovczLLxbncRMH16m7YfNTVaIqKH07JlZRUjOvrhfBbGilELiuLtmYAbTnz0D4zizX2XIYxSbntx7MtsdALY0iwMp8/4EUs6iYMHr6ChwbSznz5KS2svbjhGs9TKnR19xAUrgICXiThhBrHGN+HkxNv2Noo7q3fh5S6Ao2MkBIJU8HhpSErIg1bbg9HRGbi68qHTGX8STKMXVC3psfa/bYbZ2WVYWoTixNeu296+8bIaXXWeJ63BG3++BLm8HGJxHr75xp0NPe8lgvwTceIbF5ZyWZwghVJRjpambiwtLpObfRLx8TmPJbp8Xuj8V1ZGLnEpx7CyssLy/eUpNYiLk8HFJRZnz3jCzVVg9KtOjF5Q9AOkKZJ5vCzQBIh/ePU0EoR529pg+LIaTQ5jbRWFo5/S/BPL+PRTWyQm5ur/8r1Dc0MHW+5D1yc+Sl/fMLvpHxVUXl4N6Nb1raAdD834u5n1zLFKdHU9Pn9F88rrtL1oZWsJuWHzbSOXV7JsR3TW3tGWh48/tEZ5UctLm5N6kaYp0iJTUoY//OEsykqbkJpaRNw9iy1vur0M3S9G88RvWA5aWpXu+KWpv5ycwtDxyLo7mmnq+vUQlm03LlbBrqes5zZXPJaK2dQwCUHRgPfUKU+4uAoxT1y/t968BEc7fZKW50gf9rIaHRRR5zfh8Mc2ML8SyrLJvk3cUpr74peGStXEKkFSaJJPHx8hKw1E8/hVaprBi0hjv6PQ7zEiPB3ybA07TiDCc3ePYYXvKJmZBaipMe39YyYhKEpHB3H3fn+arZHTaJrwm9+cQESoDFUvkEZsO40uW6LzTubng/DBexaYnJyDpVkwLl7w1/+lvyzoKJ+PTzLGxibhZB9BLPWDDK+0TpSfdxza9fkOB4cmSBwUzbayb5CTo4Y9eV53dz+Ki2tQWMjVhzIY8aJc/GXfRYyTQDghPh//8cpJxPKUqC3r2PLmf9mNiokOiNhZ8Zirp9X1I1agwBt/vszyf/8SqazU4oMPrsPfX0Ssy+Ojm+mpKuLarU8jiIQySKWPT9LS/BW2tmGwtAwgAn1Q4sYUMSlBUW7Y8/DJIRu2P4YfLcNvXvkeYQEZqC599lTML9Jo3nRNUSssLobg9dfPob6+B1KZBq///gxxbbauL/tLQNc+CEvzYIwObz3hu3JrlVXs6OjohZ+XENOT69ULH2VoaBoeHrFobOzQnzFNTE5Qt1bu4NKlIBz84BrGJ6ZY+q//JKKytopAGYltnqVYwPM0dW4zG82Tp1fir5/dwP63zclNNIyMDDV+97tTyM1bTzdmDNDtDTThPivIPb1A2vojzW67tkOjY88yRVCYr8Ghg1eQnPzwxPBWbHf4fbcxOUFR7txZw4WzgThwwAIDA2OordHhvXfNcegDG8QRF5BuEnxaOZtnaXTggYqzNL8JXu6JePXV8zAzCyQingOPl43XXjsFufzhod/doq6+A34+YnxxxB4H3rTAewcsSbNi7Z23zPH+fiuc+t4DMTE5P2XHNSTTU3Nwd+JjZNh0M0A9KyYpKApdquLllYA33jiPFEkhy69Hi3O9RmKbr7+iBdfyUMoKrrWzbfPPsrKcuoxURHTQgWZXCvZJx6H3rfHuuxbE918v6mZ5JQRvvXWFuHyd+r9kd8nLryWx5Hf48+/O4tODNvjmc2ec+cYDp0mjjz8cd8NXRxxx6N1r+P1vT+Gd/Zbo6R3RP9tQ/Ij721yaZCqYrKA2oJUy3n33Cs6f92VzIjS7rLOjAG++eRkffWgN+2s8xAuUTCDUatEJYU0xfXzQ6HkqOnlWFSKCsnDlUgjefdsChz+2RmR4BhNrerqKBN/mOHfODxMTW8cBhoauLvjicwfse/USzM/64/IpX1w46YNz33ltat64SM5dPuWHSyd98cr/O4GiItOpZmFqmLygKLSy3g1HPva/ZQZn4lp0dA6jq2sAWdJS/PC9Oz4+eB2HD9nji88c8d03rrhy/iaxNOEkmA7HRfLzt8SiHT1ki48/tsGHH16HtU04VKpGdHcPQqGsxLFjTvjoo6tsO4kxUVXVjF//32/wu1fO4eBbVjj6kQ2OH72Bb4+54MQXLuyRtmPEQn3ygTXe2WeO//2/jrPEnRw7w54Q1Aa05A0tT/kuiafOnfNHaloJW1w5OTmP6hotklPymJtIk+B7eorhQZtHPMKCUpGVUcR2pdK0y2VldQgMTCUissHRo45sCY2hEuQ/DwpFKV5/7Qxe+T8niJW6iN//xyn8x7+fxKu/PY3X/vMUEdoP+K9fn8ar/3UG7//FAkeIqN7edxlHP7HBreVf1ooOQ7GnBLUBnROKj8/Hd995EEHY48QJN1y7FsJqOtENgDTZfHl5M2u0+qBUpoZ/QDwuX/bFcRJzfP6ZLRxsI1jGWppS2VgpK61CTEwmzp71wXsHLPDNsRuwsgzGTf8kRIalk/9XCjdXIT771Bp//MM5/Oe/n8AnH1qxEdKpKeNNZ2zK7ElBbYZaJ7W6BpGR6XByEuLq1QhYWYWRFs6apWUYbGx48PERszIura09bBTRFCgqqiBuqIqNdKrVdQgLSyMWNw7RYakQhKYiLCQFISEShPmL4e0ei2vXI1l1kONfe2BkZG8WhNtt9ryg9jKlpdXIzlaxXbR0LxZdBjUyMoV2XT+aGjuhqWhGWXkTmpu60NU5yIpLt7cPwNk5BktLxlu0zJThBGWk0GJjNDH/KBEIrTxCV2FXVTUyAeXklEIuL2X1Z728olmNK+r60SYUZpJjKeJiZIgXZrMWJ5Ahli9lLSgwERfPeSMtpYC8lhq+vslwc4tHQGAKS8rf1tqFhQXTKxRnLHCCMiJocbkqEt+lJCnB52fA1jYK3h4iEg9mIzExG/n5pSSua4RG08xaVVUrqqtbWX66xxr5fSWxUI829jxNC/u5grTSUvp8LbFkrVCVVEMYkwF7h2gkJyowODiu/8s4nhVOUEYAXX1dkFcJTxcBbvolQFVcC5qBdrdiucWlFeTKNaywGS27acw1bY0NTlC7jLqkFl5uMeCFp0JrZFX56LrA+Hg5cQkFqK/fW3kydgpOUAbm1q1VaLX94EXQBCe+MDfzhTy7lOXMMFaamzvh6BgBsUiBlRXjnUYwBjhBGYDVlTtQyCsR4C/GdYsAVhz7wH4znDjhAl50OqIjM3HmlCfyidtnrNCOQBSXw+ru9hp8LaDpwAlqh5meXsD5s74wu3wTMlkFWts6WWaf2dmH54G6uwZwzSoITU3Gsej2SZSX1+P69SAUFRmv+HcTTlA7jFiUjchICSLCkkkv/3S3rrmlE26O0WzI3Jjp7x+Dj2cMhMIsLC5yQ+yb4QS1g9CNfU4OUeznjLQCuLny1/edPIX4WCka64x/AIBmK0pPz2OJKVtbH60Q/8uFE9QOMjQ0weaTKLdu3YbZeR80PGW0bG3tR3a9RtOoP2P80Hkte/tw5OaaTlG5nYQT1A5CE917uQt/2tZNM6462IVhbv7hhalLS7dY/SMvrzi2woGm4DIl6Jb7oIBE+PrEY3pmPSXYLxVOUDsIFZK/fxxaSGxEWVu7ywqWnf7BAzKZCumSIvh6ixFyMxEBAWK28uFFWFu7z5Yn7TapacWwtQ4jLqtpJ1rZDpygdhiaxcfJKQLLyw9qwdaTGIkuJUqV5KMgrxZDA9sTQ3l5A3KeWlXQcLTrBuDlEQOxONfoB1d2Ak5QBiA5OQ+BgUkvfVL0FhFpcXE1y3nh5ydCX98QJifmcPv2HdZ2K4MQTfYvEGSwrLC0asovCU5QBoCm2kqKVxBLFQVtW6/+7ItBMwhVE9cwjYjU3o7H6ibRjZBKeRkSE7Lh75MAK6sIWNvwwOdlIiMtH0plFTra+3B71bAV0wsLa+HizENBQY3+zN6HE5QBKS2rR2S4BLzwdGRmlqC5QYf29i4S/4yxGGhwcGxTG0d//yja2jpQXd2IRCJIWpE9hp+G8NBU5OdqMDu7oH/lrZmamkGFphGxQgWExGKEhIoxYGCLMdA/zkQVGJjMUjPvdThB7QK06DOtx3vye1e8ue8MAgJERGCFbMdwQkIOq7dEH2mZGIWimPTwpSgsqEJTYzfm5p4sIlqGlGY0ysvTsBzhJSW15HnVqNS0Ess2zyyGjU0oenqGMNA3Co2mxSAryVfv3EFMTDZcb/CIhTb+omnbgROUAaHbMWgB5sjIZPD5MoSFS8GLkiIsNAmpyfksXdl2oIksHR34RFTVUKlqoS6tQ7a0FFbmoXC0DWfXeHsn4s03ziEiJAVp6cVsfsxQNDR0wMEhAhkZxjGAshNwgjIQHR2DuEF66OCgpMeEQ7emSzNUcLQJQ1pqwQtlWJqcnEZQQDzm57ZOvkJzwg8OjKO4sAYW5r7w9IjBj7tQaZFa2MDARISFJRlNfsOXCScoA1BZ2QoXp2jU1+n0Z7aGCo0vyIKvVyxqqtqeyx2jE8N0K/yTcHKKJRaiG1XVzVAoy1mp1anJ3UnUQldfyXMq4H4jGpryFv3ZvQEnqB2mu3uIWIfIJ1an2IrWli5EhqUiNCQRUqkK3Z0DrBDA01CrGxEaunWldFrozNc3jiVzofNDOeRmNga6Ovtx/VoYRHHZWN0j+6w4Qe0wkkQlCgtebKtDJxESrVghFKQj0C8BdnZ8WFvzYGvLIy5TKuTSElSU10HXPkQsVCf8/GLZqNqj6Np6EBeTyVxJWlFw2IhyRdAJ72heFny849DXN6Y/a7pwgtpB6EqBG/bRJG5Y1J95MagQZqbnQbPaDg5Oop+IRqfrR11tC7KzSthAAz86E6e+d8Vrvz8NAV+KNmLlBgaGWObcSxd94e0WB3//JJw/726UNZhoXkFr6xCUlNT83IJ8o4YT1A5Cs85euHjTYEPTg4OjUCiqiFUrRFZGHrJl+UhNlbNh+SRiKYsK61Df0I7AgAQIY7KxsmJci3Dp/FtUlAQODtGQSHKJuCpRW6tDc3MvS6dmCsliOEHtIFRQly8H71pl+CctPZqZXkBwYCKCgpNJbGZ8scvw8DSamtpRUFDGksTQ/POR4Wkk1spkBbHppHh7e49Rbm7kBLWDUEFdvBjE1tXtFnRAgmYsSk6Ws71W9sQFpZPK8SI5oiLTUJBvGvuYqNs7MDDMctNnZBQTC6aAu3scfH3ExO0tRImqhqXRnp7e3RTTnKB2EDqRa3M9AktLu9OTrq6uQizOIQKKY7kg6HKm2dklzM8vIfRmMiTJBQj0TfjZEURjhHYUdFKaFoaorW1mq0v8/cUQCtMhEGQhOlqGysomtqzLkPkNOUHtIDS45kWloLS0Tn/GsCjlGgQFJG0Z5CclFZCbLgeSlFxotd36s6bP/PwisVS9KCTxolyuIi5iCpyd+Ygj7mJebjmrtkKzNq2t7UzNYU5QOwxdN2dnF0a+yCb9GcPB52ezleZbQXtvhaIc2dkVSEz8+WLSpsr9+/dZrNXZ0Yd8pQYBAaksaU5f386kQuMEZQDa23thbR0MqdSwa9gyM4tQV6fVHz1MdXUzSkqqkZVVAV/fFP3ZXwY0HtupuJYTlIGgZUt9feOJC5jOcvUZArqxsaamTX/0MNnZZUhLK0Fhfi2E/Bz9WY7twgnKgFD3IyO1GB5uApRXNLLkLDtJUlIhvDxEJHh/fFAkLDgVufIqCAVStDYad3JNU4IT1C4gSSnER+9dhqsLH4KYLNTWNpFYawQjIzMYH19vY2MzbBU6rRFFhUdHtGggfe/ePTbC9aykSfLh4RELH694JIhyIBRK4WTPg71NGOKEWbgZlKC/kuNlwAnKwFRWtMD6eigLkunsf1VVC4mtChAaKoGlZQRbq0cb3cbu4hLLsrNSEfB4qcjIUEImyyOPeazgmlxRhmypGmmpJZBISpCaqvqp0ePMzFKWL4/HS8cNp2CcP+OOzz93xJfHXODmEsfWzwURQbW37+1Nf4aEE5SBcXaKRlPjs2WGpfMnCwvLbB5renoW/f1DbHKTDnJoNE1EjM0oL21AMnHthMJcxMU9aEKhksRIKlZ8ratrgFi9SbTrelmqMloJsbi4igivAAJ+Bq4TgbdtM9cFxzqcoAwI3VzH56eyiVVD0tk1hGieFOFBKRDypURMFaira0FjQwe83GPZhKi7O9/gf9dehBOUAWlt7SSuWA6LgwwFTQdtZRWMwoK6LTPSVte04ebNeOJu+pPrAtm+Ko4XhxOUAaHuV1pagf7IMNBK8XL5k+e/ZmZmSUwmJy0XSUk58PFJQHhYMrqJVeN4fjhBGRANEVRGRpH+yDCUl1dDrdLojx5nYmIKWVl0F68a+fnrGyFLimtwwymSZV3aasMix5PhBGVA6mu1SJXk6o8MQ11dG8vp9yRo7r6sLCXS0/OZqDagO2nT0orh7MhHUmKeQReYmjKcoAzI9NQsAv3jMDU5oz+z8wwPz+D8eX82t7UVHR0DEAozIZPlo6Xl8dFHOgfW1NS1Y4tJ9xqcoAwMzZPn7RVDLIDhilTn51fAxiaEzV3RXbF0wpgWTKONTvxGR0lhZx+CzMxi/TM4XhROULuARFIEZ+dItmXdUPT2jhIXLh/x8TJEhKbBwSEGTk5C4tJFsnzoocHJ5Ocolk2W48XhBLVL0AT69sQqZGWVsGF0WlCAJnWhVoPGL4tLK8yS0GHvB20cY2OzbKL3zupddv3PLUOi6wc33DW6FX9kZAqdnX0oLa2Bn18SfHyEyExft0wD/aNEaLuz1WSvwAlqF6Gb4cRiBT7/3BpeXgKWzzwyMg22tlG4Yh5GLIYAwpgsYlWyIRLJkJhI8yuIYGkRjvCQFMTFypAuyYVCWYSc7ALkKsugVtcjN7cKAkE2q0GVlJRNfk6HmVkgTp/2wxdf2JP3SIJKpUFZWQtbBb+Z7u4RtiHy3j0TTj20i3CC2kVGhqdZXgc691Nfr2XpxtbjmzVmsZ5kfajFmZ1dxOTkLBFAPzo6e6DTdqOijOZbKMKxY7aws4tGUVEtenoGMT4+BUvLYDQ2diHQPwFVmherlMjx83CC2iVmphbgZBuO4oKtd9S+KFptP7Nij+LkFEPiozYIohVQyl/ue3I8gBPULsGPyoRMqtIfvTzGRqfh7RGDvv5h/Zl1IiMzIJeXI8BPjNqaZ1ucy/H8cILaBWbn5omlSGXZYHeCbFkZ3NyikJmezwoDyDKL4ULisRhBFo4etiAuIrddY6fgBLUL0NIzKZLsHZ2LmpmZR2tzF5pbOlFT1YKCPA18PIX47jt3qFTcKN5OwQlqF1hbW0NgoJglZtxpmuo7EBqcAjcXPptjsrcXsHTNHDsDJ6hdglZvp3m8Xwa3V1dZwkdt2wAaG9pRVFgBYYwMtnaR8PcVsS33HR39LKuqjU0UlMpq/TM5XjacoHaJu3fvwc2Vh7LSF3O/iotrERychvCwdIhiMhEclAjraxGIiJBAkpwHeXYZysoa0dk5iP7+MbZmb3R0khPUDsMJahcZGhiFvXU4KiqefV6IFgCglSlcXQUskeVnRx1ZtcPlxVuIi5XD3DwEnV3DLDtqV9cQExLNGUEbJ6idhxPULkPjKGfnaOKWFTCX7GlMTc0Rq5SMoKBktuxoamoeFy7cxPjEDCbG55Acn0MsVBoTUw9pG0LiBGU4OEEZAXSFRGZ6EZwc+AghgikpqmEVCWkJz81V2unCib6+BwtqOzuHcelSEKqqtLjhwIMgMg1nTnnB3iaSJW+h6YY3C2psbBJXr0ZALn+xioovyhpxb1tbepmbu9fhBGVELC+tQqftgTS9hAhLgjhRFuLi0tkav5CQdPj7pyA0lMRLwelITFSyTLTniYWSphYhjcRNk5MzsLEKguXFEJz53gvZ2aXMWm0Iii6uDQhIYgnzDUmlpgkhxKrS5VR7HU5QRgwtRzM6OoGenmHU1LRDrW5GaWkzW0JEi2HTtXoXiYWSEeumkKtZFXknmzAkCfLh7ZqI48fdodX2soEJKigqLokknwjLcLVsx0ZnYGYWQOK5Qf2ZvQ0nKBNmYGACly4HQ5pWBHm2ilkoR+swiHgKCMJl2LfvIhFdzU+u38DAOGJiskjMxkNhYSV0ui4MDk5gdnaZldukWz1eFnRhLy1C7ekqREPt1vnV9yKcoEyYri4SQ20IKkeNiYnpnwQVHSrFvjcuEEFV/yQoOijh6MhnrmNVVROysvJYxtpLl0LIYzJLcaZQFCNXqYEip5LEWlVsEvhJjf5eKi1lyV0KCmirYj/n5FCLWQirK/6wsAiAWtXIkm3eu8/FUBxGzIagZBnFUCrKmHvoRAQVFyUnFiob7x+wIJaoCr2bBGVtHUnO1etfYR06WEBHEHt6BlgCzAIiCqFAjvDwLERESJ/Y6O9TUgqIK1oLlWq90Sru9DV6evpZptu6Oh2i+XKIYqUIu5nM9ntpNPUsjzvdTLnX4ARlwjxNUCKeHMeO2DGrsTEwsZvD5vfW7mGIuJzV1W3IzMyDg4MA0VFpSE3JRy05t7LyYDTTlOEEZcI8KqgRIih7IxXUo9ABv8H+UUgzVYgTynAzQIxw4n5qypswOTGrv8r04ARlwmwlKFu9oOKIoI4YsaAeZYKIiBaHi4nOgodbDKIj0pCrqMDY2LT+CtOAE5QJs5cEtZlVEltRNzA1qQABvvFs4EStrsPw8JT+CuOFE5QJs1cFtZnFxVvo6OgDn58JT08heUxHQV41Foy0UggnKBPmRQR17VokG+42RehcGa1vlRAvh7+XCAJeOnMTH83ctJtwgjJhnkdQdD9UH3m0sY0i7pPp79hdXFhmueIjw9MRHCJGTIwUdTVatmh4N+EEZcI8j6A6Oweg0/Uj0C8B2pZu/SvsDeh2f5qPUCSUwts9FpLkXDQ0dLGlW4aGE5QJs5WgNobNtxQUcfsCfRPQ1ry3BLUZup4xX6mBl1c8s1wSSQEGBw1XkocTlAnzqKA2T+z+UgW1GbqoWJalhrdnLBFXIokjd76OMCcoE4YT1LNBM/E2NrajpaVLf2bn4ARlwmwWVK6yfF1QNuGcoHYRTlAmDBXUZSIoaTotFlC8LijHaMRHK5mojhzlBGVoOEGZMMxCXQpiGw29vePZaJe9fSQEETKkigpx+GMb5OdVstXmnKAMAycoE4YKiiZpoXNMtrYRSE9XQRAjxfFjDvjkoDU+/8QBDXXtbHcvJyjDwAnKhKGCOncugC0g7esbIKKKhLMTH9fMb+LwYXukJBf+tLmQE5Rh4ARlwmwIitbNXV5eIsKaQqWmBRVljcRqDbLYiYrpJ0HRid0AIqhWTlA7BScoE2azoObn5zEyMoGOzkE2/0IFtCGmhwQVSATVxglqp+AEZcLQvHxnzvizLEZUUMPD49Bq+x4S0qOCCmCC2n6Rgrt37+L27VW2vGe93WHHs7MLbLUC3VL/cFs/t7x0i1374Hmr7Hl37tzRv7JpwwnKhKGV3WnqZZr8cn5+gQhq8omComm86uvbEUQENTCwdRoxmrl2YGCIXN8NjaYRpep6JCcWIIqXjdgYBVIlBazkaFpaATmfjcxMJTleb/Tn1FQ54uKkEAqliI19vAmFWUhMkD30vPXnKiCRyNnrpqcXknOFSEnKQ4xAjmh+DnmekmVvqqhoQGVlM/lfaEq0AVbqdGGBZmwyntwUnKBMmMnJOfj6JKCpqZsIapkNTrS19T4mpnVBDaGKxFehN8WYmHywC7abuIipEiWcXYQIDk4iN7UcMlk+cnJUUMjLkZVRirR0NfJyq9HU0I7m5k40N3Win8Rn9Iam2Wg3Gp0HWyIWiK74pjf55kYTstDHqekZcu3EQ88bH59kVpa+dlNTB1paOtnK8ZxsDRFXKRFcGUvamZtbQf4uNTnOQ1aWkggtDcIYKbzc42BpGc6mDsRiOaREkEWF5Sgvr0NtrY4tlNXpBsh7TbEsvdS67hScoHYAmpNuo92+fZft19ncaGHq/v5hdHR0E1eMJqJcbx0dPaznpa4RLUq9tvb0PHkzU/O46SdGfUMn6alvYWJi5omConFVYWENi6Eo9D14vDS4OvGgyCnD2PgsS/t8757xp/r68cf7LIcgdR3p3zw/v0T+n3mWY7C3dxgtze2orm6EUlmGpKRcVnPY1TUeItF6ZfzUVAXLvHvzZjqSkwvZbuCRkZezG5gT1CZonaWlpWVWqnNocJy5RvX1naiq0rH84eXlTcTlaGVps3JzVSgsKoNcVox48kXRL4umTPb3T4KFRTiuXo1kvaatbfRPLhB1eWiju09TUuTkCy+CXF74U1Moikjvm8uuuXkzmeXLCwuTIEdaTHrcKmaJFhYe7FSlNxItY1Nb2465qWXMTS9B27a1y9ffP0p69VK4uApRXtYMN+co5mLtlWxDzwKtnr+wsMisYWtrN/Lyash3UEk+8wJy3Km/anvsWUFR60A/wNu377Dea2R4gtxY3eSm1IEmZVQoyslNm4aAAAm5gbNJT6ZEkjibuBhyJBE/n4ojPj4Hnp5i0sMlsOuyslTM5Sgo0BA3oo28lpa4KTp2sw6T16cCHBubYdu2N9ry8gpzdx5tT8rSSv9u6pLQ3ndu7haGyOs2NeiQIs5jWxIEAgn8/JJQWtqAmdkFiGJlKCQ3xszkPBbmb5H/8eHRPdpoKmbq7ohEudj/1mV4Eheps6NP/44cLxOTExT1z2kAPj46he7uQZbnu6S4AaqSOhK4VpJep4T0/jlsB6ejowDXrkUgPFwCMRGHjPREeXkqlk21hFyfl1eLYvJc6ibR1xolQf3s7DwRwhJLbE9vbmODZoeliSrj42UI8IvHt185wYMIZJbEBrdvrzGXh66coCKibt7gEB356yViUuDCWW9EhaXj7p3d3dW6lzEaQVHfnfbKS0srpDedJjf4AHG3Wog1qEBiQi7c3BIQFp6BhHhiTcRSJCdSCyInViYVocHpyJapmSvW1tbBnktLZNIAmQbC9LX3YuWHRRI3Zaap4HQjmnw+ccTqVqCmRoe6unbW8vKqEBqUTDoWHnx84qFr3fn9QL90DCYoKpaZmTkMEPeooZ582bk1JA6pRHZ2MWSyAuZieXsnsLgjPDwNEuKC5SpLUKKqZj4/rfKn0/Ux12qWBPUrt385vv/PQa02jfGSkhQsd/mlS8EwNw8ln2MqFPIyZqk4DMO2BbUx2rK4uIzx8Rn25dHYQq2uQmpqPhGJmAklNpYE4skypJAvPS4mB2GhGcjILEZZWT0RSheb5Z+bW/7ZkS0ODmPmuQVFA/CMDDVpKkilhUhLoxNvGcTlEMLWNgrR0ekkeM8nsUkFsSpNqK7WscCYBsU0Nllb4/x3jr3LcwmKxuiVlVpWfTwjo4SIhc5a97FAeWXF8BlmODiMDaMZlODg2AtwguLgeGkA/x85EDHfSxiuVgAAAABJRU5ErkJggg=="/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image11"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <contained>
          <Binary>
            <id value="image12"/>
            <contentType value="image/png"/>
            <data
                  value="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"/>
          </Binary>
        </contained>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image1"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image2"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image3"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image4"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image5"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image7"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image8"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image9"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image10"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image11"/>
          </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
          <valueReference>
            <reference value="#image12"/>
          </valueReference>
        </extension>
        <identifier>
          <system value="https://www.minzdrav.gov.ru/"/>
          <value value="0d69fdcb-33cf-407f-8209-a6529856ab4f"/>
        </identifier>
        <status value="final"/>
        <type>
          <coding>
            <system value="https://www.minzdrav.gov.ru/"/>
            <code value="100000155538"/>
          </coding>
          <text value="Package Leaflet"/>
        </type>
        <subject>
          <reference value="MedicinalProductDefinition/mp50mg"/>
        </subject>
        <date value="2023-08-16T00:00:00Z"/>
        <author>
          <reference value="Organization/orgpfizerusinc"/>
        </author>
        <title
               value="Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection"/>
        <section>
          <title value="MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title
                   value="INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text
                    value="INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									<b>Registration number:</b> LSR-006652/09
								</p>
								<p>
									<b>Invented name:</b> Enbrel<sup>®</sup>
								</p>
								<p>
									<b>International non-proprietary name:</b> etanercept
								</p>
								<p>
									<b>Pharmaceutical form:</b> solution for subcutaneous
									injection
								</p>
								<p>
									<b>Composition</b>
								</p>
								<p>Composition per 1 mL of solution </p>
								<p>
									<b>active substance:</b>etanercept 50.0 mg;
								</p>
								<p>
									excipients: L-arginine hydrochloride 5.3 mg, sodium chloride 5.8 mg,
									sucrose 10.0 mg, sodium hydrogen phosphate dihydrate 1.2 mg, sodium
									dihydrogen phosphate dihydrate 2.9 mg, water for injection to 1.0
									mL.
								</p>
								<p>
									<b>Description</b>
								</p>
								<p>
									Clear or opalescent from colorless to yellow or light brown liquid.
									Small transparent to white amorphous particles are permissible.
								</p>
								<p>
									<b>Pharmacotherapeutic group:</b> tumor necrosis factor-α (TNF-α) inhibitor
								</p>
								<p>
									<b>ATC Code:</b> L04AB01
								</p>
							</div>
            </text>
          </section>
          <section>
            <title value="Pharmacological properties"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Pharmacological properties"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml"/>
            </text>
            <section>
              <title value="Pharmacodynamics"/>
              <code>
                <coding>
                  <system value="https://www.minzdrav.gov.ru/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="Pharmacodynamics"/>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
									<p>
										Tumor necrosis factor (TNF-α) is the main cytokine maintaining the
										inflammatory process in rheumatoid arthritis. An increase in the
										concentration of TNF has also been found in synovial membranes and
										psoriatic plaques in psoriatic arthritis patients, as well as in blood
										plasma and synovial tissues in ankylosing spondylitis patients.
										Etanercept is a competitive inhibitor of the binding of TNF to its
										receptors on the cell surface and thereby inhibits the biological
										activity of TNF. TNF and lymphotoxin are pro-inflammatory cytokines that
										bind to two different tumor necrosis factor receptors (TNFRs) on the
										cell surface: 55 kilodalton (р55) and 75 kilodalton (р75). Both TNFRs
										are present in the body in membrane-bound and free forms. Soluble TNFRs
										regulate the biological activity of TNF.
									</p>
									<p>
										TNF and lymphotoxin exist predominantly as homotrimers, with their
										biological activity dependent on the cross-linking of TNFRs that are
										situated on the cell surface. Dimeric soluble receptors, such as
										etanercept, possess higher TNF binding affinity than monomeric receptors
										and, therefore, are significantly more potent competitive inhibitors of
										TNF binding to its cellular receptors. Moreover, the use of an
										immunoglobulin Fc region as a fusion element in the structure of a
										dimeric receptor prolongs the blood serum half-life period.
									</p>
									<p>
										The significant portion of pathological processes in joints in
										rheumatoid arthritis and ankylosing spondylitis, and also skin
										pathologies presenting as plaque psoriasis, develop due to the effect of
										pro-inflammatory molecules involved in a network controlled by TNF. The
										mechanism of action of etanercept is thought to be its competitive
										inhibition of TNF binding to TNF receptors on the cell surface. Thus,
										etanercept prevents TNF-mediated cellular responses by rendering TNF
										biologically inactive. Etanercept can also modulate biological responses
										controlled by additional downstream molecules (e.g., cytokines, adhesion
										molecules or proteinases). And these responses may either induce or
										control TNF.
									</p>
									<p>
										In patients with active psoriatic arthritis, Enbrel<sup>
											<sup>®</sup>
										</sup> inhibits the
										progression of structural damage, improves physical activity and lowers
										the likelihood of development of lesions in the peripheral joints.
									</p>
									<p>
										After discontinuing treatment with Enbrel<sup>
											<sup>®</sup>
										</sup>, the flare-up of the
										disease is possible within a month. The efficacy of the repeated
										administration of the medicinal product within 24 months after
										discontinuing the therapy is comparable to that in patients who have not
										interrupted the treatment.
									</p>
								</div>
              </text>
            </section>
            <section>
              <title value="Pharmacokinetics"/>
              <code>
                <coding>
                  <system value="https://www.minzdrav.gov.ru/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="Pharmacokinetics"/>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
									<p>
										Etanercept is slowly absorbed from the site of subcutaneous
										injection, reaching its maximum concentration in approximately 48 hours
										after the administration of a single dose of Enbrel<sup>®</sup>. The absolute
										bioavailability is 76%. When Enbrel<sup>®</sup> is administered twice a week,
										steady-state concentrations twice as high as those observed after a
										single administration are achieved. After the single subcutaneous
										administration of Enbrel<sup>®</sup> 25 mg, the mean maximum plasma concentration
										of etanercept was 1.65 ± 0.66 µg/mL, and the area under the
										concentration-time curve (AUC) was 235 ± 96.6 µg⋅h/mL. There was no
										apparent saturation of clearance across the dosing range.
									</p>
									<p>
										The dependence of the concentration of etanercept on time is
										represented by a biexponential curve. The mean volume of distribution is
										7.6 L, whereas the steady-state volume of distribution is
									</p>
									<p>10.4 L.</p>
									<p>
										Etanercept is cleared slowly from the body. The half-life (Т1/2) is
										about 70 hours. For patients with rheumatoid arthritis, the clearance is
										approximately 0.066 L/h, which is somewhat lower than a value of 0.11
										L/h for healthy volunteers. The pharmacokinetic properties of etanercept
										in patients with rheumatoid arthritis, ankylosing spondylarthritis and
										psoriasis are similar.
									</p>

									<p>
										A single 50 mg dose of Enbrel<sup>®</sup> is bioequivalent to a dose consisting
										of two practically simultaneous injections of 25 mg of the medicinal
										product. Although there is elimination of radioactivity through the
										kidneys after the administration of radiolabeled etanercept to patients
										and healthy volunteers, no increase in the blood plasma concentrations
										of etanercept was observed in patients with acute renal or hepatic
										failure. In patients with acute renal or hepatic failure, no increase in
										the concentration of etanercept was observed.
									</p>
									<p>
										There are no significant differences in the pharmacokinetics of
										etanercept among men and women.
									</p>

									<p>
										<em>Elderly patients</em>
									</p>

									<p>
										The clearance and apparent volumes of distribution of etanercept in
										the group of patients aged from 65 to 87 years are similar to those in
										patients under 65.
									</p>

									<p>
										<em>Children</em>
									</p>

									<p>
										<u>Juvenile idiopathic polyarthritis</u>
									</p>
									<p>
										The blood serum concentration profile is similar to that of adult
										patients with rheumatoid arthritis. Simulation suggests that while older
										children (aged 10 to 17 years) and adults have roughly the same blood
										serum concentrations of etanercept, younger children will have
										appreciably lower levels.
									</p>
									<p>
										<u>Psoriasis</u>
									</p>
									<p>
										The steady-state concentrations of etanercept in the blood plasma of
										children aged from 4 to 17 years with psoriasis and children with
										juvenile idiopathic polyarthritis who had received Enbrel<sup>®</sup> at doses of
										0.8 mg/kg once a week (the maximum dose of 50 mg per week) and 0.4 mg/kg
										twice a week (the maximum dose of 50 mg per week) over the course of 48
										and 12 weeks were similar (1.6 to 2.1 μg/mL). The value of this metric
										coincided with that of adult patients with psoriasis administered
										Enbrel<sup>®</sup> at a dose of 25 mg twice a week.
									</p>
								</div>
              </text>
            </section>
          </section>
        </section>
        <section>
          <title value="Indications for use"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Indications for use"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								<em>Rheumatoid arthritis</em>
							</p>

							<p>
								In combination with methotrexate, Enbrel<sup>®</sup> is prescribed to adults for
								the treatment of moderate and severe active rheumatoid arthritis when
								response to disease-modifying anti-rheumatic drugs (DMARDs), including
								methotrexate, has been inadequate.
							</p>
							<p>
								Enbrel<sup>®</sup> may be prescribed as monotherapy in case of inefficacy or
								intolerance of methotrexate. Enbrel<sup>®</sup> is indicated for the treatment of
								severe active and progressive rheumatoid arthritis in adults who have
								not been previously treated with methotrexate.
							</p>


							<p>
								<em>Juvenile idiopathic polyarthritis</em>
							</p>

							<p>
								Treatment of active juvenile idiopathic polyarthritis (seropositive
								and seronegative) in children and adolescents aged 12 years and older
								with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup> in the
								pharmaceutical form of a solution for subcutaneous injection), who have
								had an ineffective response or intolerance to methotrexate.
							</p>
							<p>
								Treatment of extended oligoarthritis in children and adolescents aged
								12 years and older with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup>
								in the pharmaceutical form of a “solution for subcutaneous injection”),
								who have had an ineffective response or intolerance to methotrexate.
							</p>
							<p>
								Treatment of psoriatic arthritis in adolescents aged 12 years and
								older with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup> in the
								pharmaceutical form of a “solution for subcutaneous injection”), who
								have had an ineffective response or intolerance to methotrexate.
							</p>
							<p>
								Treatment of arthritis associated with enthesitis in adolescents aged
								12 years and older with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup>
								in the pharmaceutical form of a “solution for subcutaneous injection”),
								who have had an ineffective response or intolerance to standard
								therapy.
							</p>

							<p>
								<em>Psoriatic arthritis</em>
							</p>

							<p>
								Treatment of active and progressive psoriatic arthritis in adults who
								have had an inadequate response to DMARDs.
							</p>

							<p>
								<em>Axial spondylarthritis</em>
								<em>Ankylosing spondylitis</em>
							</p>

							<p>
								Treatment of severe active ankylosing spondylitis in adults for whom
								conventional therapy has not resulted in substantial improvement.
							</p>

							<p>
								<em>Non-radiographic of axial spondylarthritis</em>
							</p>

							<p>
								Etanercept is indicated for treatment of adult patients with severe
								course of axial spondylarthritis in the non-radiographic stage, in whom
								an inadequate response or resistance to standard treatment has been
								observed and who also have objective signs of active disease confirmed
								by an increased concentration of C-reactive protein (CRP) and/or MRI
								scan data.
							</p>

							<p>
								<em>Psoriasis</em>
							</p>

							<p>
								Treatment of adults with moderate and severe psoriasis, who have
								contraindications or intolerance to other systemic treatments, including
								cyclosporine, methotrexate or PUVA therapy.
							</p>
							<p>
								Treatment of children aged 12 years and older with a body weight of
								more than 62.5 kg (for Enbrel<sup>®</sup> in the pharmaceutical form of a “solution
								for subcutaneous injection”) with severe chronic psoriasis, who have had
								an intolerance or inadequate response to other systemic therapy or
								phototherapy.
							</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Contraindications"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Contraindications"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								Hypersensitivity to etanercept or any other component of the
								medication. Sepsis or risk of sepsis.
							</p>
							<p>Active infection, including chronic or localized infections.</p>
							<p>
								Patients aged under 12 years with a body weight of less than 62.5 kg
								(for Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous
								injection”).
							</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Precautions"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Precautions"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								Demyelinating diseases, chronic heart failure (CHF), immunodeficiency
								conditions, diseases that cause predisposition to the development or
								activation of infections (diabetes, hepatitis), moderate and severe
								alcoholic hepatitis, hepatitis C, blood dyscrasia, diseases of the
								nervous system (multiple sclerosis, optic neuritis, transverse
								myelitis).
							</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Use during pregnancy and breast-feeding period"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Use during pregnancy and breast-feeding period"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="Women of childbearing potential"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Women of childbearing potential"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									Women of childbearing potential should consider the use of
									appropriate contraception to avoid becoming pregnant during therapy with
									Enbrel<sup>®</sup> and for three weeks after the discontinuation of the
									therapy.
								</p>
							</div>
            </text>
          </section>
          <section>
            <title value="Pregnancy"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Pregnancy"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									The effects of etanercept on pregnancy outcomes have been
									investigated in two observational cohort studies. A higher rate of major
									birth defects was observed in one observational study comparing
									pregnancies exposed to etanercept during the first trimester, with
									pregnancies not exposed to etanercept or other TNF-antagonists. The
									types of major birth defects were consistent with those most commonly
									reported in the general population and no particular pattern of
									abnormalities was identified. No change in the rate of spontaneous
									abortion, stillbirth, or minor malformations was observed. In another
									observational multi-country registry study comparing the risk of adverse
									pregnancy outcomes in women exposed to etanercept during the first 90
									days of pregnancy to those exposed to non-biologic medications, there
									was no observed increased risk of major birth defects. That study also
									showed no increased risks of minor birth defects, preterm birth,
									stillbirth, or infections in the first year of life for infants born to
									women exposed to etanercept during pregnancy. Enbrel<sup>®</sup> should only be
									used during pregnancy if clearly needed.
								</p>
								<p>
									Etanercept penetrates the placenta and is detected in the serum of
									infants born to female patients treated with Enbrel<sup>®</sup> during pregnancy.
									The clinical impact of this is unknown, however, infants
								</p>

								<p>
									may be at increased risk of infection. The administration of live
									vaccines to infants for 16 weeks after the mother’s last dose of
									etanercept is generally not recommended.
								</p>
							</div>
            </text>
          </section>
          <section>
            <title value="Breast-feeding"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Breast-feeding"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									Limited information from the published literature indicates that
									etanercept has been detected at low levels in human milk. Etanercept
									could be considered for use during breast-feeding taking into account
									the benefit of breast-feeding for the child and the benefit of therapy
									for the woman. Although systemic exposure in a breastfed infant is
									expected to be low because etanercept is largely degraded in the
									gastrointestinal tract, limited data regarding systemic exposure in the
									breastfed infant are available. Therefore, the administration of live
									vaccines (eg, BCG) to a breastfed infant when the mother is receiving
									etanercept may be considered 16 weeks after stopping breast-feeding (or
									at an earlier timepoint if the infant’s etanercept serum levels are
									undetectable).
								</p>
							</div>
            </text>
          </section>
          <section>
            <title value="Reproductive function"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Reproductive function"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									Preclinical data on the peri- and postnatal toxicity of etanercept
									and of effects of etanercept on fertility and overall reproductive
									performance are not available.
								</p>
							</div>
            </text>
          </section>
        </section>
        <section>
          <title value="Posology and method of administration"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Posology and method of administration"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>Subcutaneously.</p>
							<p>
								Treatment with Enbrel<sup>®</sup> must be prescribed and monitored by a
								physician experienced in the diagnosis and treatment of rheumatoid
								arthritis, juvenile idiopathic polyarthritis, psoriatic arthritis,
								ankylosing spondylitis or psoriasis.
							</p>
							<p>
								Enbrel<sup>®</sup> in the form of a 25 mg ready-for-use solution (a single-use
								syringe containing 0.5 mL of the medicinal product) and 50 mg (a
								single-use syringe containing 1.0 mL of the medicinal product) or 50 mg
								(injection pen containing 1 mL of the medicinal product) is used for
								patients with a body weight of <b>more than 62.5 kg</b>. For
								patients with a body weight of less than 62.5 kg, lyophilizate for the
								preparation of a solution should be used.
							</p>
							<b>
								before-injecting-the-medicinal-product-it-is-necessary-to-read-the-instructions-for-use-at-the-end-of-this-section-carefully. Before
								injecting the medicinal product, it is necessary to read the
								instructions for use at the end of this section carefully.
							</b>
						</div>
          </text>
        </section>
        <section>
          <title value="Adults"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Adults"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								<em>Rheumatoid arthritis</em>
							</p>

							<p>
								The recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an
								interval of three to four days. An alternative dose is 50 mg once a
								week, which can be administered as a single subcutaneous injection of 50
								mg or two practically simultaneous injections of 25 mg.
							</p>


							<p>
								<em>Psoriatic arthritis</em>
							</p>

							<p>
								The recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an
								interval of three to four days. An alternative dose is 50 mg once a
								week, which can be administered as a single subcutaneous injection of 50
								mg or two practically simultaneous injections of 25 mg.
							</p>

							<p>
								<em>Ankylosing spondylitis</em>
							</p>

							<p>
								The recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an
								interval of three to four days. An alternative dose is 50 mg once a
								week, which can be administered as a single subcutaneous injection of 50
								mg or two practically simultaneous injections of 25 mg.
							</p>

							<p>
								<em>Pre-radiographic axial spondylarthritis</em>
							</p>

							<p>
								The recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an
								interval of three to four days. An alternative dose is 50 mg once a
								week, which can be administered as a single subcutaneous injection of 50
								mg or two practically simultaneous injections of 25 mg.
							</p>

							<p>
								<em>Psoriasis</em>
							</p>

							<p>
								The recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an
								interval of three to four days. It is possible to administer 50 mg of
								the medicinal product once a week as a single subcutaneous injection or
								two practically simultaneous injections of 25 mg.
							</p>
							<p>
								As an alternative, 50 mg of Enbrel<sup>®</sup> can be used twice a week for a
								period of not more than 12 weeks. If treatment needs to be continued,
								Enbrel<sup>®</sup> should be administered at a dose of 25 mg twice a week or 50 mg
								once a week. Treatment should be continued until remission is reached
								and, as a rule, for not more than 24 weeks. The administration of the
								medicinal product should be discontinued if, after 12 weeks of
								treatment, no improvement in symptoms is observed. In some cases, the
								length of treatment may be more than 24 weeks.
							</p>
							<p>
								In adult patients, depending on the physician’s evaluation and
								individual peculiarities of the patient, therapy can be either
								continuous or intermittent.
							</p>
							<p>
								If repeated administration of Enbrel<sup>®</sup> is needed, the duration of
								treatment stated above should be observed. It is recommended to
								prescribe a dose of 25 mg twice a week or 50 mg once a week.
							</p>
							<p>The duration of treatment for some patients may exceed 24 weeks.</p>

							<p>
								<em>Elderly patients (65 years and older)</em>
							</p>

							<p>There is no need to adjust the dose or method of administration.</p>
						</div>
          </text>
        </section>
        <section>
          <title
                 value="Children (aged 12 years and older with a body weight of 62.5 kg and more)"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text
                  value="Children (aged 12 years and older with a body weight of 62.5 kg and more)"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								In children aged under 12 years with a body weight of less than 62.5
								kg (see “Contraindications” section), Enbrel<sup>®</sup> in the pharmaceutical form
								of a lyophilizate for solution for subcutaneous injection should be
								used, making it possible to administer a dose of less than 25 mg.
							</p>
							<p>
								Children aged 12 years and older with a body weight of more than 62.5
								kg can be administered Enbrel<sup>®</sup> in the pharmaceutical form of a solution
								for subcutaneous injection in single-use syringes or injection pens.
							</p>

							<p>
								<em>
									Juvenile idiopathic polyarthritis (children aged 12 years and
									older with a body weight of more than 62.5 kg [for Enbrel
								</em><sup>®</sup> <em>
									in
									the pharmaceutical form of a “solution for subcutaneous
									injection”])
								</em> Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for
								subcutaneous injection” is administered in this patient group in the
								same way as in adult patients: a single 25 mg dose. The medicinal
								product is injected twice a week with an interval of three to four days.
								Treatment should be discontinued if, after four months of therapy, no
								improvement in symptoms is observed.
							</p>

							<p>The administration of a 50 mg dose once per week is possible.</p>

							<p>
								<em>
									Extended oligoarthritis (children aged 12 years and older with a
									body weight of more than 62.5 kg [for Enbrel
								</em>
								<sup>®</sup>
								<em>
									in the
									pharmaceutical form of a “solution for subcutaneous
									injection”])
								</em>
							</p>

							<p>
								Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous
								injection” is administered in this patient group in the same way as in
								adult patients: a single 25 mg dose. The medicinal product is injected
								twice a week with an interval of three to four days. Treatment should be
								discontinued if, after four months of therapy, no improvement in
								symptoms is observed.
							</p>
							<p>The administration of a 50 mg dose once per week is possible.</p>

							<p>
								<em>
									Psoriatic arthritis (adolescents aged 12 years and older, and
									with a body weight greater than 62.5 kg [for Enbrel
								</em>
								<sup>®</sup>
								<em>
									in the
									pharmaceutical form of a “solution for subcutaneous
									injection”])
								</em>
							</p>

							<p>
								Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous
								injection” is administered in this patient group in the same way as in
								adult patients: a single 25 mg dose. The medicinal product is injected
								twice a week with an interval of three to four days. Treatment should be
								discontinued if, after four months of therapy, no improvement in
								symptoms is observed.
							</p>
							<p>The administration of a 50 mg dose once per week is possible.</p>

							<p>
								<em>
									Arthritis associated with enthesitis (adolescents aged 12 years
									and older with a body weight of more than 62.5 kg [for Enbrel
								</em>
								<sup>®</sup>
								<em>
									in the pharmaceutical form of a “solution for subcutaneous
									injection”])
								</em>
							</p>

							<p>
								Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous
								injection” is administered in this patient group in the same way as in
								adult patients: a single 25 mg dose. The medicinal product
							</p>

							<p>
								is injected twice a week with an interval of three to four days.
								Treatment should be discontinued if, after four months of therapy, no
								improvement in symptoms is observed.
							</p>
							<p>The administration of a 50 mg dose once per week is possible.</p>

							<p>
								<em>
									Psoriasis (children aged 12 years and older with a body weight of
									more than 62.5 kg [for Enbrel
								</em>
								<sup>®</sup>
								<em>
									in the pharmaceutical form of a
									“solution for subcutaneous injection”])
								</em>
							</p>

							<p>
								The single dose of the medicinal product is 50 mg. The medicinal
								product is injected once a week, and the duration of therapy is not more
								than 24 weeks. The injections of the medicinal product should be
								discontinued if, after 12 weeks of treatment, no response to the therapy
								is observed.
							</p>
							<p>
								If repeated administration of Enbrel<sup>®</sup> is needed, the duration of
								treatment stated above should be observed. The single dose of the
								medicinal product is 50 mg once a week.
							</p>
							<p>
								<em>If a dose is missed at the appointed time,</em> the drug must be
								injected as soon as remembered, but only on condition that the next
								injection will not be <b>earlier than a day later</b>.
								Otherwise, the forgotten dose should be skipped. Patients should
								continue to inject the medicine on the usual day (days). If a patient
								does not remember the day that the next injection is due, instruct the
								patient not to take a double dose.
							</p>

							<p>
								<em>Impaired hepatic and renal function:</em> there is no need to
								adjust the dose.
							</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Instructions for Use"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Instructions for Use"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<b>below-are-the-instructions-for-preparing-and-injecting-a-solution-for-subcutaneous-injection-of-enbrel-in-syringes-and-injection-pens.</b> Below
							are the instructions for preparing and injecting a solution for
							subcutaneous injection of Enbrel<sup>®</sup> in syringes and injection pens.
							<p>
								<b>selecting-a-site-for-injection</b>
							</p>
							<ul>
								<li>
									<p>
										Three sites are recommended for the injection of Enbrel <sup>®</sup>: (1)
										the front surface of the middle third of the thigh; (2) the abdomen,
										except for an area 5 cm in diameter around the navel;
									</p>
								</li>
							</ul>
							<p>
								(3) the outer surface of the shoulder (see Fig. 1). If you are
								administering an injection to yourself, you should not use the outer
								surface of the shoulder.
							</p>

							<p style="text-align: center;">
								<u>Fig. 1</u>
							</p>
							<p style="text-align: center;">
								<img src="#image1" alt="Figure 1"/>
							</p>

							<ul>
								<li>
									<p>
										Each injection should be administered in a different site. The
										site of each new injection should be at least 3 cm away from the site of
										the previous injection. DO NOT INJECT the medicinal product into areas
										where there is pain, skin redness, bruising or induration. Do not inject
										in areas with scars or stretch marks. (It may be useful to write down
										the sites of previous injections).
									</p>
								</li>
								<li>
									<p>
										If a child has psoriasis, try not to inject the medicinal product
										directly into raised, thickened or red areas or lesions with flaking
										(psoriatic plaques).
									</p>
								</li>
							</ul>
							<p>
								<b>
									1) INSTRUCTIONS FOR PREPARATION AND INJECTION OF A SOLUTION FOR SUBCUTANEOUS INJECTION OF ENBREL<sup>®</sup> IN A SYRINGE
								</b>
							</p>
							<p>
								Patients or their parents/guardians who are going to perform
								injections should be informed of how to do it correctly. In cases where
								the patient or his/her parent/guardian performs the future injections by
								him-/herself, the first injection must be performed under the
								supervision of qualified medical personnel.
							</p>
							<p>
								<b>Preparation for Injection</b>
							</p>

							<p>
								<b>
									This medicinal product must not be mixed with any other
									medicinal products in a single syringe or vial!
								</b>
							</p>

							<ul>
								<li>
									<p>
										Remove the carton with pre-filled syringes of Enbrel<sup>®</sup> from the
										refrigerator and place it on a clean, well-lit, flat work surface. Take
										one pre-filled syringe. Do not shake the syringe. Put the carton with
										the remaining pre-filled syringes back in the refrigerator.
									</p>
								</li>
								<li>
									<p>
										<b>Leave the syringe with a solution of Enbrel</b><sup>®</sup>
										<b>
											for 15 to 30 minutes to allow it to reach room
											temperature.
										</b> DO NOT REMOVE the cap from the syringe needle
										until it reaches room temperature. Do not warm up Enbrel<sup>®</sup> by any other means (for example, in a microwave oven or in hot water).
									</p>
								</li>
								<li>
									<p>Wash your hands with soap and warm water.</p>
								</li>
								<li>
									<p>
										Make sure that the solution in the syringe is clear or
										opalescent, colorless to yellow or to light brown, it may contain a small amount of semi-transparent or white amorphous particles. If this is not the case, do not inject the solution. Use a different pre-filled syringe of Enbrel<sup>®</sup>.
									</p>
								</li>
								<li>
									<p>
										You will also need: an alcohol wipe, which is included in the
										kit, and a cotton ball or gauze pad.
									</p>
								</li>
							</ul>

							<p>
								<b>
									Preparation of the skin site and injection of the solution of Enbrel<sup>®</sup>
								</b>
							</p>
							<ul>
								<li>
									<p>
										Wipe the skin site where you will inject Enbrel<sup>®</sup> in circular
										motions with a clean alcohol wipe. <b>DO NOT TOUCH</b> this
										area until you have completed the injection.
									</p>
								</li>
								<li>
									<p>
										Remove the cap from the needle by pulling it forcefully from the
										syringe (see Fig. 2). <b>
											Be careful not to bend or over-twist the
											cap while removing, so as not to damage the needle.
										</b>
									</p>
								</li>
								<li>
									<p>
										When removing the cap, a drop of fluid may appear on the tip of
										the needle; this is permissible.
									</p>
									<ul>
										<li>
											<p>Do not touch the needle and do not let it touch any other surface.</p>
										</li>
									</ul>
								</li>
							</ul>
							<p>
								Do not touch or press on the plunger. This can lead to fluid leaking
								from the syringe.
							</p>

							<p style="text-align: center;">
								<u>Fig. 2</u>
							</p>
							<p style="text-align: center;">
								<img src="#image2" alt="Figure 2" style="width:1.78937in;height:1.78937in"/>
							</p>

							<ul>
								<li>
									<p>
										When a cleaned skin area is completely dry, pinch the skin into a
										fold with one hand and hold it. With the other hand, hold the syringe
										like a pencil.
									</p>
								</li>
								<li>
									<p>
										With a quick, short motion, direct the needle into the skin at an
										angle between 45° and 90° (see Fig. 3). In time you will find the angle
										that is most comfortable for the injection. Try not to push the needle
										into the skin too slowly or with excessive force.
									</p>
								</li>
							</ul>

							<p style="text-align: center;">
								<u>Fig. 3</u>
							</p>
							<p style="text-align: center;">
								<img src="#image3" alt="Figure 3"/>
							</p>

							<ul>
								<li>
									<p>
										After the needle has fully entered the skin, release the fold of
										skin you have been holding.
									</p>
								</li>
							</ul>

							<p>
								With your free hand, hold the base of the syringe to stabilize its
								position. Then press the plunger to inject all of the solution at a
								<b>slow</b>, constant speed (see Fig. 4).
							</p>

							<p style="text-align: center;">
								<u>Fig. 4</u>
							</p>
							<p style="text-align: center;">
								<img src="#image4" alt="Figure 4" style="width:1.88502in;height:1.68625in"/>
							</p>

							<ul>
								<li>
									<p>
										When the syringe is empty, remove the needle from the skin, being
										careful to keep it at the same angle as when it was inserted.
									</p>
								</li>
								<li>
									<p>
										Press on the injection site with a cotton ball or gauze pad for
										10 seconds. A small amount of bleeding may occur. <b>
											DO NOT
											WIPE
										</b> the injection site. A bandage may be applied.
									</p>
								</li>
							</ul>
							<p>
								<b>Waste disposal</b>
							</p>
							<ul>
								<li>
									<p>
										The pre-filled syringe is intended for single use only.
										<b>NEVER</b> reuse the syringe and needle.
										<b>NEVER</b> recap the needle. Dispose of the needle and
										syringe as instructed by your physician or nurse.
									</p>
								</li>
							</ul>
							<p>
								<b>
									If you have questions, please contact a physician or nurse who works with Enbrel<sup>®</sup>.
								</b>
							</p>
							<p>
								<b>
									2) INSTRUCTIONS FOR PREPARATION AND INJECTION OF A SOLUTION FOR SUBCUTANEOUS INJECTION OF ENBREL<sup>®</sup>IN AN INJECTION PEN
								</b>
							</p>
							<p>
								Do not attempt to perform an injection by yourself if you have not
								understood how to use the injection pen properly. If you have questions
								regarding injections, please ask your physician or nurse.
							</p>

							<p style="text-align: center;">
								<u>Fig. 5</u>
							</p>
							<p style="text-align: center;">
								<u>Pre-filled injection pen</u>
							</p>
							<p style="text-align: center;">
								<img src="#image5" alt="Figure 5"/>
							</p>

							<b>
								Step 1. Preparation
								for the injection of Enbrel<sup>®</sup>
							</b>
							<ul>
								<li>
									<p>Select a clean, well-lit, flat working surface.</p>
								</li>
							</ul>
							<p>
								Gather the following items needed for the injection and place them on
								the working surface:
							</p>
							<ol type="a">
								<li>
									<p>
										<b>
											One pre-filled injection pen and one alcohol
											wipe
										</b> (take them out of the carton of injection pens that you
										store in the refrigerator). Do not shake the injection pen.
									</p>
								</li>
								<li>
									<p>
										<b>
											One cotton ball or gauze
											pad.
										</b>
									</p>
									<ul>
										<li>
											<p>
												Check the expiry date on the injection pen. Do not use the
												injection pen if the date is past. Consult with your treating
												physician.
											</p>
										</li>
										<li>
											<p>
												Assess the condition of the solution in the injection pen through
												the transparent inspection window.
											</p>
										</li>
									</ul>
								</li>
							</ol>

							<p>
								It is only permissible to inject a clear or opalescent, colorless to
								yellow or light brown solution, which may contain a small quantity of
								semi-transparent or white amorphous particles. If this is not the case,
								you should use a different injection pen and then ask a pharmacist for
								assistance.
							</p>
							<ul>
								<li>
									<p>
										Without removing the white needle cap, wait approximately 15 to
										30 minutes for the Enbrel<sup>®</sup> solution in the injection pen to warm up to
										room temperature. This will make the injection more comfortable. Do not
										warm the injection pen by any other method. <b>
											Always keep the
											injection pen out of reach of children.
										</b>
									</p>
								</li>
								<li>
									<p>
										While the solution in the injection pen is warming up to room
										temperature, read the information on Step 2 activities (below) and
										select an injection site.
									</p>
								</li>
							</ul>
							<b>
								Step 2.
								Injection of Enbrel<sup>®</sup>
							</b>
							<ul>
								<li>
									<p>
										After warming the solution up to room temperature for
										approximately 15 to 30 minutes, wash your hands with soap and
										water.
									</p>
								</li>
								<li>
									<p>
										With circular motions, wipe the area of skin where you are going
										to inject Enbrel<sup>®</sup> with a clean alcohol wipe and allow to dry. <b>DO NOT TOUCH</b> this area until you have completed the injection.
									</p>
								</li>
							</ul>
							<ul>
								<li>
									<p>
										Take the injection pen and remove the white cap by pulling it
										straight toward yourself (see Fig. 7). To avoid damaging the needle,
										which is covered by the cap, do not tilt the cap when removing it, and
										do not attempt to put it back on after removing. After removing the
										needle cap, you will see a purple protective screen, which protrudes
										slightly from the edge of the injection pen. The needle itself will
										remain inside the injection pen until the moment it is activated. Do not
										use the injection pen if it dropped on the floor after you had removed
										the protective cap from the needle.
									</p>
								</li>
							</ul>

							<p style="text-align: center;">
								<u>Fig. 7</u>
							</p>
							<p style="text-align: center;">
								<img src="#image7" alt="Figure 7"/>
							</p>

							<ul>
								<li>
									<p>
										Carefully pinch the skin into a fold between the thumb and index
										finger of your free hand; this will make it easier to administer the
										medicinal product and make it more comfortable. Try not to touch the
										prepared surface of the skin.
									</p>
								</li>
								<li>
									<p>
										<b>
											Place the injection pen at a right angle (90º) to the
											injection site and press the open end firmly
										</b> against the skin,
										so that the protective screen goes fully inside the injection pen. You
										will see a slight indentation of the skin (Fig. 8). The injection pen
										will be activated only when the protective screen of the needle has
										fully gone into the injection pen.
									</p>
								</li>
							</ul>
							<p style="text-align: center;">
								<u>Fig. 8</u>
							</p>
							<p style="text-align: center;">
								<img src="#image8" alt="Figure 8"/>
							</p>

							<ul>
								<li>
									<p>
										Press the injection pen firmly against the skin and make sure
										that the purple protective screen has gone completely inside it. To
										inject, press at the center of the green button located on the upper
										part of the injection pen (Fig. 9). After pressing the button, you will
										hear a click. <b>
											Continue to hold the injection pen pressed firmly
											to the skin either until the second click or for 10 seconds after the
											first click
										</b> (whichever occurs first).
									</p>
								</li>
							</ul>
							<p>
								<em>
									<u>Note:</u>
								</em> if you cannot start the injection as described
								above, press the injection pen more tightly against the skin and press
								the green button again.
							</p>

							<p style="text-align: center;">
								<u>Fig. 9</u>
							</p>
							<p style="text-align: center;">
								<img src="#image9" alt="Figure 9" style="width:2.42172in;height:1.62823in"/>
							</p>

							<ul>
								<li>
									<p>
										After the second click (or in 10 seconds), the injection is
										complete (Fig. 10), and you can release the pressure on the skin (Fig.
										11); the purple protective screen will automatically come out and cover
										the needle.
									</p>
								</li>
							</ul>

							<p style="text-align: center;">
								<u>Fig. 10</u>
							</p>
							<p style="text-align: center;">
								<img src="#image10" alt="Figure 10" style="width:2.20542in;height:1.49635in"/>
							</p>

							<p style="text-align: center;">
								<u>Fig. 11</u>
							</p>
							<p style="text-align: center;">
								<img src="#image11" alt="Figure 11"/>
							</p>

							<ul>
								<li>
									<p>
										When this is done, the color of the inspection window of the
										injection pen will change to purple (see Fig. 12), which confirms that
										the dose has been injected correctly. If this does not occur, you should
										ask a physician, nurse or pharmacist for assistance, as there is no
										guarantee in this situation that the full dose of Enbrel<sup>®</sup> has been
										injected. Do not attempt to reuse this injection pen, and do not use a
										new injection pen without consulting with a nurse or
										pharmacist.
									</p>
								</li>
							</ul>

							<p style="text-align: center;">Fig. 12</p>
							<p style="text-align: center;">
								<img src="#image12" alt="Figure 12"/>
							</p>

							<ul>
								<li>
									<p>
										If drops of blood appear at the injection site, press a cotton
										ball or gauze pad against the site and hold it for 10 seconds. Do not
										rub the injection site.
									</p>
								</li>
							</ul>
							<b>
								Step 3. Disposal of the
								used injection pen
							</b>
							<ul>
								<li>
									<p>
										The injection pen is intended for single use only; therefore, its
										reuse is not permissible. Used injection pens should be disposed of as
										instructed by a physician, nurse or pharmacist. Do not try to re-attach
										the needle protective cap.
									</p>
								</li>
							</ul>
							<b>
								If
								you have questions, please ask a physician, nurse or pharmacist
								experienced in working with Enbrel<sup>®</sup>.
							</b>
						</div>
          </text>
        </section>
        <section>
          <title value="Side effects"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="200000029813"/>
            </coding>
            <text value="Side effects"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="Summary of the safety profile"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="200000029814"/>
              </coding>
              <text value="Summary of the safety profile"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									<u>Summary of the safety profile</u>
								</p>
								<p>
									The most commonly reported adverse reactions are injection site
									reactions (such as pain, swelling, itching, reddening and bleeding at
									the puncture site), infections (such as upper respiratory infections,
									bronchitis, bladder infections and skin infections), allergic reactions,
									development of autoantibodies, itching, and fever.
								</p>
								<p>
									Serious adverse reactions have also been reported during the use of
									Enbrel<sup>®</sup>. TNF-antagonists, such as etanercept, negatively affect the
									immune system and their use may have a negative effect on the body’s
									defenses against infections and malignancies. Serious infections affect
									fewer than one in 100 patients treated with Enbrel<sup>®</sup>. Reports have
									included fatal and life-threatening infections and sepsis. Various
									malignancies have also been reported with the use of Enbrel<sup>®</sup>, including
									cancers of the breast, lung, skin and lymph glands (lymphoma).
								</p>
								<p>
									Serious hematological, neurological and autoimmune reactions have
									also been reported. These include rare reports of pancytopenia and very
									rare reports of aplastic anemia. Central and peripheral demyelinating
									events have been seen rarely and very rarely, respectively, with the use
									of Enbrel<sup>®</sup>. There have been rare reports of lupus, lupus-related
									conditions, and vasculitis.
								</p>
							</div>
            </text>
            <section>
              <title value="Tabulated list of adverse reactions"/>
              <code>
                <coding>
                  <system value="https://www.minzdrav.gov.ru/"/>
                  <code value="200000029814"/>
                </coding>
                <text value="Tabulated list of adverse reactions"/>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
									<p>
										The following list of adverse reactions is based on experience from
										clinical trials and on post- marketing experience.
									</p>
									<p>
										Within the organ system classes, adverse reactions are listed under
										the following categories of frequency (number of patients expected to
										experience the reaction): very common (≥ 1/10); common (≥ 1/100 to &lt;
										1/10); uncommon (≥ 1/1,000 to &lt; 1/100); rare (≥ 1/10,000 to &lt;
										1/1,000); very rare (&lt; 1/10,000); and not known (cannot be estimated
										from available data).
									</p>

									<table>
										<colgroup>
											<col style="width: 14%"/>
											<col style="width: 11%"/>
											<col style="width: 12%"/>
											<col style="width: 17%"/>
											<col style="width: 18%"/>
											<col style="width: 10%"/>
											<col style="width: 15%"/>
										</colgroup>
										<thead>
											<tr class="header">
												<th>
													<p>
														<b>System Organ Class</b>
													</p>
												</th>
												<th>
													<p>
														<b>Very common ≥ 1/10</b>
													</p>
												</th>
												<th>
													<p>
														<b>Common ≥ 1/100 to &lt; 1/10</b>
													</p>
												</th>
												<th>
													<p>
														<b>Uncommon ≥ 1/1,000 to &lt; 1/100</b>
													</p>
												</th>
												<th>
													<p>
														<b>Rare ≥ 1/10,000 to &lt; 1/1,000</b>
													</p>
												</th>
												<th>
													<p>
														<b>Very rare &lt; 1/10,000</b>
													</p>
												</th>
												<th>
													<p>
														<b>Frequency not known (cannot be estimated from available data)</b>
													</p>
												</th>
											</tr>
										</thead>
										<tbody>											
											<tr class="odd">
												<td>
													<p>Infections and infestations</p>
												</td>
												<td>
													<p>
														Infections (including upper respiratory tract infections, bronchitis,
														cystitis, skin
													</p>
													<p>infections)*</p>
												</td>
												<td/>
												<td>
													<p>
														Serious infections (including pneumonia, cellulitis, arthritis
														bacterial, sepsis and parasitic infections)*
													</p>
												</td>
												<td>
													<p>
														Tuberculosis, opportunistic infection (including invasive fungal,
														protozoal, bacterial, atypical mycobacterial, viral infections, and
														<em>Legionella</em>)*
													</p>
												</td>
												<td/>
												<td>
													<p>Hepatitis B reactivation, listeria</p>
												</td>
											</tr>
											<tr class="even">
												<td>
													<p>
														Neoplasms benign, malignant and unspecified (including cysts and
														polyps)
													</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>Non-melanoma skin cancers* (see “Special warnings” section)</p>
												</td>
												<td>
													<p>
														Malignant melanoma (see “Special warnings” section), lymphoma,
														leukemia
													</p>
												</td>
												<td/>
												<td>
													<p>
														Merkel cell carcinoma (see “Special warnings” section) Kaposi’s
														sarcoma
													</p>
												</td>
											</tr>
											<tr class="odd">
												<td>
													<p>Blood and lymphatic system disorders</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>Thrombocytopenia, anemia,</p>
													<p>leukopenia, neutropenia</p>
												</td>
												<td>
													<p>Pancytopenia*</p>
												</td>
												<td>
													<p>Aplastic anemia*</p>
												</td>
												<td>
													<p>Hematophagy histiocytosis (macrophage activation syndrome)*</p>
												</td>
											</tr>
											<tr class="even">
												<td>
													<p>Immune system disorders</p>
												</td>
												<td/>
												<td>
													<p>Allergic reactions</p>
													<p>
														(see Skin and subcutaneous tissue disorders” section), autoantibody
														formation*
													</p>
												</td>
												<td>
													<p>
														Vasculitis (including anti- neutrophilic cytoplasmic antibody
														positive vasculitis)
													</p>
												</td>
												<td>
													<p>
														Serious allergic/anaphylactic reactions (including angioedema,
														bronchospasm), sarcoidosis
													</p>
												</td>
												<td/>
												<td>
													<p>Worsening of symptoms of dermatomyositis</p>
												</td>
											</tr>
											<tr class="odd">
												<td>
													<p>Nervous system disorders</p>
												</td>
												<td>
													<p>Headache*</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>
														CNS demyelinating events suggestive of multiple sclerosis or
														localized demyelinating conditions, such as optic neuritis and
														transverse myelitis (see “Special warnings” section), peripheral
														demyelinating events, including Guillain-Barré syndrome, chronic
														inflammatory demyelinating polyneuropathy, demyelinating polyneuropathy, and multifocal motor neuropathy (see “Special
														warnings” section), seizure
													</p>
												</td>
												<td/>
												<td/>
											</tr>
											<tr class="odd">
												<td>
													<p>Eye disorders</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>Uveitis, scleritis</p>
												</td>
												<td/>
												<td/>
												<td/>
											</tr>
											<tr class="even">
												<td>
													<p>Cardiac disorders</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>
														Worsening of congestive heart failure (see “Special warnings”
														section)
													</p>
												</td>
												<td>
													<p>
														New onset congestive heart failure (see “Special warnings”
														section)
													</p>
												</td>
												<td/>
												<td/>
											</tr>
											<tr class="odd">
												<td>
													<p>Respiratory, thoracic, and mediastinal disorders</p>
												</td>
												<td/>
												<td/>
												<td/>
												<td>
													<p>
														Interstitial lung disease (including pneumonitis and pulmonary
														fibrosis)*
													</p>
												</td>
												<td/>
												<td/>
											</tr>
											<tr class="even">
												<td>
													<p>Gastrointestinal tract disorders</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>Inflammatory bowel disease*</p>
												</td>
												<td/>
												<td/>
												<td/>
											</tr>
											<tr class="odd">
												<td>
													<p>Hepatobiliary disorders</p>
												</td>
												<td/>
												<td/>
												<td>
													<p>Elevated liver enzymes*</p>
												</td>
												<td>
													<p>Autoimmune hepatitis*</p>
												</td>
												<td/>
												<td/>
											</tr>
											<tr class="even">
												<td>
													<p>Skin and subcutaneous tissue disorders</p>
												</td>
												<td/>
												<td>
													<p>Pruritus, rash</p>
												</td>
												<td>
													<p>
														Angioedema, psoriasis (including new onset or worsening and pustular,
														primarily palms and soles), urticaria, psoriasiform rash
													</p>
												</td>
												<td>
													<p>
														Stevens-Johnson syndrome, cutaneous vasculitis (including
														hypersensitivity
													</p>
													<p>vasculitis), erythema multiforme, lichenoid reactions</p>
												</td>
												<td>
													<p>Toxic epidermal necrolysis</p>
												</td>
												<td/>
											</tr>
											<tr class="odd">
												<td>
													<p>Musculoskeletal and connective tissue disorders</p>
												</td>
												<td/>
												<td/>
												<td/>
												<td>
													<p>
														Cutaneous lupus erythematosus, subacute cutaneous lupus
														erythematosus, lupus-like syndrome
													</p>
												</td>
												<td/>
												<td/>
											</tr>
											<tr class="even">
												<td>
													<p>General disorders and administration site conditions</p>
												</td>
												<td>
													<p>
														Injection site reactions (including bleeding, bruising, erythema,
														itching, pain, swelling)*
													</p>
												</td>
												<td>
													<p>Pyrexia</p>
												</td>
												<td/>
												<td/>
												<td/>
												<td/>
											</tr>
											<tr class="odd">
												<td colspan="7">
													<p>*see “Description of selected adverse reactions” below.</p>
												</td>
											</tr>
										</tbody>
									</table>
								</div>
              </text>
            </section>
            <section>
              <title value="Description of selected adverse reactions"/>
              <code>
                <coding>
                  <system value="https://www.minzdrav.gov.ru/"/>
                  <code value="200000029814"/>
                </coding>
                <text value="Description of selected adverse reactions"/>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
									<p>
										<em>Malignancies and lymphoproliferative disorders</em>
									</p>

									<p>
										One hundred and twenty-nine (129) new malignancies of various types
										were observed in 4,114 rheumatoid arthritis patients treated in clinical
										trials with Enbrel<sup>®</sup> for up to approximately six
									</p>

									<p>
										years, including 231 patients treated with Enbrel<sup>®</sup> in combination
										with methotrexate in the two- year active-controlled study. The observed
										rates and incidences in these clinical trials were similar to those
										expected for the population studied. A total of two malignancies were
										reported in clinical studies of approximately two years duration
										involving 240 psoriatic arthritis patients who received Enbrel<sup>®</sup>. In
										clinical studies conducted for more than two years with 351 ankylosing
										spondylitis patients, six malignancies were reported in patients treated
										with Enbrel<sup>®</sup>. In a group of 2,711 plaque psoriasis patients treated with
										Enbrel<sup>®</sup> in double-blind and open-label studies of up to 2.5 years, 30
										malignancies and 43 non-melanoma skin cancers were reported.
									</p>
									<p>
										In a group of 7,416 patients treated with Enbrel<sup>®</sup> in rheumatoid
										arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis
										clinical trials, 18 lymphomas were reported.
									</p>
									<p>
										Reports of various malignancies (including breast and lung carcinoma
										and lymphoma) have also been received in the post-marketing period (see
										“Special warnings” section).
									</p>

									<p>
										<em>Injection site reactions</em>
									</p>

									<p>
										Compared to placebo, patients with rheumatic diseases treated with
										Enbrel<sup>®</sup> had a significantly higher incidence of injection site reactions
										(36% vs. 9%). Injection site reactions usually occurred in the first
										month. Mean duration was approximately three to five days. No treatment
										was given for the majority of injection site reactions in the groups
										receiving Enbrel<sup>®</sup>, and the majority of patients who were given treatment
										received topical preparations, such as corticosteroids, or oral
										antihistamines. Additionally, some patients developed recall injection
										site reactions characterized by a skin reaction at the most recent site
										of injection, along with the simultaneous appearance of injection site
										reactions at previous injection sites. These reactions were generally
										transient and did not recur with treatment.
									</p>
									<p>
										In controlled trials in patients with plaque psoriasis, approximately
										13.6% of patients treated with Enbrel<sup>®</sup> developed injection site
										reactions compared with 3.4% of placebo-treated patients during the
										first 12 weeks of treatment.
									</p>

									<p>
										<em>Serious infections</em>
									</p>

									<p>
										In placebo-controlled trials, no increase in the incidence of serious
										infections (fatal, life- threatening, or requiring hospitalization or
										intravenous antibiotics) was observed. Serious infections, including
										abscess (at various sites), bacteremia, bronchitis, bursitis,
										cellulitis, cholecystitis, diarrhea, diverticulitis, endocarditis
										(suspected), gastroenteritis, hepatitis B, herpes zoster, leg ulcer,
										mouth infection, osteomyelitis, otitis, peritonitis, pneumonia,
										pyelonephritis, sepsis, septic arthritis, sinusitis, skin infection,
										skin ulcer, urinary tract infection, vasculitis, and wound infection,
										occurred in 6.3% of rheumatoid arthritis patients treated with Enbrel<sup>®</sup>
										for up to 48 months. In the two-year active-controlled study where
										patients were treated with either Enbrel alone, methotrexate alone or
										Enbrel<sup>®</sup> in combination with methotrexate, the rates of serious
									</p>

									<p>
										infections were similar among the treatment groups. However, it
										cannot be excluded that the combination of Enbrel<sup>®</sup> with methotrexate
										could be associated with an increase in the rate of infections.
									</p>
									<p>
										There were no differences in rates of infection among patients
										treated with Enbrel<sup>®</sup> and those treated with placebo for plaque psoriasis
										in placebo-controlled trials lasting up to 24 weeks. Serious infections
										experienced by Enbrel<sup>®</sup>-treated patients included cellulitis,
										gastroenteritis, pneumonia, cholecystitis, osteomyelitis, gastritis,
										appendicitis, <em>Streptococcal</em> fasciitis, myositis, septic shock,
										diverticulitis and abscess. In the double-blind and open-label psoriatic
										arthritis trials, one patient reported a serious infection
										(pneumonia).
									</p>
									<p>
										Serious and fatal infections have been reported during the use of
										Enbrel<sup>®</sup>; they were caused by bacteria, mycobacteria (including
										tuberculosis), viruses and fungi. Some have occurred within a few weeks
										after initiating treatment with Enbrel<sup>®</sup> in patients who have underlying
										conditions (e.g., diabetes mellitus, congestive heart failure, history
										of active or chronic infections) in addition to their rheumatoid
										arthritis (see “Special warnings” section). Treatment with Enbrel<sup>®</sup> may
										increase mortality in patients with established sepsis.
									</p>
									<p>
										Opportunistic infections have been reported in association with
										treatment with Enbrel<sup>®</sup>, including invasive fungal, parasitic (including
										protozoal), viral (including herpes zoster), bacterial (including
										<em>Listeria</em> and <em>Legionella</em>), and atypical mycobacterial
										infections. In pooled data from clinical trials, the overall incidence
										of opportunistic infections was 0.09% for the 15,402 subjects who
										received Enbrel<sup>®</sup>. The exposure-adjusted incidence rate was 0.06 events
										per 100 patient- years. In post-marketing experience, approximately half
										of all case reports of opportunistic infections worldwide were invasive
										fungal infections. The most commonly reported invasive fungal infections
										included <em>Candida, Pneumocystis</em> Aspergillus<em>,</em> and
										<em>Histoplasma</em>. Invasive fungal infections accounted for more than
										half of the fatalities amongst patients who developed opportunistic
										infections. The majority of the reports with a fatal outcome were in
										patients with <em>Pneumocystis</em> pneumonia, unspecified systemic
										fungal infections, and aspergillosis (see “Special warnings”
										section).
									</p>

									<p>
										<em>Formation of autoantibodies</em>
									</p>

									<p>
										Adult patients had serum samples tested for autoantibodies at
										multiple timepoints. Of the rheumatoid arthritis patients evaluated for
										antinuclear antibodies (ANA), the percentage of patients who developed
										new positive ANA (≥ 1:40) was higher in patients treated with Enbrel<sup>®</sup>
										(11%) than in placebo-treated patients (5%). The percentage of patients
										who developed new positive anti- double-stranded DNA antibodies was also
										higher by radioimmunoassay (15% of patients treated with Enbrel<sup>®</sup>
										compared to 4% of placebo-treated patients) and by <em>
											Crithidia
											luciliae
										</em> assay (3% of patients treated with Enbrel<sup>®</sup> compared to
										none of the placebo-treated patients). The proportion of
									</p>

									<p>
										patients treated with Enbrel<sup>®</sup> who developed anticardiolipin
										antibodies was similarly increased compared to placebo-treated patients.
										The impact of long-term treatment with Enbrel<sup>®</sup> on the development of
										autoimmune diseases is unknown.
									</p>
									<p>
										There have been rare reports of patients, including rheumatoid factor
										positive patients, who have developed other autoantibodies in
										conjunction with a lupus-like syndrome or rashes that are compatible
										with subacute cutaneous lupus or discoid lupus by clinical presentation
										and biopsy.
									</p>

									<p>
										<em>Pancytopenia and aplastic anemia</em>
									</p>

									<p>
										There have been post-marketing reports of pancytopenia and aplastic
										anemia, some of which had fatal outcomes (see “Special warnings”
										section).
									</p>

									<p>
										<em>Interstitial lung disease</em>
									</p>

									<p>
										In controlled clinical trials of etanercept across all indications,
										the frequency (percentage of patients) of interstitial lung disease in
										patients receiving etanercept without concomitant methotrexate was 0.06%
										(frequency “rare”). In the controlled clinical trials that allowed
										concomitant treatment with etanercept and methotrexate, the frequency
										(percentage of patients) of interstitial lung disease was 0.47%
										(frequency “uncommon”). There have been post-marketing reports of
										interstitial lung disease (including pneumonitis and pulmonary
										fibrosis), some of which had fatal outcomes.
									</p>

									<p>
										<em>Concurrent treatment with anakinra</em>
									</p>

									<p>
										In studies when adult patients received concurrent treatment with
										Enbrel<sup>®</sup> plus anakinra, a higher rate of serious infections compared to
										Enbrel<sup>®</sup> alone was observed and 2% of patients (3/139) developed
										neutropenia (absolute neutrophil count &lt; 1000/mm3). While
										neutropenic, one patient developed cellulitis that resolved after
										hospitalization (see “Special warnings” and “Interaction with other
										medicinal products” sections).
									</p>

									<p>
										<em>Elevated liver enzymes</em>
									</p>

									<p>
										In the double-blind periods of controlled clinical trials of
										etanercept across all indications, the frequency (percentage of
										patients) of adverse events of elevated liver enzymes in patients
										receiving etanercept without concomitant methotrexate was 0.54%
										(frequency “uncommon”). In the double- blind periods of controlled
										clinical trials that allowed concomitant treatment with etanercept and
										methotrexate, the frequency (percentage of patients) of adverse events
										of elevated liver enzymes was 4.18% (frequency “common”).
									</p>

									<p>
										<em>Autoimmune hepatitis</em>
									</p>

									<p>
										In controlled clinical trials of etanercept across all indications,
										the frequency (percentage of patients) of autoimmune hepatitis in
										patients receiving etanercept without concomitant methotrexate was 0.02%
										(frequency “rare”). In the controlled clinical trials that allowed
									</p>

									<p>
										concomitant treatment with etanercept and methotrexate, the frequency
										(incidence proportion) of autoimmune hepatitis was 0.24% (frequency
										“uncommon”).
									</p>
								</div>
              </text>
            </section>
            <section>
              <title value="Adverse reactions in children"/>
              <code>
                <coding>
                  <system value="https://www.minzdrav.gov.ru/"/>
                  <code value="200000029814"/>
                </coding>
                <text value="Adverse reactions in children"/>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
									<p>
										<em>
											Adverse events in pediatric patients with juvenile idiopathic
											arthritis
										</em>
									</p>

									<p>
										In general, the adverse events in pediatric patients with juvenile
										idiopathic arthritis were similar in frequency and type to those seen in
										adult patients. Differences from adults and other special considerations
										are discussed in the following paragraphs.
									</p>
									<p>
										The types of infections seen in clinical trials in juvenile
										idiopathic arthritis patients aged 2 to 18 years were generally mild to
										moderate and consistent with those commonly seen in outpatient pediatric
										populations. Severe adverse events reported included varicella with
										signs and symptoms of aseptic meningitis, which resolved without
										sequelae (see also “Special warnings” section), appendicitis,
										gastroenteritis, depression/personality disorder, cutaneous ulcer,
										esophagitis/gastritis, group A streptococcal septic shock, type I
										diabetes mellitus, and soft tissue and post-operative wound
										infection.
									</p>
									<p>
										In one study in children with juvenile idiopathic arthritis aged 4 to
										17 years, 43 of 69 (62%) children experienced an infection while
										receiving Enbrel<sup>®</sup> after three months of the study (part 1, open-label),
										and the frequency and severity of infections were similar in 58 patients
										completing 12 months of open-label extension therapy. The types and
										frequency of adverse events in juvenile idiopathic arthritis patients
										were similar to those seen in trials of Enbrel<sup>®</sup> in adult patients with
										rheumatoid arthritis, and the majority were mild. Several adverse events
										were reported more commonly in 69 juvenile idiopathic arthritis patients
										receiving Enbrel<sup>®</sup> for three months compared to the 349 adult rheumatoid
										arthritis patients. These included headache (19% of patients, 1.7 events
										per patient year), nausea (9%, 1.0 event per patient year), abdominal
										pain (19%, 0.74 events per patient year), and vomiting (13%, 0.74 events
										per patient year).
									</p>
									<p>
										There were four reports of macrophage activation syndrome in juvenile
										idiopathic arthritis clinical trials.
									</p>
									<p>
										There have been reports of inflammatory bowel disease and uveitis in
										JIA patients treated with Enbrel<sup>®</sup> from post-marketing sources, including
										a very small number of cases indicating a positive rechallenge (see
										<em>“Special warnings”</em> section).
									</p>

									<p>
										<em>
											Adverse events in pediatric patients with plaque
											psoriasis
										</em>
									</p>

									<p>
										In a 48-week study in 211 children aged 4 to 17 years with pediatric
										plaque psoriasis, the adverse events reported were similar to those seen
										in previous studies in adults with plaque psoriasis.
									</p>
								</div>
              </text>
            </section>
          </section>
        </section>
        <section>
          <title value="Overdose"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Overdose"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								<em>
									In the case of an overdose of Enbrel
										<sup>®</sup>,
								</em>
								<em>
									contact a physician or pharmacist immediately.
								</em>
							</p>

							<p>
								Save the carton of Enbrel<sup>®</sup>, even if it is empty.
							</p>
							<p>
								The maximum dose of Enbrel<sup>®</sup> has not been established. In a clinical
								study, a single 60 mg/m2 dose was administered to healthy volunteers,
								which did not lead to the development of dose- limiting toxicity.
							</p>
							<p>
								In the treatment of patients with rheumatoid arthritis, no cases of
								the toxic dose limit being exceeded were documented. The highest dose
								injected intravenously was 32 mg/m2, with a subsequent subcutaneous
								injection of 16 mg/m2 twice a week. There is no known specific antidote
								for Enbrel<sup>®</sup>.
							</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Interaction with other medicinal products"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Interaction with other medicinal products"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>
								<em>Anakinra</em>
							</p>

							<p>
								During combined therapy with etanercept and anakinra, a significant
								increase in the frequency of serious infections and neutropenia was
								observed as compared with patients who were injected with only
								etanercept or only anakinra.
							</p>
							<p>
								Combined therapy with etanercept and anakinra did not show any
								clinical benefit and, therefore, is not recommended.
							</p>

							<p>
								<em>Abatacept</em>
							</p>

							<p>
								The simultaneous use of abatacept and etanercept was accompanied by
								an increase in the frequency of serious undesirable events. This drug
								combination did not show any clinical benefits and, therefore, is not
								recommended.
							</p>

							<p>
								<em>Sulfasalazine</em>
							</p>

							<p>
								In patients administered etanercept during treatment with
								sulfasalazine, a significant reduction in leukocyte count was documented
								compared to patients who received only etanercept or only
								sulfasalazine.
							</p>

							<p>
								<u>
									<em>Absence</em>
									<em>of</em>
									<em>interaction</em>
								</u>
							</p>

							<p>
								No adverse interactions were observed during the simultaneous use of
								etanercept with glucocorticosteroids, salicylates (with the exception of
								sulfasalazine), non-steroidal anti- inflammatory drugs (NSAIDs),
								analgesics or methotrexate.
							</p>

							<p>
								<em>Methotrexate</em>
							</p>

							<p>
								Methotrexate has no effect on the pharmacokinetics of etanercept. The
								effect of etanercept on the pharmacokinetics of methotrexate in humans
								has not been studied.
							</p>

							<p>
								<em>Digoxin</em>
							</p>

							<p>
								No clinically significant cross-effect on the pharmacokinetics of
								etanercept has been found.
							</p>


							<p>
								<em>Warfarin</em>
							</p>

							<p>
								No clinically significant cross-effect on the pharmacokinetics of
								etanercept has been found.
							</p>

							<p>
								<em>Vaccination</em>
							</p>

							<p>
								Live vaccines should not be administered during treatment with
								etanercept. There is no data on the secondary transmission of an
								infection through a live vaccine to patients receiving etanercept.
								Before beginning treatment with etanercept, it is recommended that
								children and adolescents receive all necessary vaccinations according to
								the current national vaccination calendar, if possible.
							</p>
							<p>
								An increase in B-cell immune response to the pneumococcal
								polysaccharide vaccine was observed in the majority of patients with
								psoriatic arthritis who had received etanercept, even if titers were
								slightly lower on the whole. A twofold increase in titers was observed
								in a lower number of patients in comparison with patients not receiving
								etanercept.
							</p>
						</div>
          </text>
          <section>
            <title value="Special warnings"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Special warnings"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									After the discontinuation of Enbrel<sup>®</sup>, disease symptoms may recur.
								</p>

								<p>
									<em>Infections</em>
								</p>

								<p>
									Patients should be examined for infections before starting treatment
									with Enbrel<sup>®</sup>, during treatment and after completing the course of
									treatment, taking into account the mean half-life of etanercept, which
									is approximately 70 hours (seven to 300 hours).
								</p>
								<p>
									During treatment with Enbrel<sup>®</sup>, sepsis, tuberculosis, parasitic
									infections (including those caused by protozoa organisms) and severe
									infections, including opportunistic infections, such as invasive fungal
									infections, listeriosis and legionellosis (some with lethal outcomes),
									and viral infections (including caused by herpes zoster) were reported.
									The most commonly reported invasive fungal infections were caused by
									<em>Candida Pneumocystis, Aspergillus</em> and <em>Histoplasma.</em>
									Incorrect diagnosis of the above-mentioned infections, especially fungal
									and other opportunistic infections, led to the delayed prescription of
									necessary treatment and, in some cases, to lethal outcomes. In many
									cases, patients received treatment with other medicinal products,
									including immunosuppressants. When examining patients, it is important
									to consider the possible development of opportunistic infections, for
									example, endemic mycoses. Patients who develop new infections during
									treatment with Enbrel<sup>®</sup> should be kept under close observation.
									<b>The administration of Enbrel</b><sup>®</sup> <b>
										should be
										discontinued if a patient develops a severe infection.
									</b> The
									administration of Enbrel<sup>®</sup> requires caution in patients with a history of
									frequent or chronic infections or underlying diseases, which may
									facilitate the development of infections (such as severe or poorly
									controlled diabetes mellitus).
								</p>
								<p>
									The safety and efficacy of Enbrel<sup>®</sup> in patients with chronic
									infections have not been evaluated.
								</p>

								<p>
									<em>Tuberculosis</em>
								</p>

								<p>
									During treatment with Enbrel<sup>®</sup>, cases of active tuberculosis have been
									reported, including miliary tuberculosis and extrapulmonary
									tuberculosis. Among rheumatoid arthritis patients, there is apparently a
									higher frequency of the development of tuberculosis infection.
								</p>
								<p>
									The development of tuberculosis infection may be connected with the
									reactivation of a latent infection or with the development of a new
									infection.
								</p>
								<p>
									Before starting treatment, all patients should be screened for the
									presence of active or latent tuberculosis. The screening should include
									a detailed examination of the patient’s medical history with regard to
									contraction of tuberculosis or contact with tuberculosis patients in the
									past and information on previous or current immunosuppressive therapy.
									All patients should undergo necessary screenings in accordance with
									local requirements. These must include: a tuberculin skin test and a
									chest x-ray. The possibility of a false negative tuberculin skin test
									should be considered, especially in patients in a serious condition or
									in immunocompromised patients. It is also necessary to consider the
									possibility of the development of tuberculosis in patients in whom signs
									of tuberculosis infection were not found before beginning treatment with
									Enbrel<sup>®</sup>. The attending physician should monitor the condition of the
									patient for any signs of tuberculosis, including patients who originally
									tested negative for tuberculosis infection.
								</p>
								<p>
									Enbrel<sup>®</sup> should not be used if a patient has active tuberculosis. If
									inactive tuberculosis is present before beginning the treatment with
									Enbrel<sup>®</sup>, a standard anti-tuberculosis therapy should be prescribed in
									accordance with local recommendations. In this case, the benefit-to-risk
									ratio of treatment with Enbrel<sup>®</sup> should be thoroughly analyzed.
								</p>
								<p>
									All patients should be advised to contact a physician if symptoms
									typical of tuberculosis (for example, persistent cough, weight loss,
									low-grade fever) appear during or after treatment with Enbrel<sup>®</sup>.
								</p>

								<p>
									<em>Activation of hepatitis B virus</em>
								</p>

								<p>
									Cases of the activation of hepatitis B virus in carrier patients who
									received TNF inhibitors, including Enbrel<sup>®</sup>, have been reported. The
									majority of these cases took place in patients who had simultaneously
									been receiving other medicinal products that suppress the immune system
									and could also promote the reactivation of hepatitis B virus. Before
									using Enbrel<sup>®</sup> in patients with a high risk of contracting hepatitis B,
									appropriate diagnostic screening should be conducted. Despite the fact
									that no connection with the use of Enbrel<sup>®</sup> has been proven, special care
									should be taken when using Enbrel<sup>®</sup> in patients who are carriers of
									hepatitis B virus. It is necessary to monitor the condition of patients
									for signs of hepatitis B. If symptoms of the disease appear, the
									possibility of specific therapy should be discussed.
								</p>

								<p>
									<em>Exacerbation of hepatitis C</em>
								</p>
								<p>
									Cases of the exacerbation of hepatitis C have been documented in
									patients receiving treatment with Enbrel<sup>®</sup>; however, no cause-and-effect
									relationship with the use of etanercept has been proven. Nevertheless,
									caution should be exercised when administering Enbrel<sup>®</sup> to patients with
									a history of hepatitis C.
								</p>
								<p>
									<em>Allergic reactions</em>
								</p>
								<p>
									The use of Enbrel<sup>®</sup> is frequently accompanied by allergic reactions.
									<u>In case of any severe allergic</u> or anaphylactic reactions,
									treatment with Enbrel<sup>®</sup> should be discontinued immediately, and
									appropriate treatment should be started.
								</p>
								<p>
									The protective cap of the injection pen contains latex (dry natural
									rubber). Patients or caregivers should consult their physician before
									taking Enbrel<sup>®</sup> when the needle protective cap is handled by or when
									Enbrel<sup>®</sup> is administered to a patient with known or possible latex
									sensitivity (allergy).
								</p>
								<p>
									<em>Immunosuppression</em>
								</p>
								<p>
									During treatment with TNF inhibitors, including Enbrel<sup>®</sup>, there is a
									possibility of suppressing the body’s defense mechanisms against
									infections and malignant neoplasms, since TNF is involved in
									inflammation processes and modulates cellular immune responses. However,
									in adult patients with rheumatoid arthritis, there was no evidence of
									depressed delayed-type hypersensitivity reactions, decreased
									immunoglobulin levels or changes in the effector cell population size
									during treatment with Enbrel<sup>®</sup>.
								</p>
								<p>
									In rare cases, children with juvenile idiopathic polyarthritis
									developed varicella infection and symptoms of aseptic meningitis, which
									resolved with no complications. Patients who have been in contact with
									varicella virus should temporarily discontinue Enbrel<sup>®</sup> and start
									prophylactic treatment with immune globulin to <em>
										Varicella
										Zoster
									</em>.
								</p>
								<p>
									The efficacy and safety of Enbrel<sup>®</sup> in patients with immunosuppression
									have not been studied.
								</p>
								<p>
									<em>Malignant and lymphoproliferative diseases</em>
								</p>
								<p>
									In the post-marketing period (see “Side effects” section), reports of
									various malignant neoplasms (including breast and lung carcinoma and
									lymphoma) were received.
								</p>
								<p>
									In a number of controlled clinical studies, lymphoma was diagnosed
									more frequently in patients taking TNF inhibitors compared to patients
									who did not receive them. However, these cases were rare, and the
									observation period for the patients in the placebo group was shorter
									than for the patients receiving treatment with TNF inhibitors. There are
									reports of the development of leukemia in patients undergoing treatment
									with TNF inhibitors. There is a high risk of lymphoma and leukemia
									developing in patients with rheumatoid arthritis – a long-term disease
									characterized by active inflammation, which in itself complicates risk
									evaluation. A subsequent analysis of the clinical studies of etanercept
									in patients with rheumatoid arthritis did not confirm or exclude an
								</p>

								<p>
									increase in the risk of developing cancers in patients who receive
									etanercept. However, based on current data, the possible risk of
									developing lymphomas, leukemia or other malignant neoplasms cannot be
									ruled out in patients receiving TNF inhibitors.
								</p>
								<p>
									Malignant neoplasms (in half of the cases, Hodgkin’s and
									non-Hodgkin’s lymphomas), some of which had lethal outcomes, were
									reported in children and adolescents who had received treatment with TNF
									inhibitors, including Enbrel<sup>®</sup>. The majority of patients received
									concomitant treatment with immunosuppressants. In other cases, there
									were various malignant neoplasms, including rare varieties, linked with
									immunosuppression. During the use of the medicinal product, it is
									necessary to consider the risk of developing malignant neoplasms.
								</p>

								<p>
									<em>Skin cancer</em>
								</p>

								<p>
									Melanoma and non-melanoma skin cancer (NMSC) were documented in
									patients who had received treatment with TNF inhibitors, including
									Enbrel<sup>®</sup>. NMSC is most frequently diagnosed in psoriasis patients. The
									development of Merkel cell carcinoma has been reported.
								</p>
								<p>
									For all patients at high risk, periodic skin examinations are
									recommended.
								</p>

								<p>
									<em>Formation of autoimmune antibodies</em>
								</p>

								<p>
									Treatment with Enbrel<sup>®</sup> may be accompanied by the formation of
									autoimmune antibodies (see “Side effects” section). These are not
									neutralizing antibodies and usually disappear shortly. No correlation
									has been observed between the formation of antibodies and the clinical
									efficacy of the medicinal product or the frequency of adverse
									reactions.
								</p>
								<p>
									Isolated cases of the formation of additional autoantibodies in
									conjunction with lupus-like syndrome or rash similar to a subacute form
									of lupus erythematosus or a discoid form of lupus erythematosus (data
									from clinical examination and biopsy) were observed in patients,
									including those with rheumatoid arthritis with a positive rheumatoid
									factor.
								</p>

								<p>
									<em>Hematological reactions</em>
								</p>

								<p>
									Rare cases of pancytopenia and very rare cases of aplastic anemia
									were reported, including lethal cases, in patients who had received
									Enbrel<sup>®</sup>. Caution should be exercised when using Enbrel<sup>®</sup> in patients with
									a history of blood disorders. All patients and their
									relatives/caregivers should be advised to seek medical attention
									immediately if a patient develops signs or symptoms typical of an
									infection or hematological disorders (for example, persistent fever,
									tonsillitis, bruises, bleeding, pallor) when taking Enbrel<sup>®</sup>. These
									patients should undergo examination immediately, including a complete
									blood count. If the diagnosis of a hematological disorder is confirmed,
									treatment with Enbrel<sup>®</sup> should be discontinued.
								</p>

								<p>
									<em>CNS disorders</em>
								</p>

								<p>
									There have been rare reports of demyelinating diseases of the CNS in
									patients receiving treatment with etanercept. There have also been very
									rare reports of peripheral demyelinating
								</p>

								<p>
									polyneuropathies (including Guillain-Barré syndrome). The studies of
									treatment with Enbrel<sup>®</sup> in patients with multiple sclerosis have not been
									conducted; however, studies of other TNF inhibitors in patients with
									this condition showed the possibility of its exacerbation. Before
									beginning the treatment with Enbrel<sup>®</sup>, a thorough evaluation of the
									risk-to-benefit ratio and a neurological assessment are recommended in
									patients with pre-existing or recent-onset demyelinating diseases as
									well as patients with a high risk of developing a demyelinating
									disease.
								</p>

								<p>
									<em>CHF</em>
								</p>

								<p>
									Caution should be exercised in prescribing Enbrel<sup>®</sup> for patients with
									CHF. Rare (&lt; 0.1%) cases of CHF were reported, including those in
									patients without a confirmed underlying cardiovascular disease. Some
									patients were under 50 years old. The data from a number of studies
									suggest the possibility of exacerbation of CHF in patients receiving
									Enbrel<sup>®</sup>.
								</p>

								<p>
									<em>Combination therapy</em>
								</p>

								<p>
									The combination of Enbrel<sup>®</sup> and methotrexate yielded no unexpected
									results in safety testing. The long-term study of this combination
									continues. Data on the safety of Enbrel<sup>®</sup> prescribed in combination with
									methotrexate were similar to those from reports on the use of either
									Enbrel<sup>®</sup> or methotrexate alone. The long-term safety of taking Enbrel<sup>®</sup> in
									combination with other disease- modifying anti-rheumatic drugs has not
									been studied.
								</p>
								<p>
									No studies on Enbrel<sup>®</sup> in combination with other systemic therapy or
									phototherapy for psoriasis have been conducted.
								</p>

								<p>
									<em>Wegener’s granulomatosis</em>
								</p>

								<p>
									The frequency of developing various types of malignant extracutaneous
									tumors was significantly higher in patients with Wegener’s
									granulomatosis who had received Enbrel<b>
										<sup>®</sup>
									</b> than in the
									control group.
								</p>
								<p>
									Therefore, Enbrel<b>
										<sup>®</sup>
									</b> is not recommended for the
									treatment of Wegener’s granulomatosis patients.
								</p>

								<p>
									<em>Alcoholic hepatitis</em>
								</p>

								<p>
									The administration of etanercept for the treatment of alcoholic
									hepatitis is not recommended.
								</p>

								<p>
									<em>Hypoglycemia in patients with diabetes mellitus</em>
								</p>

								<p>
									There have been reports of hypoglycemia during treatment with Enbrel<sup>®</sup>
									in patients taking hypoglycemic medications, requiring their dose
									adjustment.
								</p>

								<p>
									<em>Effect on the ability to drive and operate machinery</em>
								</p>

								<p>
									No studies on the effect of Enbrel<sup>®</sup> on the ability to drive motor
									vehicles and operate complex machinery have been conducted. Therefore,
									caution should be exercised when driving or operating machinery.
								</p>
							</div>
            </text>
          </section>
          <section>
            <title value="How supplied"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="How supplied"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>50 mg/mL solution for subcutaneous injection.</p>
								<ol type="1">
									<li>
										<p>
											0.5 mL (25 mg) or 1.0 mL (50 mg) of the medicinal product in
											colorless glass (type I) single- use syringes fitted with a
											stainless-steel needle covered with a two-layer cap, a plastic finger
											grip and a plunger rod with a rubber seal.
										</p>
										<p>
											Four syringes in a set with four individually wrapped alcohol wipes
											in a plastic package with a ventilation hole.
										</p>
										<p>
											One, two or six plastic packages (25 mg) or one, two or three plastic
											packages (50 mg) along with Instructions for Use in a carton with or
											without a tamper-evident seal.
										</p>
									</li>
									<li>
										<p>
											1.0 mL (50 mg) of the drug in a single-use injection pen with a
											white plastic needle cap and a purple protective screen. The syringe
											inside the pen is of colorless glass (type I) and is fitted with a
											stainless-steel needle.
										</p>
										<p>
											Four injection pens in a set with four individually wrapped alcohol
											wipes in a plastic package with an air vent. One plastic package with
											Instructions for Use in a carton with or without a tamper-evident
											seal.
										</p>
									</li>
								</ol>
							</div>
            </text>
          </section>
          <section>
            <title value="Storage conditions"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Storage conditions"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>
									Store between 2 °C and 8 °C. Do not freeze. 
								</p>
                <p>Keep out of reach of children!</p>
							</div>
            </text>
          </section>
        </section>
        <section>
          <title value="Shelf life"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Shelf life"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>Three years.</p>
							<p>Do not use after the expiry date indicated on the package!</p>
						</div>
          </text>
          <section>
            <title value="Dispensing conditions"/>
            <code>
              <coding>
                <system value="https://www.minzdrav.gov.ru/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Dispensing conditions"/>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
								<p>Dispensed by prescription.</p>
							</div>
            </text>
          </section>
        </section>
        <section>
          <title value="Manufacturer"/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Manufacturer"/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
							<p>Pfizer Manufacturing Belgium NV, Belgium</p>
							<p>Address: 12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium</p>
						</div>
          </text>
        </section>
        <section>
          <title value="Marketing Authorization Holder "/>
          <code>
            <coding>
              <system value="https://www.minzdrav.gov.ru/"/>
              <code value="100000155538"/>
            </coding>
            <text value="Marketing Authorization Holder "/>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p><b>Pfizer Inc, USA</b></p>
							<p>
								<b>Organization receiving consumer claims</b>
							</p>

							<p>Pfizer Innovations LLC</p>

							<p>123112, Moscow, Presnenskaya nab., d. 10,</p>
							<p>
								BTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C) 
							</p>
              <p>Phone: + 7 (495) 287-5000</p>
							<p>Fax: +7 (495) 287-5300/287-5067</p>
						</div>
          </text>
        </section>
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/etanercept50mg"/>
    <resource>
      <Ingredient>
        <id value="etanercept50mg"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_etanercept50mg"> </a><p><b>Generated Narrative: Ingredient</b><a name="etanercept50mg"> </a><a name="hcetanercept50mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;etanercept50mg&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/OP401G7OJC (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>ETANERCEPT <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#OP401G7OJC)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>50 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="OP401G7OJC"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072072"/>
            <display value="Active"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="OP401G7OJC"/>
                <display value="ETANERCEPT"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="50"/>
              <unit value="mg"/>
            </presentationQuantity>
            <basis>
              <coding>
                <system
                        value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
              </coding>
              <text value="active ingredient - basis of strength"/>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/ingredientARGININEHYDROCHLORIDE"/>
    <resource>
      <Ingredient>
        <id value="ingredientARGININEHYDROCHLORIDE"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientARGININEHYDROCHLORIDE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientARGININEHYDROCHLORIDE"> </a><a name="hcingredientARGININEHYDROCHLORIDE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredientARGININEHYDROCHLORIDE&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/F7LTH1E20Y (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>ARGININE HYDROCHLORIDE <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#F7LTH1E20Y)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="F7LTH1E20Y"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="F7LTH1E20Y"/>
                <display value="ARGININE HYDROCHLORIDE"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/ingredientSodiumChloride"/>
    <resource>
      <Ingredient>
        <id value="ingredientSodiumChloride"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientSodiumChloride"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientSodiumChloride"> </a><a name="hcingredientSodiumChloride"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredientSodiumChloride&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/451W47IQ8X (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Sodium Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#451W47IQ8X)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="451W47IQ8X"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="451W47IQ8X"/>
                <display value="Sodium Chloride"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/ingredientSucrose"/>
    <resource>
      <Ingredient>
        <id value="ingredientSucrose"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientSucrose"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientSucrose"> </a><a name="hcingredientSucrose"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredientSucrose&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/C151H8M554 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Sucrose <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#C151H8M554)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="C151H8M554"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="C151H8M554"/>
                <display value="Sucrose"/>
              </coding>
            </concept>
          </code>
          <strength>
            <basis>
              <coding>
                <system
                        value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/ingredientsodiumdihydrogenphosphatedihydrate"/>
    <resource>
      <Ingredient>
        <id value="ingredientsodiumdihydrogenphosphatedihydrate"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientsodiumdihydrogenphosphatedihydrate"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientsodiumdihydrogenphosphatedihydrate"> </a><a name="hcingredientsodiumdihydrogenphosphatedihydrate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredientsodiumdihydrogenphosphatedihydrate&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/5QWK665956 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>sodium dihydrogen phosphate dihydrate  <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#5QWK665956)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="5QWK665956"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="5QWK665956"/>
                <display value="sodium dihydrogen phosphate dihydrate "/>
              </coding>
            </concept>
          </code>
          <strength>
            <basis>
              <coding>
                <system
                        value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/ingredientWATERFORINJECTION"/>
    <resource>
      <Ingredient>
        <id value="ingredientWATERFORINJECTION"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientWATERFORINJECTION"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientWATERFORINJECTION"> </a><a name="hcingredientWATERFORINJECTION"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredientWATERFORINJECTION&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/059QF0KO0R (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Manufacturer</b></td></tr><tr><td style="display: none">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>WATER FOR INJECTION <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#059QF0KO0R)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="059QF0KO0R"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <allergenicIndicator value="false"/>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/orgpfizerbe"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="059QF0KO0R"/>
                <display value="WATER FOR INJECTION"/>
              </coding>
            </concept>
          </code>
          <strength>
            <basis>
              <coding>
                <system
                        value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="SubstanceDefinition/substancetanercept"/>
    <resource>
      <SubstanceDefinition>
        <id value="substancetanercept"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="SubstanceDefinition_substancetanercept"> </a><p><b>Generated Narrative: SubstanceDefinition</b><a name="substancetanercept"> </a><a name="hcsubstancetanercept"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource SubstanceDefinition &quot;substancetanercept&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/OP401G7OJC (use: official)</p><p><b>version</b>: 1</p><p><b>status</b>: Validated (UNII) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#1)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>Etanercept</td><td>Protein <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="OP401G7OJC"/>
        </identifier>
        <version value="1"/>
        <status>
          <coding>
            <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
            <code value="1"/>
            <display value="Validated (UNII)"/>
          </coding>
        </status>
        <manufacturer>
          <reference value="Organization/orgpfizerbe"/>
        </manufacturer>
        <name>
          <name value="Etanercept"/>
          <type>
            <coding>
              <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
              <code value="x"/>
              <display value="Protein"/>
            </coding>
          </type>
        </name>
      </SubstanceDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="ManufacturedItemDefinition/mid50mg"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="mid50mg"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid50mg"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid50mg"> </a><a name="hcmid50mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition &quot;mid50mg&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.minzdrav.gov.ru/</code>/99b900c6-4776-4cde-8125-4f6de8e98b98 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Solution for injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073863)</span></p><p><b>unitOfPresentation</b>: Syringe <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002150)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://www.minzdrav.gov.ru/"/>
          <value value="99b900c6-4776-4cde-8125-4f6de8e98b98"/>
        </identifier>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi/"/>
            <code value="100000073863"/>
            <display value="Solution for injection"/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002150"/>
            <display value="Syringe"/>
          </coding>
        </unitOfPresentation>
        <manufacturer>
          <reference value="Organization/orgpfizerbe"/>
        </manufacturer>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="AdministrableProductDefinition/ap50mg"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="ap50mg"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap50mg"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap50mg"> </a><a name="hcap50mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition &quot;ap50mg&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.who-umc.org/phpid</code>/identifier</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>administrableDoseForm</b>: Solution for injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073863)</span></p><p><b>unitOfPresentation</b>: Syringe <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002150)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Subcutaneous use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073633)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="https://www.who-umc.org/phpid"/>
          <value value="identifier"/>
        </identifier>
        <status value="active"/>
        <formOf>
          <reference value="MedicinalProductDefinition/mp50mg"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000073863"/>
            <display value="Solution for injection"/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002150"/>
            <display value="Syringe"/>
          </coding>
        </unitOfPresentation>
        <producedFrom>
          <reference value="ManufacturedItemDefinition/mid50mg"/>
        </producedFrom>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073633"/>
              <display value="Subcutaneous use"/>
            </coding>
          </code>
          <targetSpecies>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi"/>
                <code value="100000109093"/>
                <display value="Human"/>
              </coding>
            </code>
          </targetSpecies>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="RegulatedAuthorization/authorization50mg"/>
    <resource>
      <RegulatedAuthorization>
        <id value="authorization50mg"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorization50mg"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization50mg"> </a><a name="hcauthorization50mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;authorization50mg&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/6ae5b5d9-7372-494c-874b-7dc67d386d2e (use: official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>region</b>: Russia <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2023-08-16 00:00:00+0000</p><p><b>holder</b>: See on this page: Organization/orgpfizerusinc</p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e"/>
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/mp50mg"/>
        </subject>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000061"/>
            <display value="Marketing Authorisation"/>
          </coding>
        </type>
        <region>
          <coding>
            <system value="urn:iso:std:iso:3166"/>
            <code value="RU"/>
            <display value="Russia"/>
          </coding>
        </region>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2023-08-16T00:00:00Z"/>
        <holder>
          <reference value="Organization/orgpfizerusinc"/>
        </holder>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/orgpfizerusinc"/>
    <resource>
      <Organization>
        <id value="orgpfizerusinc"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_orgpfizerusinc"> </a><p><b>Generated Narrative: Organization</b><a name="orgpfizerusinc"> </a><a name="hcorgpfizerusinc"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;orgpfizerusinc&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/placeholder (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: Pfizer Innovations LLC</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>123112, Moscow, Presnenskaya nab., d. 10, BTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C)(work)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="placeholder"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000034"/>
            <display value="Marketing authorisation holder"/>
          </coding>
          <text value="Marketing authorisation holder"/>
        </type>
        <name value="Pfizer Innovations LLC"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text
                  value="123112, Moscow, Presnenskaya nab., d. 10, BTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C)"/>
            <line value="Presnenskaya Naberezhnaya"/>
            <city value="Moscow"/>
            <country value="RU"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/orgpfizerbe"/>
    <resource>
      <Organization>
        <id value="orgpfizerbe"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_orgpfizerbe"> </a><p><b>Generated Narrative: Organization</b><a name="orgpfizerbe"> </a><a name="hcorgpfizerbe"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;orgpfizerbe&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/placeholder (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: Pfizer Manufacturing Belgium NV, Belgium</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium(work)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="placeholder"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer"/>
          </coding>
          <text value="Manufacturer"/>
        </type>
        <name value="Pfizer Manufacturing Belgium NV, Belgium"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium"/>
            <line value="12 Rijksweg"/>
            <city value="Puurs-Sint-Amands"/>
            <country value="BE"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="PackagedProductDefinition/ppd50mgsyringe4"/>
    <resource>
      <PackagedProductDefinition>
        <id value="ppd50mgsyringe4"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd50mgsyringe4"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd50mgsyringe4"> </a><a name="hcppd50mgsyringe4"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition &quot;ppd50mgsyringe4&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab (use: official)</p><p><b>name</b>: Enbrel four syringe plastic package</p><p><b>type</b>: Biological Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155530)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2023-08-16 00:00:00+0000</p><p><b>containedItemQuantity</b>: 50 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></td><td>4</td><td>Plastic <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003208)</span></td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab"/>
        </identifier>
        <name value="Enbrel four syringe plastic package"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000155530"/>
            <display value="Biological Medicinal Product"/>
          </coding>
        </type>
        <packageFor>
          <reference value="MedicinalProductDefinition/mp50mg"/>
        </packageFor>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2023-08-16T00:00:00Z"/>
        <containedItemQuantity>
          <value value="50"/>
          <system value="http://unitsofmeasure.org"/>
          <code value="mg"/>
        </containedItemQuantity>
        <manufacturer>
          <reference value="Organization/orgpfizerbe"/>
        </manufacturer>
        <packaging>
          <identifier>
            <system value="https://spor.ema.europa.eu/pmswi"/>
            <value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
          </identifier>
          <type>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073498"/>
              <display value="Box"/>
            </coding>
          </type>
          <quantity value="4"/>
          <material>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="200000003208"/>
              <display value="Plastic"/>
            </coding>
          </material>
        </packaging>
      </PackagedProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="MedicinalProductDefinition/mp50mg"/>
    <resource>
      <MedicinalProductDefinition>
        <id value="mp50mg"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp50mg"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp50mg"> </a><a name="hcmp50mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition &quot;mp50mg&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://www.mhra.gov.uk/</code>/471bb15-7f52-4fcd-b615-8674ce6eb91e</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Enbrel (etanercept) 50 mg/ml solution for subcutaneous injection</p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>Russia <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></td><td>Russia <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></td><td>Russian <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#ru)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="http://www.mhra.gov.uk/"/>
          <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e"/>
        </identifier>
        <type>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-type"/>
            <code value="MedicinalProduct"/>
            <display value="Medicinal Product"/>
          </coding>
        </type>
        <domain>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-domain"/>
            <code value="Human"/>
            <display value="Human use"/>
          </coding>
        </domain>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="active"/>
          </coding>
        </status>
        <legalStatusOfSupply>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072084"/>
            <display
                     value="Medicinal product subject to medical prescription"/>
          </coding>
        </legalStatusOfSupply>
        <name>
          <productName
                       value="Enbrel (etanercept) 50 mg/ml solution for subcutaneous injection"/>
          <usage>
            <country>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="RU"/>
                <display value="Russia"/>
              </coding>
            </country>
            <jurisdiction>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="RU"/>
                <display value="Russia"/>
              </coding>
            </jurisdiction>
            <language>
              <coding>
                <system value="urn:ietf:bcp:47"/>
                <code value="ru"/>
                <display value="Russian"/>
              </coding>
            </language>
          </usage>
        </name>
      </MedicinalProductDefinition>
    </resource>
  </entry>
</Bundle>